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Abstract
Peripheral vascular disease (PVD) and/or peripheral arterial disease (PAD) are sicknesses known to
inadequate delivery of either arterial or venous blood towards the extremities. Such sickness may
trigger complications owing to the lack of transport of oxygen and nutrients, thus causing hypoxic
events that may eventually prompt to ischaemic tissue or even the loss of the compromised limb.
One of the most prominent indicators of prosperous health is blood volume and flow. The basic
information within these health parameters may show cardiovascular problems or the advance of
further complications related to other diseases like diabetes. In clinical setting, there effective methods
to measure these parameters like Doppler ultrasound, photoplethysmography or venous occlusion
plethysmography.
These methods take measurements from either single vessels and/or small volume of tissue.
However, it is difficult to establish a relation between the obstruction of arterial and/or venous
circulation and the amount of blood received by the tissue. Bioelectrical impedance plethysmography
(iPG) measures blood changes by driving a small amount of AC current into the body and after
measuring the potential created by fluids flowing through tissue. This technique apart from taking
measures within defined volumes of tissue, it is easy to use as only needs four electrodes on the skin.
Hence, a bespoken bioelectrical impedance device including hardware and software was built
ready to measure changes in blood volume/flow in the upper limbs. The system was assessed in
an in-vivo controlled environment with 8 participants. The blood flow towards their left arms was
altered by constricting the upper arm with a cuff at three levels: 1) below venous pressure 2) amongst
venous and arterial pressure and 3) during total occlusion. Simultaneously, measurements from
various instruments like ECG, Doppler ultrasound, laser Doppler flowmetry and PPG were taken and
compared to the measurements obtained from the iPG instrument and defining its correlation with the
impedimetric signal.
The results from the experiments showed that the bioelectrical impedance signal changed in basal
and arterial pulses showing specific characteristics for each kind of occlusion. The data indicated that
it is possible to differentiate between a venous and arterial occlusion by examining both components
of the impedance signal. The impedance during venous occlusion dropped in average 0.658±0.230 %
from the baseline. On the other hand, during arterial occlusion the base impedance dropped in a
higher rate approximately 1.13±04.82 %, indicating a differentiator during both type of blood flow
disruption. Furthermore, the impedance plethysmography waveform morphology also reshaped
during these occlusive periods. The whole waveform during artificial venous obstruction increased in
magnitude, the systolic peak rose 31.80 %, the dicrotic notch 47.73 % and the diastolic point 31.92 %,
where the value of the latter was higher than the dicrotic notch point. In contrast, in the time of partial
arterial occlusion the waveform also increased in size at all these points, but its shape was altered.
The impedance magnitude at the diastolic point went below the ones at the dicrotic notch. These
fluctuations provided additional further information that it might be possible to differentiate amongst
venous and arterial occlusions. By consolidating the data obtained by the iPG device, it is possible to
produce an index ratio between the basal impedance and these three reference points which may help
to identify early circulatory problems in the arterial and/or venous systems.
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Chapter 1
Introduction
Peripheral vascular disease (PVD) and/or peripheral arterial disease (PAD) [1] are illnesses
that affects blood vessels when these narrow, block or spasm. It could affect both either veins
or arteries, thus the two different names. This blood circulation disorder can be attributed to
hereditary factors or lifestyle choices; when combined with other risk factors such as diabetes
or smoking, the chances of contracting the disease increase drastically, making frequent
clinical visits for diagnostic tests imperative. An inadequate delivery of blood towards the
extremities may trigger complications owing to the lack of transport of oxygen and nutrients,
thus causing hypoxic events that may eventually lead to ischaemic tissue. If left untreated,
this illness may result in the loss of the compromised limb.
Blood volume and flow [2] is one of the most valuable indicators of good health not
only in extremities but in the general body. The underlying information within these health
parameters may indicate cardiovascular problems or the progress of further complications
pertaining to other diseases such as diabetes. Currently, there are methods that can measure
changes of blood flow or volume in the extremities. However, most of these techniques
estimate the instant flow or change of volume in a vessel or in a small volume of tissue. The
information provided by these instruments is valuable but it misses to judge good perfusion
towards vast amount of tissue, like in large muscles.
1.1 Methods for measuring blood flow and volume
Blood delivery towards a limb can be estimated by measuring either the change of blood
volume or flow rate. In the clinical setting, both parameters are widely-used aid methods to
examine critical problems in the periphery [3, 4]. In this regard, one of the most popular
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ways is instruments based on the Doppler technique. The instruments can be applied using
ultrasound [5] or optical [6] methods which, blood volume/flow can be estimated. One
of the disadvantages of the Doppler method is that necessitates specific skills to place the
sensor correctly, often leading to erroneous outcomes if the sensor is even slightly misplaced.
Moreover, it measures a single point only, focusing on an artery, vein or micro-circulation.
Devices involving optical techniques are widely available to measure changes of volume,
also known as plethysmography. Moreover, optical sensors can uncover useful information
about the absorption of oxygen in the deep tissue within an area of the body [7]. Qualitatively,
blood flow rate can be estimated when using light in the near-infrared spectrum (NIRS)
[8–11] or the speed of movement of red cells with Laser Doppler techniques [6, 12]. The
use of light is quite useful in home or low resource setting, although its penetration can
be quite superficial around the muscle tissue [13]. The lack of depth is one of the main
limitations of this method; furthermore, the volume of the tissue being monitored is quite
small or shallow [13]. Moreover, it is not feasible to accommodate large volumes or deep
tissue measurements. New approaches including NIRS and optical imaging techniques look
promising in the context of overcoming these drawbacks. Indeed, a system referred to as
Laser speckle contrast imaging (LSCI) is a suitable candidate to estimate blood circulation
to a more comprehensive area of tissue with an adequate representation on a screen [14].
However, the signal obtained is merely from the surface of the skin. Having a measurement
from over a large would reduce the need for multiple and accurate point measurements,
thereby obviating the need of a skilled user for such a diagnostic device.
Venous occlusion plethysmography (VOP) is another known method to assess circulatory
problems in the periphery. This technique is primarily used to examine issues in the venous
system by occluding on the upper section of the extremity. Performing this action blocks the
return of venous blood into the heart by increasing the volume of the limb. By measuring
and analysing this enlargement, it becomes possible to gather information about blood
flow and the health of the veins in that specific part of the body [15]. Thus, this method
requires two devices one that blocks veins like a pneumatic cuff, and an instrument to
measure plethysmography. The latter can be achieved by availing different technologies such
as the chambers of air/water or strain gauges. Nonetheless, using a chamber to measure
plethysmography in a home setting can be quite cumbersome. Positioning the arm in a tight
cylinder filled with air or water and using the other hand to accommodate other instruments
is incongruous with the principle of usability of a home device. Meanwhile strain gauges
could be another viable option, but some sensors are filled with mercury, which is highly
toxic. Some strain gauges can use another type of electrodes, but they are just confined to
2
1.1 Methods for measuring blood flow and volume
a small volume of tissue. Additionally, there are instances where a pressure cuff cannot be
used in a patient. For instance, people with a ulnar nerve compression [16] and superficial
phlebitis [17]. In such special cases, it is imperative to monitor changes of blood without
obstructing the normal blood flow towards the extremity.
1.1.1 Bioelectrical impedance plethysmography
Bioelectrical impedance denotes a technique that can perform plethysmography measurement
and also detects arterial pulses waveform. In entirety, this method is called bioelectrical
impedance plethysmography, or simply impedance plethysmography (iPG). It measures
the changes of blood volume by injecting a tiny amount of AC current into the body and
subsequently measuring the potential created by blood flow [18] as shown on figure 1.1. One
of the advantages of this technique is that it can measure a larger volume of tissue, as opposed
to a single vessel or superficial body part. A pair of electrodes is enough to drive current, with
another couple measuring the voltage drop in any part of the body. Using the measurement
of current and potential, it is possible to calculate the impedance of the segment of the body
contained within these electrodes. The table 1.1 provides a more descriptive information
about the type of measurements that the method can provide as well as advantages and
disadvantages.
The data sourced from bioelectrical impedance plethysmography is quite rich and in-
formative about circulatory problems. From this technology, different methods have been
developed to estimate plethysmography, blood flow and cardiac output. Some of these
methods may require the use of venous occlusion plethysmography or an analysis of the
arterial pulse waveform. Regardless of the technique, iPG has proven to be a useful tool to
investigate circulatory problems in the extremities [18–24]
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Figure 1.1 Bioelectrical impedance plethysmography measures changes in volume. The cylinder represents a
section of limb. Taking a measurement requires electrical current and manuring the potential through it.
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Table 1.1 Advantage and disadvantages of technologies or methods that measure blood volume or flow
Instrument/Technique Measure Advantage Disadvantage
Doppler Ultrasound
and Optical
• Blood velocity
• Instant blood flow estima-
tion
• Non-invasive
• Portable
• Low energy consumption
• Skilled operation
• Single vessel measurement
• Low depth penetration
Photoplethysmography
(PPG)
• Blood volume
• NIRS (blood flow esti-
mation)
• Non-invasive
• Easy to use
• High fidelity
• Small volume of tissue
measurement
• Localised measurement
Venous occlusion
plethysmography
• Changes of blood vol-
ume
• Blood flow estimation
• Non-invasive
• Requires multiple instru-
ments
• Cumbersome
• Skill operation
Bioelectrical
Impedance
• Blood volume
• Blood flow estimation
• Non-invasive
• Portable
• Low energy consumption
• Easy to use
• Measures large volumes of
tissue
• Signal close to noise floor
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1.1.2 The need of a method to assess arterial and venous problems
Measuring the amount of blood that flows into a known volume of tissue allows understanding
if this is being perfused properly [20–22]. If variations in the delivery of arterial or return of
venous blood were detected, it will be possible to minimise the time on assessing a patient
and recommend a treatment to follow. As can be seen in table 1.1 there are methods that are
used to detect changes in blood in specific vessels or concealed volumes of tissue. This kind
of measurements only provide information of arterial flow and/or microcirculatory changes.
However, there is not a single device technique that provides data to analyse the changes of
arterial or venous blood in a larger volume of tissue continuously.
Providing information on which circulatory path might be blocked will allow taking
preventive measurements when a population falls within recognised risk factors. Hence,
monitoring changes of either circulation continuously not only provides early diagnostic
but also detecting variations in tissue health might grant early pointers in the progress of a
circulatory illness. The combination of detecting disturbance on the circulation, indicating if
the problem is located in either arterial or venous path and the health of the perfused tissue
would be of vital importance accelerating the implementation of corrective actions before
any complication. For this reason, a system that continuously monitors and detects changes
of blood or volume would provide further actionable information in order to facilitate better
decisions for preventive treatments.
Bioelectrical impedance has been acknowledged to give information about the health of
tissue by correlating total impedance with the healthiness of tissue. Different experimental
settings demonstrated that changes in the basal impedance are related to perfusion of tissue. If
the tissue is not properly nourished with blood, its basal impedance tends to increase as there
are not enough ions to promote electric conduction. Additionally, bioelectrical impedance
also contains a waveform that is synchronous with arterial pulsations. This signal is known
to be related to the amount of blood being pumped through the volume of tissue being sensed.
Previous studies demonstrated a correlation between the impedimetric signal amplitude and
blood flow, indicating that bioelectrical impedance can quantify tissue perfusion. Moreover,
the analysis of the waveform morphology has been used in previous studies to analyse the
development of lymphedema in a female population.
Hitherto, most of the efforts have been centred in analysing the basal and arterial ampli-
tude impedance separately. In this project, a novel method to analyse the combination of
both signals is presented. For this, a bioelectrical impedance device was built to gather basal
and arterial pulses from an upper extremity. An experiment with healthy volunteers was
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performed where their arterial and venous circulation was limited evaluating the performance
of the method and compared with other instruments. A full analysis of the basal and are
trials pulses is presented, including algorithms that analyse the changes of signal morphology
characteristic of each kind of blood flow restriction. Finally, a ratio between basal and
amplitude pulses is presented showing that changes in the wave format are an indication of
possible arterial or venous blockage.
1.2 Motivation of the thesis and project aims
Bioelectrical impedance plethysmography has the potential to provide further information
about the general health of a large volume of tissue and blood circulation, something that
is beyond the scope of other methods. This technique has also been proven to be useful in
research and medical settings, particularly when measuring plethysmography and blood flow.
However, using this technology to quantify a relationship between poor circulation and the
health of the tissue remains an uncommon phenomenon. In principle, an instrument such
as this should be simple to use, safe for patients and likely portable for low resources area
use. In this dissertation, I am presenting a novel method to use a bioelectrical impedance
plethysmography device that has the potential to meet the conditions previously mentioned.
This enables this technique to be used in either home or any remote area where there is no
access to more than one instrument. The results derived from the experimental work not
only highlight a portable, non-invasive, effective and potentially cheap instrument but also
show the way forward to differentiate changes in arterial and venous circulation by analysing
waveforms.
The main aim of this project is to use the bioelectrical impedance plethysmography
waveforms to identify low perfusion in tissue caused by circulatory blockages. For this,
the basal impedance signal is used to pinpoint changes in blood circulating through a large
volume of tissue. Additionally, this study presents arterial pulses shape analysis which may
indicate blockages in either arterial or basal circulation. Combining the information from
these two signals provide a numeric quantification that indicates low perfusion or circulatory
impediment.
The other main aim is to design and implement a bioelectrical impedance device for
capturing the aforementioned waveforms within the forearm’s common impedance range.
The apparatus able to continuously monitor blood changes safely and straightforward which
may enable its use in low setting resources places or even at home.
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1.3 Novelty and contribution of the thesis
Although some instruments are focused on measuring either overall tissue impedance (includ-
ing blood), to assess perfusion levels [20–22] or only arterial pulses [23–28], the proposed
method, to the best of the author’s knowledge, is the first one that distinguishes whether low
perfusion in tissue is due to restriction of arterial or venous blood. This is achieved through
combining impedance measurements of basal values and arterial pulses. This thesis has been
structured to present both impedimetric signals. Chapter 5 analyses the basal impedance
of all the study participants. By isolating the basal readings during the measurements, the
errors produced by the instrument were analysed. The results obtained from here were used
as the denominator for the novel index shown in this work. Chapter 6 focuses on the study of
the arterial pulses, identifying three inflection points of the plethysmographic waveform to
determine alterations compared to baseline conditions. The method shows that an increase
in arterial peaks pulses are early indicators of possible arterial blood restriction, whereas
additional changes in the dicrotic notch and diastolic pulse amplitude impedance may be a
clue of possible circulatory blockage. Although arterial pulses amplitude has been previously
used to analyse haemodynamic factors on female population with lymphedema [29] or the
quantification of blood flow [23–28], the analysis of the full waveform morphology has not
been adopted before in studying alterations on arterial or venous circulation.
Further to the novelty of distinguishing between arterial and venous occlusions, the work
presented here is the first one to introduce an index that combines the basal and pulsing
measurements to give a numerical value that classifies the severity of occlusion. The section
6.3 described in full detail of how this index ratio is calculated.
Assessing the aforementioned novel aspects of this new method was only achievable
through the use of custom made instrumentation and electronics. Although basal limb
impedance has been used for studying tissue health and blood flow [23–28], in some instances,
this was previously carried out using commercial instrumentation that was originally designed
for other impedimetric applications (e.g. cardiothoracic impedance [30, 31]) rather than
through an application specific device, such as the one developed here, presented in Chapter
4.
1.4 Work done
In order to gather the signals required by the study, a bioelectrical impedance device, including
hardware, software and algorithms, has been developed as part of the work for this thesis.
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This device was needed as the instruments available in the laboratory were not able to take
readings continuously. More important, the devices at one’s fingertips were designed for
industrial applications but not for medical purposes. Therefore, this device was designed
with the aim of getting basal impedance and the arterial pulses contained within it in a human
arm.
Bioelectrical impedance is calculated as a ratio between alternating current (AC) driven
to a material and a the alternating voltage produce by it. Section 4.1 describes in more detail
how biolectrical impedance is computed and how this interfaces with tissue. As a brief
introduction, the instrument must provide a continues sinusoidal current which is driven into
the body by a pair of electrodes, a second pair of electrodes placed nearby measures the
potential caused by the interaction of the current and the tissue components. With this in
mind, the instrument was designed and manufactured as a modular system, where every PCB
board performs a specific task - for instance, wave generation, current injection and sensing.
The instrument while in operation uninterruptedly measures the two signals produced by the
instrument (current and voltage peak value) which are needed for further off-line processing.
A USB DAQ card and a custom software application developed in LabView [32] were used
to capture and display the waveforms emitted by the instrument. The application interface
also controls some parameters of the apparatus, such as frequency and trigger of the wave
generator. Another program developed in Matlab [33] post-process all the captured data.
In this application a custom graphic user interface was created to compare windowed data,
apply filters, obtain statistical data and detect peaks and valleys. Chapter 4 illustrates the full
instrument design including designs and algorithms used.
From the data analysis standpoint, different mathematical equations and algorithms were
applied in Matlab to convert the information recorded into meaningful clinical units like flow
rate. Chapter 7.2 shows the data quantification of the instruments used in the experiment. In
there, the Doppler ultrasound sources to arterial flow; the PPG signal the changes in volume
and the laser Doppler flowmetry the cell movement in the microcirculatory bed. Furthermore,
this chapter presents the correlational analysis of the tailor-made bioelectrical impedance
device and the other instrument, providing an understanding of the main contributors to the
impedimetric signal.
1.5 Organisation of the thesis
The thesis has been organised in different chapters covering clinical and technical background.
The chapter 2 will cover the origin of the plethysmographic signal and the clinical problems
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derived from not monitoring it on patients at risk. Later on, this chapter will elaborate on some
of the different instruments available to measure changes in blood flow and volume. Some of
the methods covered include Doppler ultrasound, optical techniques and plethysmography
covering bioelectrical impedance.
Meanwhile, chapter 3 will describe, in an in-depth manner, how bioelectrical impedance
works and the different techniques to measure it. It includes an explanation of the ionic
conduction in the human body, electrodes positioning, mathematical representations and the
methods to measure bioelectrical impedance including mono and multi-frequency. Finally,
the chapter will describe the principles and the kind of signals that can be obtained from a
bioelectrical impedance plethysmography device on the forearm, including basal impedance,
venous occlusion plethysmography and the arterial pulse amplitude.
Chapter 4 will explain the works performed towards the development of the bioelectrical
impedance plethysmography device and the experimental procedure to gather data from the
participant’s left arm. Some detail of the electrical characteristics of the bespoken impedance
device will be explained, including the frequency of operation and maximum current delivery,
but more details will be found in the Appendix sections. The experimental protocol will be
explained, including instruments placement and the different levels of pressure applied to the
cuff in the upper arm in order to alter the blood flow to the forearm. Finally, the algorithms
and mathematical formulas will be presented to show how to convert data to clinical units,
including the ones from the bioelectrical impedance method.
The following chapters elaborate on the analysis of the signals obtained. Chapters 5 will
analyse the basal impedance of all the participants. By isolating the basal readings during
the experiments, the errors produced by the instrument were analysed. Furthermore, the
effects of occlusion on the basal impedance during the three different kinds of occlusion -
below systolic pressure, in between systolic and diastolic and during total occlusion - were
also described. Chapter 6 will focus on the analysis of the waveform shape of the arterial
pulses during the experiment, including the changes occurring in three different points within
the plethysmographic waveform. The novel method denominated impedance index ratio is
introduced to identify possible circulatory obstruction in the arterial or venous path.
Meanwhile, chapters 7.2 will illustrate the data correlation between the additional instru-
ments and the designed bioelectrical impedance plethysmography (iPG) device. Here, the
signals from iPG at different levels of occlusion will be correlated with the arterial flow of
Doppler ultrasound, changes in amplitude pulses in PPG and the movement of red cells in
laser Doppler flowmetry.
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Finally, chapter 8 will comprise of a general conclusion and achievements of the per-
formance of the bioelectrical impedance plethysmography device, the merits of the novel
index ratio and how it correlates with the measurements from other instruments. Further-
more, additional work is proposed to investigate further into the morphological changes of
impedimetric arterial pulses under other physiological triggers.
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Principles of Plethysmography and
Plethysmographic Methods
Measuring the changes of blood in extremities provides the clinical community with valuable
information about the overall health of a patient. Estimating immediate changes of blood
volume within a limb offers insightful data on the wellness of "highways" that transport
oxygen and nutrient to these tissues via the vasculature. Some diseases are attributed to
problems in either the micro or macro vasculature. For instance, some of the disorders
may include cardiovascular disease, peripheral vascular disease, diabetes and Raynaud’s
syndrome. In the absence of adequate blood supply, these tissues are liable to become
ischaemic (isch in Greek means to stop or block, which emia implies blood flow). If severely
compromised, it can even lead to necrosis (death of tissue). In medicine, the clinician always
attempts to salvage tissue whenever is possible. Therefore, measuring the progression of
disease or acute problems with the vasculature (in the extremities) can help clinicians decide
on the optimal line of treatment, which may include a bypass graft or in extreme cases,
amputation.
This chapter presents the principles involved in the generation of a plethysmographic
signal. It also cover the methods available to measure changes of arterial blood or micro-
circulation.
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2.1 Origin of the plethysmography signal in the
circulatory system
The origin of the word plethysmography originates from two Greek words plethysmos which
means population and grapho which is the word for writing [34] and is an instrument used to
record changes of blood volume or blood flow during every heart cycle . From the circulatory
standpoint, a plethysmographic signal forms when blood cell pushes through the circulatory
systems generating a pulsating waveform synchronous with the heart’s cycle [35].
A plethysmography device produces an output waveform that is synchronous to the
heart cycle. The shape of the signal is similar to an arterial pressure waveform. In fact, the
plethysmography plot represents the volume of the arterial vasculature that related to the
amplitude of the arterial pulse. This waveform gives vital insights into the pulse velocity and
indications of possible circulatory obstruction.
The circulatory system divides in systematic or peripheral circulation and pulmonary
circulation. The human body entails a closed circulatory system where blood vessels are the
main paths to move blood. In this sense, the heart works as a pump transporting blood to
all the tissued around the body. The primary function of the circulatory system is to carry
oxygen and nutrients to every cell in the body. It also collects the final by-product of the
entire metabolic process. Blood flows through the vessels that form a complex, elastic tubular
network which reaches all cells of the body. The arteries are capable of carrying oxygenated
blood, whereas the veins return de-oxygenated blood [36].
Blood is transported from the arterial to venous circulation within the capillaries. Mean-
while plasma passes through capillaries that are only about a cell’s thickness in diameter.
Subsequently, an increase of blood pressure expels interstitial fluid out of the capillary
walls. In the end, some part of this fluid returns to the capillaries, with the rest flowing into
lymphatic vessels [37].
The amount of blood cells in tissue relates to the amount of blood flow and the dilation/-
contraction of the surrounding vessels. For blood to flow, there should be a differential in
pressure between arterial and venous pressure. Because the heart pumps blood in a rhythmic
way, the blood pressure changes accordingly. When blood comes out of the left ventricle
into the aorta, the highest blood pressure forms at this point with an of average 100 mmHg.
Then blood flows towards the large arteries where pressure varies between systolic pres-
sure commonly around 120 mmHg and diastolic pressure in roughly 80 mmHg. Figure 2.1
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shows in more detail the different pressures in different parts of the systemic and pulmonary
circulation.
As blood flows through the systemic system, the pressure in the arteriolar capillaries is
around 35 mmHg and 10 mmHg in the venous end. The average functional pressure of the
vascular bed is 17 mmHg, which is high enough to allow the exchange of nutrients between
tissue and blood. At the end of the systemic circulation in the inferior and superior venae
cavae, the pressure falls to nearly 0 mmHg where blood pours back in the right atrium of the
heart.
On the other hand, the pressures in the pulmonary circulation are lower in comparison.
The pulmonary artery systolic pressure is around 25 mmHg and diastolic pressures averages
about 8 mmHg. The pulmonary capillary pressure averages 7 mmHg which is adequate to
allow gas exchange in the lungs.
Figure 2.1 Common pressures in different parts of the systemic and pulmonary circulation of a person laying
in horizontal position. Figure adapted from [37].
The circulatory systems is quite complex to go more in deep but there are three basic
principles that describe the whole process and how is controlled [37]:
1. Blood flow is delivered according to the needs of the tissue. Depending of the level of
activity, tissue requires more nutrients to operate. Hence, a larger supply of blood is
required but heart alone cannot cope with the whole demand. For this, micro-vessels
reduce or increase the amount of blood into the tissue by changing its cross sectional
diameter. Controlled by the central nervous system these micro-vessels can contract
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and dilate according to the tissue needs, thus manipulating the amount of blood passing
by the surrounding fibres.
2. Total cardiac output is equivalent to the sum of all the local tissue flows. The total
blood coming in and out of tissue must be equal to zero. All the arterial blood pushed
into any tissue must return to the heart via the veins. Hence, the heart works as a dual
pump, pushing out arterial and collecting venous blood. As explained before, the heart
can react to the needs of blood in tissue by increasing its pumping frequency. This is
also controlled by special nerve signals that trigger the heart to pumps the required
amounts of blood.
3. Arterial pressure is regulated independently from either local blood flow control or
cardiac output control. The human body always tries to keep the arterial pressure to a
minimum value. For this, a complex network of special nerves operates to maintain
this arterial pressure to a level where red blood cells can be passed through tissue.
For example, if a trauma occurs and arterial pressure falls below 100 mmHg then
(a) the nervous system send signals to increase the heart’s pumping force (b) same
signals contract large venous reservoirs to send more blood back to the heart and (c)
the arterioles that transport blood into tissue contract increasing the amount of blood
contained in large arteries resulting in an increase of the arterial pressure.
Plethysmography in the circulation aims to measures the changes of volume of blood
caused by the increase of pressure against vessels walls in any part of the body. Due to the
heart’s pumping effect, blood components move through vessels which diameter increases
slightly in major arteries are veins. For instance, according to the elastic constant of the
aorta, when its inner pressure is 100 mmHg the diameter of the vessels distend about 5 %
[38]. Therefore, this additional diameter increments the total amount of blood cells during
the systolic peak.
A plethysmographic waveform forms by the effect of the blood being pushed all the way
the circulatory system. The forwarding-going pressure wave is transmitted all the way from
the heart’s left ventricle to the periphery creating the systolic peak. The diastolic waveform
forms from pressure waves being transmitted from the aorta to small arteries in the periphery
[39]. Regardless of the method, the plethysmography waveform seems to have similar shape
as described in figure 2.2, where systolic peak, dicrotic notch and diastolic peak can be
identified.
Figure 2.2 shows the comparative waveforms between flow measured with an ultrasound
instrument and the instrument produced by it in a upper limb. A normal blood flow waveform
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contains three different phases during a cardiac cycle. The systolic peak reference the point
after the ejection of blood from the heart. The reverse diastolic flow is an indicative of healthy
blood flowing trough a limb, any absence on these valley may indicate arterial problems
[40, 41]. Finally the forward diastolic flow peak completes the waveform. This change
of flow also traduces in a change in volume which is compared in the same figure. The
time that the pressure takes to travel from generates the systolic peak seen on the figure.
The dicrotic notch is generated when the aorta valve closes, this point in the waveform is
synchronous with the reverse diastolic flow. The diastiolic peak which is in phase with the
forward diastolic flow is caused by the recoil effect of the elastic wall in arteries that propel
slightly blood forward.
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Figure 2.2 Common triphasic flow waveform and volume change waveform. The most common peaks an
valleys are marked as systolic peak, dicrotic notch and diastolic peaks. Figure adapted from [40, 42].
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2.2 Problems derived from poor blood delivery
The plethysmography waveform indicates the amount of blood volume in any part of the
body which is key in the metabolic process. In the human body, blood requires different
paths to circulate blood which carries oxygenated and deoxygenated blood. Arteries transport
arterial blood (oxygenated blood) flowing from the heart through the lungs. Meanwhile,
veins are used to return venous blood (deoxygenated blood) into the heart and back to the
lungs [37].
More in detail, the blood in humans comprises of plasma and specialised cells. Approxi-
mately half of its volume is made up of plasma, which consists mostly of salt and water. In
fact, it is quite similar to seawater, albeit with a lower concentration of ions. Some other ions
present in significant numbers include sodium (Na), chloride (Cl−) and bicarbonate (HCO−3 ).
Additionally, traces of calcium, magnesium, copper, potassium and zinc are also found. The
remaining half volume includes red blood cells (erythrocytes) which transport oxygen (O2),
white blood cells (leukocytes or monocytes)that are in charge of the immunological response
and platelets (thrombocytes) which aid in the clotting process [37, 43].
The red blood cells are key to move around oxygen and nutrients. These cells contain
Haemoglobin (Hb) which gives the red colour to the blood, it has a high affinity to oxygen that
is an essential component in one’s metabolic process. Oxygen is required for the chemical
reactions that eventually convert biochemical energy created by nutrients coming from food
into cellular energy known as coenzyme or adenosine triphosphate (ATP). As a result of
these reactions, a waste product is released from the cell and collected by the blood. Part of
this byproduct includes carbon dioxide (CO2) collected by haemoglobin that also has a high
affinity to transport this molecule.
2.2.1 Ischaemia
It is clear that human cells cannot survive without oxygen and other nutrients for more
than a few minutes [44]. A restriction in the blood flow delivering any of these basic cell’s
fuels might have critical consequences to one’s well being. Ischaemia is one of the harmful
consequences of the insufficient supply of blood to tissue. This medical ailment develops
when one of the main vessels restrict the flow of red blood cells due to any sort of blockage,
all the tissues below that blocked path will suffer from the starvation of oxygen and other
critical nutrients. In general, ischaemia signifies a major cause of disability, cardiovascular
morbidity and mortality around the globe [45].
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Different causes could account for the blockage of an artery; these can include internal or
external factors. Section 2.3 describes more in depth some of the illnesses that may develop
ischaemia. For instance in limbs, peripheral arterial disease (PAD) could evolve into critical
limb ischaemia (CLI), whereby the patient could lose their limb in the absence of timely
medical intervention. The diagnosis of this type of diseases starts when symptoms start to
manifest, which for some cases could be already to late. One of the first manifestations is
that the patient experiences continuous pain at the extremity, even at rest [1].
2.2.2 Hypoxia
Hypoxia is one of the consequences of not delivering properly oxygenated blood to an organ.
As explain in the previous section, an occlusion of a main vessel may result on a reduction of
red blood cells volume, as a result this may lead to tissue hypoxia (reduced oxygen) or anoxia
(absence of oxygen). ischaemia always lead to hypoxia; but hypoxia can occur without
ischaemia. Marie et al. [46] have classified this illness in four different kinds depending on
its cause as shown in table 2.1.
Table 2.1 Hypoxia classification according to Marie et al. [46]
Disease Condition Causes
Anaemic
Hypoxia
Poor O2 delivery to tissue • Small count of RBCs and abnormal or inade-
quate Hb levels
Ischaemic
(stagnant)
hypoxia
Blood circulation is re-
duced or blocked
• Congestive heart failure that may cause body-
wide hypoxia
• Emboli or thrombi blocking oxygen supply to
the tissue distal from the occlusion.
Histotoxic
hypoxia
Metabolic poisoning (i.e.
ingestion of cyanide)
• The cell is unable to use O2 for metabolic
purposes, even though there is an appropriate
amount of O2 being delivered by the body
Hypoxemic
hypoxia
Decrease in the arterial
oxygen partial pressure
(PO2)
• Imbalance in the ventilation-perfusion cou-
pling mechanism
• Poor ventilation attributed to pulmonary dis-
ease and breathing air with a low O2 content.
• Carbon monoxide (CO) poisoning as it has
200 times more affinity with Hb than O2.
Thus, in scenarios that involve high concen-
trations of CO, such as fires, this could easily
lead to death.
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2.3 Diseases derived from poor blood delivery
There are different illnesses that may lead to the development of either ischaemic or hypoxic
tissue derived from internal or external causes. The study presented in this document focuses
on a method to detect either arterial or venous blockage caused by diseases affecting the
limbs. Hence, the following sections describe some of the most common disorders associated
with poor blood delivery towards the periphery of the body.
2.3.1 Peripheral vascular disease
Peripheral vascular disease (PVD), also known as peripheral arterial disease (PAD) is a
disease that causes the reduction of blood towards a limb. This illness is a progressive
vascular condition caused by the blockage, narrowing, or spasms in a blood vessel (arteries,
veins or lymphatic vessels), thereby, altering the blood circulation to and from upper or lower
extremities. It most commonly affects the lower limbs, particularly most distally, which
explains the derivation of its name as peripheral because it mostly affects the periphery of
a body. It affects 5 % of people over 50 and between 12 % to 20 % of people over 65 years
old. To some extent, it is more common in men than women. People with certain risk factors
are more likely to suffer PVD such as patients with diabetes or smokers, as some studies
have demonstrated [47–51]. Patients with diabetes are more likely to develop occlusion of
large arteries in the lower extremities that also could lead to gangrene and ulcers. In contrast,
smokers may present intermittent claudication, in other words, pain, cramp, numbness or
sense of muscle fatigue.
Different factors could cause the narrowing of the blood vessels. The most common cause
of PVD is atherosclerosis [36], which in short is the deposit of fatty material on the arterial
walls. Accumulation of cholesterol builds a plaque that that reduces the blood flow within
the vessels. This in turn, lessens the transport of O2 and nutrients as explained previously
in section 2.2. Moreover, this uneven deposit increases the chances of clots to form on the
artery walls reducing the internal size of the vessel and increasing the risk of obstructing a
major artery.
Different risk factors are contributing to the development of this illness. Some can be
inherited; others are based on lifestyle choices. The combination of two or more of the
following risks may exacerbate the complications from PVD, such as smoking and diabetes
[47, 48, 51]. To elaborate further, some of the documented risk factors are:
• Age (especially over 50)
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• Family history (high blood pressure, high cholesterol or PVD)
• Diabetes
• Smoking
• Obesity
• Infections
• Coronary artery disease
• Injury to vessels
• Physical inactivity
• High blood pressure
• Autoimmune diseases
• Nutritional deficiencies
• High blood cholesterol
• Emboli from other locations in the body
• Inflammation of the blood vessels
During the first stages of the illness, symptoms are unnoticeable, which makes the
condition difficult to diagnose. The most common presentation occurs when the illness has
progressed to the extent of causing pain. However, performing a qualitative assessment of
the extremity might help to diagnose the illness at earlier stages. This assessment makes
use of helpful indicators such as coldness of the extremity to touch, poor skin condition
(thinning, shining or brittle), poor nail health (thickening or opaque nails), hair loss in the
extremity, reduced pulse sensation (in the extremity), impotence, infections or injuries that
do not get healed properly, insufficient muscle condition (numbness, weakness or heaviness),
pain while walking and stopping at rest, local skin discolouration (pale, blue or dark red) and
restricted mobility [52, 53]. Table 2.2 describes one of the methods to damage caused by the
obstruction of a main vessel.
2.3.2 Compartment syndrome
All the muscles, blood vessels and nerves are contained within a tissue known as fascia. When
the pressure in a limb within this compartments increases owing to bleeding or swelling, it
could lead to total or partial restriction of micro-vascular blood flow [54]. Some cases may
present with rapid discolouration and blistering of the affected limb, which is commonly
associated with oedema, cyanosis and severe pain [55]. Hence, it can lead ultimately to
venous hypertension and loss of blood plasma. If the arterial flow is reduced, it may also
cause severe ailments such as gangrene, limb loss or even death [56]. This syndrome can
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be catalogued as acute when it is caused by an injury, accident or medical emergency and
chronic when it occurs gradually during any sports activity.
The most common method to diagnose this illness is Doppler sonography [55]. Neverthe-
less, detecting foot compartment syndrome could be challenging as opposed to other parts of
the body because its symptoms and indicators are less reliable [57].
2.3.3 Diabetic foot infection
Diabetes can develop into further health complications like the absence of blood supply
towards an extremity. Some of the most common problems that diabetic patients are required
to deal with are diabetic foot infection, which is a clinical syndrome characterised by local
findings of inflammation or purulence in a person suffering from diabetes. This disease also
leads to a decrease in peripheral circulation, vascular disease and loss of nerve sensation,
ending up in the formation chronic ischaemic ulcers and bacterial infection. Diabetes is
the leading cause of lower extremity amputation in developed countries, and is responsible
for 60 % of these amputations [58]. Currently, Doppler ultrasound flowmetry remains one
of the primary tools to diagnose the advance of diabetes foot infection. New techniques
that are aimed to follow up the progress of this illness have been researched, such as
bioelectrical impedance [59], planar pressure analysis [60], imagine technique analysis [54],
near infrared [61] and electronic noses [62]. Until now, no medical advancement has taken
place which allows the detection of this problem at an early stage before the occurrence of
ulceration. With regard to bioelectrical impedance technology used in this study, previous
studies have focused on the detection of ischaemia of the sole of the feet, signifying a good
correlation with laser Doppler flowmetry [59].
2.3.4 Upper extremity venous occlusion
Upper extremity venous occlusion, also known as Paget-von Schröetter Syndrome, upper
extremity deep vein thrombosis (DVT), axillo-subclavian vein thrombosis and effort throm-
bosis is a condition that primary affects mostly young people (below 40 years old) due to
practising repetitive tasks. Nonetheless, in the secondary type of the disease, it can develop
in the elderly population after medical procedures like the implant of cardiac pacemakers
[63]. This disease is caused by the narrowing, blocking or pinching of the vein coming from
the arm to the chest. People who perform heavy and repetitive tasks with their upper arms,
like swimmers or house painters, are at higher risk of contract this type of illness [64]. It has
been noticed that the exaggerated use of their arms thickens the upper muscles. As a result, it
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can squeeze the vein above the first rib that collects the blood coming from the arm causing a
reduction in the blood flowing towards the chest.
The obstruction of venous blood in the upper arm is normally acute. However, some of
the initial symptoms are discomfort, pain, swelling and reddish or bluish discolouration of
the arm. The treatment of this disease may require a surgical procedure to open the vein
segment and maintaining open using balloon angioplasty. Blood clots may also form as a
secondary effect of the disease, therefore it is common to prescribe anticoagulants to prevent
or dissolve any clots in acute cases and post-surgery [63, 64].
2.4 Clinical assessment of peripheral vascular diseases
The initial assessment of the diseases described in the previous section focuses on qualitative
inspection of the affected extremity. The medical practitioner inspects patients with this
method but in many cases, symptoms are already noticeable which may indicate some sort of
tissue damage. Although this technique seems to be effective to control the progression of
the ailment, it may miss early stages of the disease, at the right moment when it could be
treated more effectively. The development and evolution of these illnesses are quite complex
because it can be also asymptomatic, thus further tests might be required to confirm the
diagnosis.
Clinically, there are different methods to assess the development of the illnesses affected
by the low flow of blood. Some scales of qualitative evaluation have been developed,
such as the Rutherford classification, the Leriche-Fontaine classification, and the TACS II
classification of femoral and popliteal lesions [52, 65]. Following any of these procedures,
health practitioners perform a visual inspection and a survey, which aims to reveal any
indication of pain when walking as well as discoloration and skin wounds. This makes it
possible to determine the severity of the damage derived from an arterial occlusion.
Table 2.2 illustrates the Leriche-Fountaine classification which is one of the methods
commonly used by the clinical personnel. This classification considers 5 stages to evaluate
the progression of the illness. As shown by this table, there are various levels of stratifying
the severity of this disease in accordance with the symptoms and pathophysiology which can
vary from asymptomatic stages up to the development of necrotic tissue.
Upon a qualitative or physical examination, and the classification of the illness’s progres-
sion, additional tests may help in ascertaining the severity of the arterial occlusion. In some
cases, sophisticated medical equipment may be needed to fully complement the diagnosis of
the patient, which some of these are described in the next section. Nevertheless, additional
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Table 2.2 Leriche-Fontaine classification
Stages Symptoms Pathophysiology Pathophysiological
classification
Stage I Asymptomatic or
effort pain
Relative hypoxia Silent Arteriopathy
Stage II A Effort pain
Pain free walking
distance > 200 m
Relative hypoxia Stabilized Arteriopathy
Non-Invalidant claudication
Stage III A Rest Pain
Ankle arterial
pressure > 50 mmHg
Cutaneous hypoxia
Tissue acidosis
Ischemic neuritis
Instable arteriopathy
Invalidant claudication
Stage III B Rest pain
Ankle arterial
pressure < 50 mmHg
Cutaneous hypoxia
Tissue acidosis
Ischemic neuritis
Instable arteriopathy
Invalidant claudication
Stage IV Trophic lesions
Necrosis or Gangrene
Cutaneous hypoxia
Tissue acidosis
Necrosis
Evolutive arteriopathy
medical procedures have come into place where clinical practitioners use common medical
devices to try to indicate the location of the blockage. The following shows some of the
therapeutic methods that do not require bulky or cumbersome devices in a clinical setting.
• Ankle-brachial index (ABI): This is the ratio of the differential measurement of
systolic blood pressure measured at the ankle to the measurement undertaken at the
brachial artery [66]. This necessitates a comparison in blood pressure between the arm
and the ankle, as well as recording the ankle’s blood flow using a Doppler ultrasound
instrument.
• Treadmill exercise test: Under this method, the patient needs to walk or run in order
to monitor the circulation during exercise. Pain or problems experienced during the
test are recorded to examine the severity of the obstruction.
• Reactive hyperaemia test: This test refers to a temporary increase (hyper) of blood
flow (emia) of the extremity. It is usually performed on people who are not able
to walk on a treadmill. In this case, the person remains in a supine position after
which, comparative measurements of blood flow are taken using a Doppler ultrasound
instrument on the thighs and ankles. Subsequently, an occlusion is applied on the limb
to compare any decrease in the flow rate between both the sites.
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2.5 Methods to measure blood flow and volume
It is clear that complementing qualitative with a quantitative method would provide further
physiological data which increases the chances of detecting any circulatory problem at
an early stage of the disease. Blood flow obstructions in the limbs can be quite complex
to diagnose as may affect different parts of the circulatory path. As described in this
document, some of these illnesses affect the arterial circulation, venous return or even the
microcirculation. Different technologies have been developed aiming to identify circulatory
issues in localised areas of the body. However, currently, to have the whole picture of the
development of circulatory diseases affecting tissue in the limbs require to combine one or
more technologies, which makes it less efficient and requires extra training for clinicians.
Nowadays the measurement of blood volume or flow can be performed with non-invasive
techniques. There are different kind of portable technologies that can be used in medical
devices as a single source of information or combined with other methods to get a proper
clinical diagnosis. Moreover, there are several variations of a single technique in order to
assess the blood volume or flow. For instance, Doppler technique can be implemented using
either light or sound waves. It also can be used as a continued monitor or diagnostics image
technique.
The following list of equipment describes the methods or instruments that can measure
blood volume or flow in an extremity. It must be taken into consideration that devices that
measure blood volume measure changes of blood in defined volumes of tissue, whereas blood
flow is usually restricted to single blood vessel measurement. However, this list is confined
to devices that are portable, and need minimum assistance from a specialist. Diagnostic
imaging techniques do impart high accuracy, but they are confined to a clinical setting.
2.5.1 Doppler ultrasound
The widely used ultrasound method can be applied on different fields such as diagnostic
imaging, localising tissues and the most common blood flow measurement at a single vessel.
Currently, it is commonly used in medical practice when measuring the blood flow in different
part of the body, such as in the brachial or femoral arteries [67] as shown in figure 2.3.
From the technical viewpoint, this method derives from the Doppler effect principle,
which describes the relationship between the frequency of a source and its velocity relative
to its source [69]. This method operates on any wavelength above the ultrasound spectrum
(above 20 kHz). Conventional equipment operates in the range of 2 MHz to 15 MHz [70].
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Figure 2.3 Doppler ultrasound instrument used measuring blood flow in femoral artery [68]
The principle behind this technique in terms of medical use was the propagation of
ultrasound waves through the tissue. The Doppler method measures the velocity of particles in
a liquid solution using the frequency shift of backscattered ultrasound [5, 36]. In other words,
if an electromagnetic wave is transmitted at a fixed frequency and is reflected by a moving
body, the frequency of the received signal will be shifted (see Figure 2.4) [67, 70, 69, 71].
A device using this principle can detect moving blood cells within a vessel. When an
erythrocyte passes through a vessel under the electromagnetic beam, a frequency shift occurs,
which is proportional to the blood flow velocity [72].
Figure 2.4 Representation of the Doppler technique measuring blood flow. The cylinder represents the vessel;
the red dots are the RBCs. The Ft and Fr are the frequencies of transmission and reception of the sensor. The
phase shift between both signals change according to the movement of the particles.
Estimating blood flow based on this principle requires the measurement of arterial
diameter and the blood velocity. Using these parameters, it becomes possible to calculate the
blood flow by multiplying the blood’s mean velocity (cms−1) by the cross-sectional area of
the artery in cm2, before multiplying it by 60 seconds to express the value in millilitres per
minute (mlmin−1) [67].
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Some of its advantages include non-invasiveness, the ability to measure velocity con-
tinuously, portability (and hand-held), and less energy consumption, which makes it an
excellent choice for low clinical setting use. However, this method is not without its share of
disadvantages. First, the operator requires some skill to be able to locate the artery accurately.
Some instruments provide a sound feedback pertaining to the flow velocity of the artery.
However, there are different levels of sound or pitch in order to identify the right vessel
correctly. Second, it is recommended to use a low insonation angles (∼ 60°) for limiting the
number of errors [73] which also require steady hands from the operator. Third, it is effective
when the limb and the artery remain in a fixed position; it is quite sensitive to motion. Lastly,
as mentioned previously, it requires measuring the arterial diameter to convert velocity into
flow, which marks a significant disadvantage because the only way to measure this parameter
accurately is by making use of imaging methods [74] but this could be quite an ardours task
in a home setting.
2.5.2 Optical methods measuring blood volume and flow
Light is one of the most common electromagnetic energies applied on the field of medicine.
Using optical methods makes it possible to estimate blood flow by measuring volume changes
or by applying complex imaging techniques. One of the key features of this method is its
mostly non-invasive or inclusive contact-less for some applications. Furthermore, optical
imaging techniques are advantageous in that they offer a high resolution; they are also cost
effective when compared to magnetic resonance imagining (MRI) or positron emission
tomography (PET), apart from being a non-ionising source [70].
It is one of the most popular methods to monitor continuously volume changes using
the principle of optical absorption of the arterial blood. In principle, it requires a coherent
light source provided by a laser/light emitting diode (LED) set to a specific wavelength in
accordance to the application. The light propagates due to the transport of individual photons,
which under the area of influence, may be absorbed or scattered [75].
This method is so popular that it is used in mostly every clinical setting as well as
for personal use. The latter has become extensively available owing to the use of activity
monitors that utilise optical methods, such as one employed in the Apple Watch [76]. This
makes it clear that this method can be applied to home settings owing to its versatility and
portability. The following application describes the methods to estimate the rate of flow.
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2.5.2.1 Photoplesthymography
Photoplethysmography or PPG measures change of blood volume using light as the emitting
source. Nowadays, it is one of the most popular methods in the parlance of medical applica-
tions. It is non-invasive and can accommodate a wide range of light wavelengths to obtain a
plethysmography graph. It is widely used for the purpose of monitoring heart rate, oxygen
saturation, peripheral arterial pressure and peripheral microcirculation after skin grafting,
drug ingestion, burns or revascularization [7].
There are two different techniques to obtain the readings. One is transmission-mode
(see figure 2.5a.) which works by placing the tissue of interest (i.e. finger, toe or ear lobe)
between the light emitting diode (LED) and the photoreceptor (PD). The other is in the
PPG reflectance-mode (see figure 2.5b) by placing the LED next to the photoelectric cell
over the surface of the tissue. PPG leverages the AC component of the signal for arterial
pulse detection and the DC component for venous evaluation [77]. It also uses different
kinds of wavelengths to avoid interference from external sources of light. The underlying
principle behind PPG detects the degree of attenuation of backscatter light from the superficial
layers of skin about 1.5 mm to 2 mm [7, 13, 78]. The amount of reflected light varies in
accordance with the total number of RBC’s in the cutaneous micro-circulation, which alters
the wavelength during each cardiac cycle. This method provides valuable insights based
on the waveform analysis into the initial diagnostics of peripheral arterial disease (PAD)
[79–81] and chronic peripheral venous insufficiency (CVI) [82, 83].
One of the biggest disadvantages of PPG is that it only measures a small volume of tissue
at a given point in time. Therefore, it is not possible to get a spatial distribution of the blood
volume change over a significant portion of the skin [84]. Additionally, skin pigmentation
has proven to be a factor of error and nail polish [85]. Also, light scattering in tissue makes it
impossible to estimate its complete penetration in the skin. Therefore, it is not possible to
calculate the volume of tissue being measured.
(a) Placement of LED and photodetector in trans-
mission mode
(b) Placement of LED and photodetector in re-
flectance mode
Figure 2.5 PPG light emitter placement and receptor according to the mode, transmission and reflectance
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2.5.2.2 Laser Doppler Flowmetry
LDF refers to a non-invasive optical method to estimate the blood perfusion within the
microcirculatory bed under the skin. This device uses the same Doppler principle described
in section 2.5.1. However, as the name suggests, it uses a beam of light as the electromagnetic
source. It requires a laser diode emitting a wavelength commonly between 633 nm (red) and
780 nm (near-infrared) with an intensity of close to 1 mW [6]. A flexible fibre optic delivers
and detects the light applied to a roughly 1 mm3 of tissue. Subsequently, the light scatters
by tissue as well as the moving blood cells. Scattering by way of a moving blood cell with
haemoglobin produces a frequency shift, whereas scattering from stationary tissue yields the
opposite results. The velocity of the red blood cell passing through the beam is equivalent to
the frequency shift.
An analysis of the backscattered light provides crucial information on blood cell velocity
given by the frequency of Doppler shift [6, 12], and the fraction of the backscattered light
that is Doppler shifted is proportional to the total volume of moving blood cells concentrated
within the tissue [12]. As a result, an index of red blood cells flow is calculated from the
product of mean Doppler shift and the fraction of light that is Doppler shifted [12]. This
blood perfusion index is also called flux. Figure 2.6 overviews the laser doppler flowmetry
theory, whereas additional details behind this principal are illustrated described in the works
of Fredriksson et al. [6].
Some instruments can monitor blood flow in absolute blood flow units. However, some
doubts persist about this quantification because the value is premised on an empirical calibra-
tion correlated to other methods [86]. Another drawback is that the measurement is quite
superficial; the penetration of the wavelength used by LDF is quite shallow. For instance,
light in the wavelength of 840 nm only penetrates up to 2.5 mm [13], with the total volume
of tissue being studies being quite small - at about 0.1 mm3 or less [14]. Therefore, location
remains a key component in the context of obtaining a proper measurement as an area with a
good amount of capillaries equals to a greater blood flow distribution around the surface of
the skin. Thus, more blood particles can be detected without having to go deeper into the
tissue.
This method can be used within a home setting as well; it is portable, easy to locate
and battery operated. Nonetheless, it does suffer from some shortcomings. Firstly, the
measurement is affected by temperature in that it is recommended to have a stable room
temperature. Secondly, it is vulnerable to motion artefact, and the probe must be attached
firmly [6].
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Figure 2.6 The electromagnetic wave is emitted by light EL(t), the interaction with a red blood tissue produce
backscatter light βL. The photodetector detects the light and process the frequencies of the backscattered light
that produces a power spectral density P(ω) that allows to estimate the concentration of moving blood cells
(CMBC) and the perfusion index (Perf ). This image has been copied from [6] to explain the theory behind LDF
2.5.2.3 Laser speckle contrast imaging (LSCI)
The Laser speckle laser is a fairly new technique that is still being studied. Some medical
applications under this method have measured cerebral blood flow [87], microcirculatory
research [88], dentistry [89] and wound assessment [90] to name a few. This method can
be catalogued as an imaging technique because it requires processing of images in order to
obtain a coherent result.
The set-up of a LSCI instrument is a fairly simple process, but the processing behind it can
be quite complicated. Figure 2.7 illustrates a common experimental procedure. A coherent
(laser) light beam illuminates a sample recorded by a CCD (Charge Coupled Device) camera.
A custom software captures the speckle pattern, which is then processed by a computer
and displayed as an image [70, 91, 92]. The software controls the camera’s exposure time,
amount of pixels, local contrast area as well as the option of colours to code the contrast.
Speckle images are generated by the interference pattern produced by the laser beam
scattered on a rough surface, which is a random intensity distribution pattern created by the
random refractive index fluctuations of the sample. This speckle pattern can only be explained
by statistics [93]. As is the case with LDF, stationary tissue produces a constant intensity
contrast; however, scattering from moving particles like blood cells produce fluctuations in
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Figure 2.7 A LSCI device requires a laser illuminating a surface, a CCD camera and a computer for the
statistical analysis of the images. Image retrieved from [91]
the intensity of the speckle pattern [91]. These fluctuations end up reducing the local speckle
contrast; hence the contrast value is inversely proportional to the blood flow speed.
LCSI can be used within a home setting. Some of the advantages of the device are as
follows: it is portable and can probably be battery operated if a mobile device replaces the
computer. No exogenous material is required to produce a high spatial-temporal resolution
image [92], thus making it completely non-invasive. The image generated is easy to decipher
even for non-experts.
A technical improvement with Doppler techniques is that area is confined to the focal
distance of the camera, whereas Doppler targets a single point measurement. However, there
are some disadvantages of this method. For instance, the image is merely a representation of
the surface vasculature; it is not possible to monitor the blood flow of large vessels. Although
studies are being performed in order to quantify regional blood flow, this method continues
to be a qualitative method until the statistics behind it are better-understood [92].
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2.5.3 Additional methods to measure limb plethysmography and blood
flow
The methods described in the previous section can measure either blood flow in a single
vessel like in Doppler ultrasound (see section 2.5.1), single-cell velocity or plethysmography
over the skin with optical methods (see section 2.5.2.1). Nevertheless, these techniques
cannot provide perfusion details of a large volume of tissue, like in the whole forearm.
If one wants to measure the changes of blood volume in substantial sections of the body,
other techniques are required to assess the blood coming in and out from the limb. Hence,
different approaches have been developed to diagnose vascular problems in the extremities.
Venous occlusion plethysmography (VOP) is one of the methods accepted by the clinical
community. This technique has been around for more than 100 years, providing valuable
insights into the behaviour and extent of the vascular endothelium in health and disease [94].
It requires the measurement of plethysmography to evaluate the patient’s vascular response.
Additionally, the blood flow rate could be derived from the change of volume of the limb
when used in conjunction with other instruments.
The principle behind VOP is that a pneumatic cuff is inflated around the upper arm or
thigh below diastolic pressure, commonly about 40 mmHg to 50 mmHg. Thus, the arterial
inflow continues toward the limb even as the venous outflow is blocked [67, 94]. As a
result, the blood pooling effect swells the limb and raises its volume. The blood flow rate is
calculated as linear hikes of the limb’s volume over time, which is believed to be proportional
to the rate of arterial inflow [67, 95]. Plethysmographic methods then measure the increase
of volume in the limb. In a clinical setting, there are different techniques available to take
this measurement. The following section describes some of the methods available, including
pros and cons.
2.5.3.1 Air/Water plethysmography
Air/water plethysmography is not a common method to measure a limb’s change of volume.
This method has more relevance in the research environment than in clinical setting. Accord-
ing to Chuah et al. [42], it measures plethysmography without the need of venous occlusion.
This approach encloses the limb in a special chamber with transducers and calibration devices
connected through orifices. The arm is introduced into the case using a tight rubber sleeve
to ensure that the instrument is airtight. The plethysmography pulsations are detected by
measuring the displacement of the surrounding air/water with a sensor connected to the
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chamber; this also moves the rubber diaphragm whereby a Doppler ultrasound transducer
measures the extent of displacement.
Figure 2.8 Representation of an air plethysmography device. It requires a one-side open cylinder with a rubber
sleeve. There is a compartment where the air displacement caused by each cardiac cycle can be measured.
Image reproduced from [42]
This method can provide reasonably accurate results, but motion artefact may cause
ripples movement affecting the final reading. Furthermore, this method could be burdensome
in a low resource setting, or even for surgical applications. It also requires an extra participant
to aid with the arm positioning in the chamber and performing the adequate calibration.
Also, the portability of this method is quite questionable as it requires many parts to work
simultaneously.
2.5.3.2 Strain gauge plethysmography
This method also known as SGP (strain gauge plethysmography), and is a non-invasive
method to quantify retrograde outflow in the deep venous system and peripheral arterial
disease [7]. It works by applying a strain gauge around the limb being studied. The transducer
could be a tube filled in with a conductive material, such as mercury and gallium connected
to a source of electricity.
However, alternative methods that do not use clinically banned mercury have been de-
veloped using electrical conductive fluids [96]. When the gauge experiences variations of
circumference triggered by a change in volume of the rib cage or the pulse in a limb, the resis-
tance of the sensor varies accordingly, thus obtaining an electrical waveform. Increasing the
sensitivity for venous filling measurements requires occlusion cuffs, as shown in Figure 2.9.
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This method does not provide reliable quantitative data for venous occlusion, although it
does offer qualitative data for the function of the extremity in venous insufficiency [7].
Figure 2.9 Image of a strain gauge plethysmography device [97]. The sensor is attached around the limb under
test.
This method presents some advantages when used within a home or low resources setting.
First, it is portable since only a single point of measurement is required. Second, it is
non-invasive, and requires minimal skills. However, one latent problem is the use of mercury
on some sensors; it is a poisonous metal and is not recommended to be used at home. New
electrodes can be used [96] instead. Moreover, the instrument merely measures changes of
volume in a confined circumference around the sensor. In other words, it does sense changes
around a large volume of tissue.
2.5.3.3 Bioelectrical Impedance plethysmography
Bioelectrical impedance plethysmography is yet another method that measures changes in
blood volume in different parts of the body, such as the thoracic cavity or limbs [18]. In
principle, it senses small changes of bioelectrical impedance due to the increase of blood
cells in a volume of tissue. For instance, when the heart’s systole increases the blood flow, the
volume of a limb rises in accordance with the inflow of blood (swelling) [98]. Consequently,
the changes of impedance are correlated to the small variation of volume and flow in a limb.
Some medical applications might necessity the use of pneumatic cuffs in order to analyse
venous filling. There are several medical applications for this kind of technique, such as
heart stroke volume (SV) measurement, cardiac output (CO), thoracic respiratory volume,
oedema and the detection of deep vein thrombosis (DVT) [7]. Studies carried out by
Mohapatra [20] and Schraibman [99] revealed a significant linear relationship between
bioelectrical impedance plethysmography and strain gauge.
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In chapter 3 the principles of operation of this technology are described in greater detail.
In summation, this method requires the application of a small amount of current into the body
at a specific frequency and amplitude, usually between 1 kHz to 500 kHz [100] and bellow
5 mA. The body’s bioelectrical impedance is a relation between the electrical potential and
the electrical current applied. Commonly, a set of four electrodes is placed atop the surface
of the skin where a pair converts the electrical conductivity into ionic conductivity to sense
the voltage drop. An increase in the amount of blood within a section of body drops its total
impedance. Therefore, there is a direct correlation between the population of red blood cells
and the measurement of impedance [101].
The blood flow rate can be estimated from the impedance plethysmography signal.
Indeed, impedance maybe regarded as a measurement of both volume and flow; a change
of volume must be attributed to a flow [98]. Some studies incorporate venous occlusion
plethysmography as a method to estimate the flow rate [20–22], whereas other techniques
focus on the analysis of the plethysmographic signal without integrating occlusion [23–26].
Nyboer et al. [102] proposed the reigning equation (see equation 4.22) from which,
the blood flow is estimated. The author opined that the the blood flow is proportional to
the change of impedance in relation to the distance between the potential electrodes and
basal impedance of the tissue. The section 3.8 describes the equation required to convert
impedance into the blood flow in greater detail.
Calculating blood flow from the impedance signal is applicable in home or low resources
settings as well. Being non-invasive, it only requires four electrodes for measurement,
which is one of its main advantages. Additionally, the device uses low-energy in that the
current required to read impedance is below 5 mA which can be obtained from a battery
operated instrument. Furthermore, the tissue’s volume being monitored is more substantial as
compared to other techniques, given that the boundary of this measurement is limited by the
position of potential electrodes. In fact, the body measurements can be attained as described
in free-fat measurements undertaken by Kyle et al. [100].
IPG is less affected by temperature [18]; furthermore, it provides more data than sin-
gle point measurements to better assess venous blood volume and arterial pulsations [18].
However, this technique does have some shortcomings as well. Like all the methods, it is
also sensitive to motion. Secondly, electric current is required for undertaking a measure-
ment, which makes is unsuitable for a certain category of population. Finally, there is an
electrode-skin impedance error in the absence of a full contact.
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2.5.4 Comparison of the different methods
The previous sections described the general merits and shortcomings of the multiple methods
available to measure changes in blood volume or flow. These are just a list of the most
common methods in a clinical or research environment.
In general, optical methods provide relevant information about haemodynamics of the
vasculature in the body. In fact, PPG is a common method to measure blood oxygenation in
the clinical setting present in practically every monitoring device. New technologies based in
optics methods are being developed which may allow in the future blood flow quantification,
tissue perfusion (i.e. NIRS) and vasculature imaging (LSCI).
However, the most common drawback of the optical methods is the low penetration of
the light in the body. This issue presents significant challenges as it is not possible to monitor
deep tissue and main vessels blood flow. Another common issue is the uncertainty of the
volume of tissue monitored, although surface perfusion may provide details of blood in the
vasculature, it cannot provide too much detail of the perfusion of large volumes of muscle
tissue.
On the other hand, measuring plethysmography in cylindrical volumes of tissue around
limbs present valuable physiological data. It provides details about the total volume of arterial
and venous blood coming in and out of an extremity. However, it lacks the level of detail
provided on single vessel measurement and superficial vasculatures like those described in
section 2.5.1 and 2.5.2. One of the advantages of combining VOP with any of the methods
described previously is that it allows estimating blood flow by occluding the upper section
of the arm. It also provides an overview of the general health of the vasculature in a greater
volume of tissue. Nevertheless, not all patients can have their upper arm obstructed; for this
reason, it is recommended to seek ways to monitor venous blood changes without a cuff.
Bioelectrical impedance plethysmography seems to provide an even more in-depth
analysis of the tissue compared to the other plethysmography methods since electrical current
propagates through all tissue. Hence, it can provide details about the general health of tissue
as well as the arterial flow coming into the limb. The capability of having two sources of
information may provide double validation of any prognosis. In the following chapter section
3.8, more details about the principle and origin of the impedance plethysmography signal
will be cover.
The table 2.3 shows the comparison of the different methods presented here. For a better
overview of each method, this table summarises the medical application, the advantages and
disadvantages of each technique previously described.
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Table 2.3 Comparison of the different methods to measure bioelectrical impedance
Method Application Advantages Disadvantages
Photoplethysmography • Measurement of blood vol-
ume
• Indirect blood flow quantifi-
cation using NIRS
• Quantification of oxygen
saturation in blood
• Non-invasive method
• Highly portable
• Easy to use, no need of clinical
expertise
• Widely adopted by the medical
community
• Low light penetration for red and
infra-red light
• Light scattering in tissue makes it
impossible to estimate light pene-
tration in skin
• Unable to determine the volume of
tissue being measured
• Measurement diverges with skin
dark pigmentation
Laser doppler flowme-
try
• Measurement of red blood
cells velocity
• Quantification of vascular
bed blood flow
• Assessment of micro-
circulatory blood flow
• Non-invasive method
• Portable
• Single sensor on the surface of the
skin
• Blood flow quantification based
on empirical calibration with other
instruments
• Information provided is valuable
for research but not for medical
purposes
• Low light penetration, total volume
of tissue being measured 0.1 mm
Laser speckle contrast
imagining
• Monitoring of cerebral blood
flow
• Micro-circulatory assess-
ment
• Dentistry
• Wound assessment
• Produces images of vessels perfu-
sion
• Colour map of the image provides
easy interpretation
• No contact device
• It can be portable, if processing
unit is replaced by a mobile device
• Higher surface area covered
• Low light penetration, image is
a representation of the surface
vasculature
• No quantification of blood flow
• No information of blood flow of
large and deep vessels
• Still under development
Continued on next page ...
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Table 2.3 – continued from previous page
Method Application Advantages Disadvantages
Air/water plethysmog-
raphy
• Measurement of blood vol-
ume in whole extremity
• Blood flow quantification
using VOP
• Evaluation of vascular re-
sponse
• Non-invasive method
• High sensitivity
• Allow to measure large volumes of
tissue
• It is cumbersome, it requires a
chamber filled with air/water
• It requires expertise to place all the
instruments required
• More than one instrument needed
to take measurements
• Motion affects readings greatly
Strain gauge plethys-
mograpny
• Quantification of retrograde
outflow in the deep venous
system
• Assessment of peripheral
arterial disease
• Combined with VOP weighs
venous filling
• Non-invasive method
• It is portable as only once sensor is
required
• Easy to use, no clinical training
required
• Some sensors use banned mercury
• Measures plethysmography in a
confined circumference around the
sensor location
• It does not measures large volumes
of tissue
Biolectrical
impedance plethys-
mography
• Monitoring of blood volume
in thoracic cavity or limbs
• Measurement of heart stroke
volume
• Quantification of cardiac
output
• Thoracic respiratory volume
• Blood flow estimation
• Oedema and detection of
deep vein thrombosis (DVT)
• Non-invasive technique. Com-
monly, two or four electrodes are
required
• Easy to use, adhesive electrodes
can be attached to predefined
points in the body
• Low energy required, it can be
portable
• Not affected by temperature or skin
pigmentation
• It measures large volumes of tis-
sue. Boundary limited by sensing
electrodes
• Signal sensitive to motion
• Electric current not suitable for
whole population (i.e. patients with
pacemakers"
• Requires measurement of limb
section to correct measurement
quantification
• Requires skin preparation, sweat
or alien substances on skin may
interfere the readings
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2.6 Conclusion
This chapter presented the concept of circulatory system plethysmography and how can be
measured with different instruments. The measurement of blood volume or flow getting
in an out from tissue ensures the adequate interchange of nutrients and by-products. It is
clear that any disease that limits the supply of either arterial or venous blood may lead to
the development of ischaemia or hypoxia. The diseases that cause this circulatory problem
usually are assessed clinically by qualitative methods, therefore methods that allow the early
detection of circulatory blockage are desirable. This section provided a an explanation of
the rationale behind monitoring blood volume and flow in a home or low clinical setting.
Subsequently, different instruments were elaborated upon, along with the potential to quantify
blood flow. In addition, the Doppler Ultrasound method was described along with the various
optical instruments. The venous occlusion plethysmography is a useful tool for quantifying
blood rate but it is not suitable for whole population. Three different apparatuses have the
potential of being used at home or low resource setting. However, obtaining the flow rate
from the bioelectrical impedance plethysmography seems to be an excellent choice because
it is able to assess a larger volume of tissue as compared to other methods.
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Chapter 3
Bioelectrical impedance plethysmography
One of the primary objectives of this work is to produce a device capable of detecting,
measuring, and quantifying changes in the venous and arterial circulation on a continuous
basis. As described in the previous chapter, plethysmography is one of the most common
methods used to measure these changes. Armed with this information, it becomes possible
to quantify changes in blood volume that can be translated into changes of blood volume
or even flow rate. Before delving deeper into the design of this device, it is necessary to
understand the principles of operation and theories behind this technology.
This chapter describes the underlying principles behind bioelectrical impedance plethys-
mography in greater detail. But before doing that, the effect of alternate current (AC) will
be described to identify the safe limits when applied to the human body. Subsequently, the
basics of the electrical impedance in conductors are illustrated, including the manner in which
electrical current distributes in volumes. Next, the electrode-skin interface is examined in
order comprehend how electric current conduction converts into ionic conduction, including
electrodes topologies.
Biolelectrical impedance elaborates on the effect on AC current flow and the potential
differential this generates in the human body. In the following sections of this chapter, a
scope of the latest bioelectrical impedance technology will be described, including essential
components and methods needed to measure it. Thereafter, the clinical application of
impedance plethysmography will be covered in greater detail.
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3.1 Electrical current in the human body
Injecting electric current into biological tissue requires some safety measurements to guaran-
tee the patients’ welfare. Driving current into the human body may cause unpleasant effects
such as heating, electrolysis at the electrode-tissue interface or neuromuscular stimulation
[98, 103]. Any direct current above 2 Volts potential may cause electrolysis in the skin. The
positive charge ions will migrate to the negative electrodes and the negative charge ions to the
positive electrode. As a result, the moisture in the interface skin-electrode becomes alkaline
causing full-thermal epidermis damage because of electrolysis of water, oxidation of saline,
reduction of hydrogen ions and oxidation (corrosion) of the electrode metal [104].
Neuromuscular stimulation is the most dangerous adverse effect because it controls blood
circulation and respiration. At any cost, this effect should be avoided by controlling the
current’s amplitude, waveform and frequency. The levels of current sensation vary from
person-to-person, sex and even electrode geometry. Brown et al. [105] have established
a threshold current whereby sensation increases when the frequency rises, the figure 3.1
displays the relation between the threshold current sensation and frequency dependency of
the human body. The maximum sensitivity of the nervous system is in the frequency range
between 10 Hz to 1 kHz. At frequencies above 1 kHz sensitivity is considerably reduced and
is entirely imperceptible above 100 kHz. In fact, the heat effect at these frequencies is so high
that electro-surgical devices use it. Square waves should be avoided because they combine
the DC and AC effect in one signal. In this case, special consideration should be taken in
pulse duration as this increases the DC value of the signal [98].
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Figure 3.1 Threshold current sensation vs. frequency. Adapted from [105]
The table 3.1 illustrates the tolerance of the human body to different levels of electric
current. These effects are mostly predicated on current rather than frequency. When frequen-
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cies scale beyond 100 kHz especially on the radio-frequency (RF) range (400 kHz to 3 MHz)
the heating effect of the tissue tends to be more common. As seen below, in order to avoid
discomfort among patients, currents below 5 mA must be used in a biolectrical impedance
device.
Table 3.1 Effect of electric current in the human body at different levels, which may induce ventricular
fibrillation. Including levels of tolerance. Table adapted from information from Brown et al. [105]
Current Level Effect
< 1 mA • Usually not perceptible
1 mA • Threshold of current perception
• Tingling sensation
5 mA • Sensory nerve stimulation
• Shock sensation
6 mA to 25 mA (Women) • Painful electric shock
• Lack of muscular control
9 mA to 30 mA (Men) • Difficult to let go - freezing current range
• High muscle contraction
50 mA to 150 mA • Extreme pain
• Possible respiratory arrest
• Possible ventricular fibrillation
• Sever muscular contraction
• Possibly death
1 A to 4.3 A • Heart’s electric coordination compromised
• Muscular contraction and nerve damage
• Death likely
10 A • Cardiac arrest
• Severe burns
• Highly probability of death
Recommendations, guidelines and norms for patient safety are contained in international
standards compiled by the International Electrotechnical Commission (IEC). The standard
applicable to medical equipments or equipments to be used for humans is referenced as IEC
60601, or IEC 601 [106]. Some of these recommendations regarding safety are expressed
as follows: first, the commission considers any frequency below 0.1 Hz as direct current
in order to avoid ulcers created by electrode-skin interface; this type of current should be
limited to 10 µARMS. Moreover, for frequencies up to 1 kHz, it is recommended to limit
the frequency of current at 100 µARMS. Secondly, avoiding nerve stimulation is paramount
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for patient safety; at frequencies above 1 kHz, muscular stimulation becomes very difficult.
Therefore, it is recommended to use frequencies higher than this value. Thirdly, one important
recommendation of the standard is that the maximum amount of current flowing through skin
contact must be limited to 500 µARMS with a single fault equipment. Lastly, as explained
before, in the RF range tissue that could be heated, tissue burns can be avoided by limiting
the density and duration of current; for instance, it is recommended to use densities of less
than 1 mAmm−2 [105]. As a final recommendation, the commission has established that
regardless of waveform and frequency, no leakage current shall exceed 10 mARMS in normal
condition or in single fault condition [106].
3.2 Electrical impedance principle
From the electrical point standpoint, impedance is defined as the opposition that a medium
presents to either an alternating current (AC) or voltage (see figure 3.2) [107]. Impedance is
equal to the complex ratio between electrical voltage and current. This mathematical fraction
produces a complex number which is known as symbol Z (see equation 3.2). This comprises
of a resistance (also known as conductance) and/or reactance value, which is commonly
represented by the letters R and X respectively. Hence, the impedance measurement can be
expressed as a relation of the output magnitude and the phase difference between real and
imaginary parts, as shown in equation 3.1; it can be plotted in the complex plane as shown in
figure 3.3.
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Figure 3.2 Schematic representation of electrical impedance. The three elements that are required are the
voltage v(t), the alternating current i(t) and the opposition to the current (z(t)). The impedance can be driven
by either current or voltage. Image adapted from [107].
Z = |Z|∠φ (3.1)
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There are different ways to represent impedance. However, bioelectrical impedance can
be described in the form of either resistance (R) or reactance (X). Notaby, in this complex
number, the resistive part signifies the real actual part of the measurement, whereas the
reactance constitutes an imaginary one. Therefore, the impedance magnitude can be written
as a function in these two values, as illustrated in the equation 3.2.
Re
Im
X
R
Z
θ	
|Z|
Figure 3.3 Plot of the impedance in the complex plane.
Z = Z′+Z′′ = R+ jX = |Z|e jθ (3.2)
|Z|=
√
ZZ∗ =
√
R2+X2 (3.3)
θ = tan−1
X
R
(3.4)
R = |Z|cos(θ) (3.5)
X = |Z|sin(θ) (3.6)
As seen above, when the angle difference of the impedance is 0°, the load is completely
resistive. In contrast, when the phase difference is 90° the load is purely reactive. On the
basis of the previous equations, it is possible to represent impedance in the complex plane, as
illustrated in figure 3.3.
Another way to express and analyse impedance is using sinusoidals. For instance, when
a sinusoidal steady-state waveform injects a current i(t) = IAcos(ωt) into an unknown
load, the response is a shifted in a sinusoidal waveform with a potential equivalent of
v(t) =VBcos(ωt +φ). Figure 3.4 illustrates the representation of both waveforms. Hence,
the impedance can be denoted as the ration of these two quantities based on Ohm’s law (see
equation 3.7).
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Z =
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Figure 3.4 Waveform plot of a current (IAcos(ωt)) compared to the potential representation (VBcos(ωt+φ))
of an unknown load.
However, performing mathematical operations with trigonometry identities could be
quite tedious. Therefore, equivalent methods are used in order to analyse impedance in an
electric circuit. Using Euler’s formula allows us to express trigonometric functions in order
of e. The equation 3.8 illustrates the relation between both entities.
e jωt = cos(ωt)+ jsin(ωt) (3.8)
Therefore, voltage and current can be rewritten in the form of complex exponential thanks
to Euler’s equation.
v(t) =VBcos(ωt+φ) =VB(e j(ωt+φ)) (3.9)
i(t) = IAcos(ωt) = IA(e jωt) (3.10)
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Using Ohm equation 3.7 makes it possible to calculate the resultant impedance of the
waveforms. Therefore, the expression using complex exponentials would be equal to:
Z =
v(t)
i(t)
=
VB(e j(ωt+φ))
IA(e jωt)
=
VB
IA
e jφ (3.11)
Based on Euler’s equation, it is possible deduct the real and imaginary parts of the
complex exponential of equation 3.11.
Z =
VB
IA
e jφ =
VB
IA
(cos(φ)+ jsin(φ) (3.12)
Using the principle of superposition, it becomes possible to assume that the real and imag-
inary components of impedance are signified by the following formulae that are equivalents
to the ones obtained with phasor analysis equations 3.5 and 3.6.
Z′ = R =
v(t)
i(t)
=
VB
IA
cos(φ) (3.13)
Z′′ = X =
v(t)
i(t)
=
VB
IA
sin(φ) (3.14)
In conclusion, it is possible to obtain real and imaginaries values of impedance if the
maximum amplitude of the voltage (VB) and current (IA) are known, in addition to their
difference in phase (φ ).
3.3 Current distribution in conductors (Geselowitz
theorem)
Geselowitz [108] studied the change in conductivity within a constant geometry. In short, his
analysis entailed the application of lead field theory into electrical impedance. Simplifying
the origin of the equation, the total impedance of the entire volume is equivalent to the sum
of all the small impedances within each small volume dV [98].
The analysis of this equation begins from the study of the four-electrode measurement
and the change in conductivity of the internal region of a volume conductor [103]. Figure 3.5
posits that a volume conductor is electrically linear and surrounded by an insulator ξ . If the
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Figure 3.5 Volume conductor V of conductivity σ1. A:B represent current injection electrodes and C:D are
sensing electrodes. Image adapted from [98]
internal conductivity changes from σ1 to σ2 (equivalent to σ1+∆σ ) then the potential field
of the current injection will change from φ to φ ′ (equal to φ +∆φ ) although the potential
field ψ will remain unchanged. Then, the field equation will be as follows:
∫
Ω
σ .(φ −φ ′).∇ψdS =
∫
V
(σ1−σ2).(∇φ ′ •∇ψ).dV (3.15)
By replacing the terms with the equivalents, the equation can be rewritten in accordance
to the next equation.
−∆φCD.(−Iψ) =−
∫
V
∆σ .[∇(φ +∆φ)•∇ψ].dV (3.16)
The impedance change can be deducted by dividing the function by the currents involved
Iphi and Iψ . As a result, the Geselowitz equation is equivalent to:
∆Z =
∆φCD
Iφ
=−
∫
V
∆σ(x,y,z).
[
∇(φ +∆φ)
Iφ
• ∇ψ
Iψ
]
.dV (3.17)
The previous equation is the key to calculating the change in impedance in a volume
within defined boundaries. However, this only applies to homogeneous and isotropic volume
conductors. The equation can be simplified if is assumed that a unit of current passes through
and the volume conductor can be denoted by a number of discrete elements of uniform
conductivity within a three dimensional space (x,y,z). As a result, the equitation can be
simplified as follows:
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∆Z =−∆σ ·
∫
V
∇(φ +∆φ)•∇ψ.dV =−∆σ ·S (3.18)
where S denotes the sensitivity matrix in three dimensions; it is independent of con-
ductance. Calculating this variable requires a series of assumptions, such as the initial
conductivity distribution being uniform [109]. This document is not centred on the math-
ematical analysis of the sensitivity S, but deducting those impedance changes are directly
related to the change of geometry within this segment. Several studies provide credence
to the fact that sensitivity varies in accordance to the electrodes position and geometry, as
researched by Bertemes [103].
3.4 Electrode-skin interface
Electrodes play a crucial role in a bioelectrical impedance system. Indeed, the nuances of
electrode geometry, distance and material may influence the final readings from a biological
standpoint. Consequently, the impedance of the electrodes should be significantly lower than
the ones from the subject under test. For this, highly conductive materials are used in the
manufacturing of electrodes like platinum (Pt), gold (Au) or stainless steel. Furthermore,
other independent variables such as temperature, ionic tissue contents and protein adhesion
may also influence the changes of electrode impedance [98, 110]. In terms of electrode
geometry, Ohm’s law (equation 3.19) explains, for instance, how changing the length of the
electrode affects its resistance (R).
R = ρ
L
A
(3.19)
In the previous equation, ρ denotes the electrical resistivity of the material, A refers to the
area of the electrode, and L signifies the longitude or thickness. The resistance (R) reduces
when the area (A) of the electrode increases. However, the total resistance (R) is directly
proportional to the length of the electrodes.
A physical effect takes place when electrical current passes through the electrode-skin
interface. First, only ion conduction takes place in the human body; therefore, at the
electrode, an exchange of charges convert electrical current into a transport of ions. Second,
an electrochemical reaction known as electrolysis follows at the electrode-tissue boundary.
This effect creates a "double layer capacitance (DLC)" which, as its name indicates, adds
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a capacitive effect to the boundary creating an unwanted DC charge [111]. Consequently,
applying an AC waveform inverts the electrode polarity during each cycle, thereby minimising
this capacitive effect. However, this is also a frequency dependent development which is
more noticeable at low frequencies [103].
Figure 3.6 shows the equivalent circuit model of the electrode-tissue interface. This
model characterises by the half-cell potential of the dual-layer, portrayed as a battery (Ehc),
the impedance and polarisation of the electrode-electrolyte interface represented by a charge
transfer resistance (RCT ) in parallel with the interface’s impedance (ZCPE). This circuit is
incongruity with the tissue impedance (Zt) which is equivalent to an RC network [111, 112]
(see figure 3.9). Some authors have defined the interface’s impedance as either a constant
phase or angle impedance or constant phase element (ZCPE) [113–115]. In short, the ZCPE is
a correction factor on the empirical electric model of the electrode. This term has been added
to fit the experimental data of the electrode’s RC response, which deforms and broads the
Nyquist diagram when a frequency sweep is applied. This element behaves as an imperfect
capacitor; hence, it is frequency-dependent.
+ −Ehc
ZCPE
Zt
RCTMetal Tissue
Figure 3.6 Equivalent circuit of the electrode-tissue interface (Adapted from Franks [113])
The value of ZCPE can be calculated from the following empirical equation 3.20 given by
McAdams [116, 117].
ZCPA = K( jω)−β (3.20)
where K denotes a measure of the magnitude of ZCPE , β represents a constant (0≤ β ≤ 1)
signifying inhomogeneities in the surface (typically 0.8 for a number of biomedical electrode
systems) and ω = 2π f . When β = 1, ZCPE is equivalent to a purely capacitive impedance
element [113, 115–117].
Electrodes are also a source of error when taking measurements. Some blunders can
even distort the original signal; for instance, thermal or Johnson-Nyquist noise. This type
of noise is entirely inherent to the electrode and is predicated on external variables such as
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temperature and bandwidth of the measurement [116]. Another source of errors caused by
electrode can be derived from their position in the body, lack of surface contact, or mismatch
in materials and geometries. Therefore, in order to improve and maximise the area of contact,
some electrodes necessitate conductive gel. In this matter, according to Caicedo et al. [118],
using commercially available electrodes for electrocardiogram (ECG) purposes demonstrated
to provide good impedimetric readings, as opposed to specially designed electrodes.
In regards to re-positioning electrodes, an experiment using ECG electrodes was con-
ducted to determine whether removing one or four electrodes and putting them back in the
same position could cause errors in readings. It was found that putting electrodes away
and then getting them back into the same position for an extended period caused minimum
changes in impedance readings. But, the sensitivity to impedance changes depended on the
position and area of the voltage-detecting electrodes with respect to those of the current
injection electrodes [119].
Using the right amount and position of electrodes in the body may minimise errors in the
readings. For this, various electrode topologies are used to take impedance measurements.
Some of these options include two-electrode (bipolar), three-electrode (tripolar) and four-
electrode setting (tetrapolar). A bipolar or tripolar configuration adds the electrodes complex
impedance in series with the tissue. This unknown electrode impedance results in a significant
error that is added to the total measurement. If the impedance of the electrodes were
greater than the one of the skin, this might completely conceal the actual value of the tissue
impedance. Thus, a bipolar configuration is not the best option for bioelectrical impedance
measurements.
In the present work, a tetrapolar electrode configuration was used during the experiments.
The following section analyses the equivalent circuit of four electrodes measurement showing
its effectiveness on diminishing the electrode’s impact on the total impedance measurement.
3.4.1 Analysis of tetrapolar electrode configuration
The tetrapolar configuration is the most common method to measure bioelectrical impedance
in human limbs [19, 21, 22, 120]. Some of the advantages of this approach are that in theory,
it cancels out the added electrode impedance. However, it must comply with the following:
first, the input impedance of the measuring instrument should be infinite, or as per the best
estimate, the impedance should be higher than the one from the body. Second, the electrode’s
contact area with the skin surface should flat and even.
Currently, it is difficult to meet these requirements, but it is possible to get close to them.
Measuring impedance using state of the art of integrated circuits (IC) is likely to achieve high
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input impedance, in the order of GΩ [121]. When compared with hundreds of ohms of the
soft tissue in humans [122, 123], the error minimises dramatically. Additionally, the contact
area can be improved if the electrodes contain an electrolytic solution. Using this type of gel
moisturises the skin reducing its impedance and improving ionic conduction [123, 124].
The figure 3.7 illustrates the common electrode topology and the equivalent circuit.
Usually, the outer pair drives current into the body, and external ones measure the potential
generated (see figure 3.7a). The figure 3.7b shows the simplified equivalent circuit and the
current path. From there, the following analysis will be performed to estimate the impedance
contribution of electrode ZC2 and ZC3.
Skin
E1 E2 E3 E4
I
V
(a) Tetrapolar electrode position for most of bioelectrical impedance measurements. The outermost electrodes
(E1 and E4) are connected to the AC source. Similarly, the potential electrodes are connected to the inner
electrodes (E2 - E3).
ZC1
I
+
−Eh1
I
+
−Eh2
ZC4
I
Zt2
IZt
IZt1
I
ZC2
I=0
+
−Eh1
V
+
−Eh1
ZC3
(b) Simplified model of the tetrapolar electrodes model. ZC denotes the impedance of these electrodes. Zt
refers to the impedance of the body at each end of these electrodes. In an ideal setting, the voltmeter has an
infinite input impedance; therefore, no current flows through the electrodes ZC2 and ZC3.
Figure 3.7 Tetrapolar electrodes position in a measurement over the skin with the equivalent circuit.
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In accordance to the figure, the applied sinusoidal current is equal to I(t) = Ie jωt . Fol-
lowing the current path, the equivalent potential drop around the tissue (Zt) will be given by
the equation 3.21.
V (t) = ZtIe jωt (3.21)
V (t) =Vte j(ωt+θ) (3.22)
Due to the high impedance of the measurement device, the current flowing through ZC2
and ZC3 would be close zero. Then, the measured potential will be equivalent to the one
taken from the body segment (Zt). Therefore, the total impedance (Zm) measured by the
instrument can be calculated using equation 3.23.
Zm(t) =
Z(t)
I(t)
=
Vte j(ωt+θ)
Ie jωt
(3.23)
Zm(t) = Zte jθ (3.24)
Finally, the measured impedance Zm is equivalent to the one complex impedance from
the body segment Zte jθ , thus reducing the incidence of the potential electrodes.
At the moment of taking measurements for localised bioelectrical impedance using
tetrapolar configuration, Bertemes et al. [103] demonstrated that the distribution of the
electrodes impacts the sensitivity of the system along with the geometry of the cells contained
within the tissue. According to the author of the experiments, the separation of injection and
detection electrode pairs affects the existing depth of penetration. In other words, the bigger
the separation between the pair of electrodes, the deeper the AC signal is likely to go.
3.5 Bioelectrical impedance
Before describing the manner in which impedance plethysmography operates, it would be
more prudent to understand how the principle of bioelectrical impedance is defined. Firstly,
the term electrical impedance spectroscopy (EIS) refers to the study of the absorption of
energy in accordance to the frequency of electromagnetic (EM) waves. When measurements
are performed in a biological sample, this method could be referred to as either electrical
bioimpedance or bioelectrical impedance [110]. The term to be used in the context of this
document will be bioelectrical impedance. The interaction with tissue occurs in the frequency
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range from 100 Hz to 10 MHz [103]. In this thesis, the frequencies of interest are focused in
the lower range of the spectrum. Indeed, plethysmography devices are known to commonly
operate in the radio wave frequency of the electromagnetic spectrum.
The human body comprises of four basic tissues known as epithelium, muscle, connective
tissue and nervous tissue. Epithelium covers the whole surface of the body. Muscles are in
charge of the movement, whereas connective tissues impart protection to organs. Nervous
tissue provides the internal transmission line for the electrical impulses coming from the
brain. Cells that create these tissues play a fundamental role with regard to ionic conduction
when an analogue current (AC) is applied to the body [111]. Hence, impedance readings vary
based on the parameters of these cells and their protein content. It is especially important to
understand the geometry and characteristics of the red blood cells, which transport 02 around
the body.
In the human body, there are more RBCs than any other cells, and they entail particular
resistive properties. Its disk shape can be ideally represented as a spherical particle with
membranes around the surface, as represented by Figure 3.8. Live cells can be represented as
multilayer cells where its internal cytoplasm has a specific permittivity (εcp) and conductivity
(σcp). Likewise, these characteristics are similar to the one surrounding the cell known as
extracellular fluid (εm and σm). However, the membrane suffers from a very low permittivity
(εMBR) and conductivity (σMBR) which behaves as a dielectric. In contrast, in the case of dead
cells the membrane becomes loose and does not provide resistance to electric current [111].
	
𝜺𝒎 − 𝝈𝒎	
𝜺𝑴𝑩𝑹 − 𝝈𝑴𝑩𝑹	
Figure 3.8 Representation of a cell with its electric characteristics. Internal cytoplasm characteristic permittivity
εcp and conductivity σcp. Extracellular fluid permittivity εm and conductivity σm). Membrane permittivity
described as (εMBR) and conductivity (σMBR). Adapted from [98]
A cell can change its internal cytoplasm using two different means, either changing the
permeability of their bilayer lipid membrane (BLM) or through the use of ionic channels
or pumps. The BLM is about 7 nm thick. Altering its permeability allows lipids and water
molecules to pass through [110]. The interface between the extracellular space, the cell
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membrane and intracellular space (σm → σMBR ← σcp) behave as a capacitor since membrane
is a dielectric between two conductors, denoted as Cm in figure 3.9a.
In contrast, parallel to BLM, the ionic channels and pumps enhance the functionality
of membranes. Ionic channels or "channel proteins" allow for the transport and exchange
of certain types of ions such as Na+, K+, Chloride (Cl−) and Calcium (Ca2+) between the
inside and outside part of the cell [111]. Ion pumps are caused by sensitivity of the membrane
to a voltage and are responsible for the membrane’s non-linear properties as a response to
low voltage. This pump causes cell polarisation, enabling the flow of ion charges in the body.
Electrically, these channels act as a resistor (Rm).
According to previous analysis, the cell can be simplified in an equivalent electric
circuit model, as shown in Figure 3.9. This model indicates that if AC is pumped into the
extracellular medium, there are two possible paths for the current to go through. One way
is around the cell - represented by the resistive characteristic of the extracellular medium
(Re). Under the second route, current flows through the cell. It is possible that AC flows
initially either over the BLM, which is represented as a capacitance (Cm), or across ionic
channels (Rm). Upon reaching the cell, current travels via the intracellular medium (Ri) that
is mostly resistive. Finally, the electrical current exits from the cell through the membrane,
which again lies in the same Cm and Rm.
Re 2Rm Ri
Cm/2Re
Rm
Rm
Ri
Cm
Cm
extra-cellular
intra-cellular
a) b)(a) Cell’s equivalent circuit model
Re 2Rm Ri
Cm/2Re
Rm
Rm
Ri
Cm
Cm
xtra-cellular
intra-cellular
a) b)(b) Simplified circuit model
Figure 3.9 Electrical model of the cell and its simplified version. Re is the resistivity of the extracellular
medium, Ri is the resistivity of the intracellular medium and Rm and Cm are the resistivity and capacitance of
the membrane. Image adapted from [98]
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Since Cm and Rm share the same values when the current enters and exits the cell, this can
be simplified in the electric model as the two resistors in series (2Rm) and two capacitances
are parallel to each other (Cm/2) as indicated by figure 3.9b.
When an EM field is applied on the tissue, cells respond based on the frequency applied,
highlighting three distinctive areas in the spectrum, as described by Schwan et al. [125,
126]. Figure 3.10 displays the dielectric response against frequency, which reveals valuable
information about the functional and structural properties of the cell [111]. According to
the graph, there are three denominating areas α , β and γ dispersion. Firstly, α dispersion
(from 10 Hz to a few kHz) is generally associated with frequency dependent properties of
the cells’ membrane. Secondly, β dispersion (10 kHz to several MHz) is related to the
dielectric property of the cell membrane as well as the interaction between the internal and
external mediums. Finally, γ dispersion (> 10 GHz) is attributed to the dielectric relaxation
of bulk dispersing media, the Debye dispersion in water (17 GHz), and the presence of small
molecules.
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Figure 3.10 Representation of a cell with its dielectric characteristics. Internal cytoplasm characteristic
permittivity εcp and conductivity σcp. Extracellular fluid permittivity εm and conductivity σm). Membrane
permittivity described as (εMBR) and conductivity (σMBR). Adapted from [98, 111]
In addition, the β dispersion region provides supplementary information about the cell.
Lvovich [111] divides this area into three subregions in accordance to the interaction of the
electrical current with the cell. The β1 relaxation is caused by the capacitive membrane Cm,
occurring in the low kHz range. When the frequency increases between kHz and low MHz
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range, the internal cytoplasm of the cell produces a β3 dispersion owning to a change from
resistive to capacitive conduction. However, this capacitive component is often disregarded,
thereby simplifying the model into a resistive element Ri. Ultimately, β2 occurs in the range
of low MHz when the electrical charge movement through the cell shifts into a capacitive
conduction.
This research document is centred on the β dispersion region between 100 Hz to 1 MHz.
The designed impedance plethysmography device presented in chapter 4 operates in a wide
selection of frequencies of up to 200 kHz.
The ideal electrical model of the cell is shown in figure 3.9 is a very close approximation
that facilitates the prediction of bioelectrical impedance behaviour for dilute cell suspension.
However, the tissue is more complex than this particular simplified model because it is
comprised of additional elements that must be added to the analysis. For instance, tissues like
muscle exhibits extreme anisotropy (conductivity is not the same when measured in different
directions) [111, 127, 128]. In addition, different resistivity values have been obtained when
measuring bioelectrical impedance during the cardiac cycle longitudinally and transversely
[129]. Another instance of how impedance changes in the context of tissues properties can
be seen in the performed by Casas et al. [130]. This study showed the differences between
normal and ischaemic tissue of a pig’s myocardium muscle. Impedance clearly presented a
different impedimetric response when a frequency sweep was done between 10 Hz to 1 MHz.
3.5.1 Mathematical representation of electrical impedance
Electrical impedance can yield a different response based on the frequency. In a bioelectrical
impedance analysis (BIA), the impedimetric response needs to be represented as a function
of the frequencies used along with the magnitude and phase obtained. Different mathematical
models have been studied based on the basic and ideal framework, as shown in figure
3.9b. However, this model does not entirely encapsulate the effect of the membrane at high
frequencies. Debye came up with the following equation that took the suspension of free
poles into consideration [103].
ε∗r = εHF +
εLF − εHF
1+ jωτ
(3.25)
In this equation, ε∗r signifies the complex relative permeability, εLF and εHF represents
the permeability at low and high frequency, respectively and τ denotes the relaxation time
constant. Meanwhile jω = 2π refers to the angular frequency in radians. However, it was not
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until 1941 when Cole brothers took into account, dispersion by factoring the Debye equation
that an additional parameter called α resulted in the equation 3.26. This mathematical
formula is widely used to obtain the approximate value of impedance during the course of
taking biomedical measurements [131].
ε∗r = εHF +
εLF − εHF
(1+ jωτ)1−α
(3.26)
The parameter α is limited for values between 0 and 1. When its value is equal to zero,
the Cole-Cole equation will yield the Debye equation (3.25) as a solution for polar dielectrics.
Consequently, from this mathematical statement, it is possible to obtain data representation
known as the Cole-Cole plot. It is a two-dimensional graph where the plot of ε ′′ or the
imaginary part of the equation lies in the y-axis vs ε ′ in the x-axis, which forms the real part
of the solution.
The representation of data using Cole-Cole representation allows to see changes in
frequency for different tissues. This information is valid when spectroscopy studies are being
performed. Regarding the most suitable frequency to measure impedance plethysmography,
whole body bioelectrical impedance analysis has shown that limbs contributed significantly
to the impedance at frequencies 0.5 kHz, 50 kHz and 100 kHz [132]. Therefore, any AC with
this frequency spectrum is suitable for an impedance plethysmography instrument.
3.6 State of the art of commercial bioelectrical impedance
devices
Measuring impedance plethysmography requires of devices tuned in within the impedance
range of the section of the body being studied. Bioelectrical impedance is the technology
used to estimate changes of volume in the body using electrical current, the name of the
technique is impedance plethysmography (iPG). This kind of technology still keeps the
same principles when was first implemented in the 1950s [102] described deeply in the
following section. However, the modern development of this method has been centred in the
miniaturisation of the electronics, reduction of measurement errors and the development of
signal processing algorithms.
There are not many commercial products certified for the measurement of impedance
plethysmography. In fact, to the knowledge of the author, only one device is commercially
being used for iPG measurements. Three kinds of methods can record impedance plethysmog-
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raphy: specially purposed circuits, impedance cardiography and impedance plethysmography
devices. Table 3.2 summarises the different commercially available devices including features
and applications.
Designing custom bioelectrical impedance devices allow flexibility to work with different
signal parameters, like waveforms, frequencies and amplitudes. Additionally, it is possible
to apply new algorithms to the raw signal. Off the shelf devices may require the use of
the equipment in alternative ways; for instance, some studies used impedance cardiography
devices to record plethysmography waveforms from limbs [102]. However, technically, it is
still acceptable to use this kind of devices as the technical characteristics are similar to the
ones used in impedance plethysmography (see table 3.2). The following are examples of the
state of the art of devices capable of taking impedance plethysmography signals.
Nowadays, there are efforts to incorporate this technology as part of wearable devices.
For instance, Samsung Electronics has released a hand-wrist size wearable device called
simband [133]. This is a device designed as a research and development platform. In their
product announcement, Samsung uses electrical impedance in order to measure the galvanic
impedance response (GSR) and Bio-Impedance (Bio-Z). This sensor performs heart rate
measurement by measuring the pulse wave of blood flow in the artery around the wrist. The
device acquires different physiological signals but interestingly their architecture is open to
develop algorithms that process these waveforms.
In the medical field, a significant number of devices use bioelectrical impedance for
different medical applications, such as impedance cardiography (ICG) devices. They have
been developed to measure different properties of the heart such as stroke volume (SV),
cardiac output (CO) and systemic vascular resistance (SVR) [134]. Nevertheless, apart from
its main application, this kind of instrument has also been used to measure plethysmography
in limbs aiming other medical application such as detection proximal vein thrombosis
(PVT) [135] or the levels of ischaemia during orthopaedic surgery [136].
Another company that has successfully created an FDA approved medical device using
bioelectrical impedance in the market is Cheetah Medical [137] from Israel. This company
based out of Boston (US) has developed a medical device called Cheetah NICOM which
gauges haemodynamics non-invasively using as many as four electrodes configuration. The
device is used in different hospital areas such as critical care, haemodialysis, emergency
department and operating theatres.
Finally, German company Medis (Medizinische Messtechnik GmbH) [138] is a spin-off
company from Institute of Biomedical Engineering of the Technical University Ilmenau.
They manufacture medical equipment for the purpose of cardiovascular diagnosis, including
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Table 3.2 Commercial devices for measuring bioelectrical impedance plethysmography
Devices Manufacturer Features Application
Simband [133] Samsung Electronics • Four electrode measurements in the
wrist
• Current frequency: 40 KHz
• Current amplitude: 200 µA
• Current shape: Square
• ADC Resolution: 12 bits
• Sampling frequency: 1024 Hz
• Research purposes, design of algorithms
• Measurement of galvanic skin response
(GSR)
• Heart rate measurement
• Measurement of pulse wave of blood flow
in wrist artery
Cheetah NICOM
[139]
Cheetah Medical • Four electrodes measurement in the
thorax
• Current frequency: 40 KHz
• Signal amplitude: 600 mW
• Current shape: Sine
• Cheetah’s proprietary algorithms in-
terpret the signal to provide stroke
volume
• Measurement of cardiac output
• Stroke Volume Index (SVI)
• Cardiac Index (CI)
• Total Peripheral Resistance Index (TPRI),
which is a measure of vascular tone
VasoScreen 5000
[138]
Medis • Four electrodes measurement in the
legs, arms and head
• Current frequency: 85 KHz
• Signal amplitude: 1 mA
• Current shape: Sine
• Pulse wave analysis in legs, arms and
head
• Diagnose of artereosclerotic changes
• Detection of stenoses
• Diagnose of occlusions
• Combination of PPG and cuff occlusion
for VOP assessment
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impedance cardiograph and impedance plethysmography devices. Furthermore, their devices
are combined with other methods such as PPG and ECG to obtain a better assessment of the
haemodynamics in the body.
3.7 Basic components of a bioelectrical impedance device
Evidently, there are several medical instruments that incorporate either bioelectrical impedance
technology. Nonetheless, regardless of the application, most of the instruments follow the
block diagram illustrated in figure 3.11 as part of their basic designs.
	
Figure 3.11 A bioelectrical impedance device requires front-end and back-end components in order to detect
changes of impedance efficiently.
An impedance system can be categorised into three different blocks: the first one known
as back-end commonly comprises of signal generation and a digital signal processing system
which analyses the sensed signal. Next is the front-end block comprised of all the circuitry
before establishing contact with the skin, such as current injection and signal detection
electronics. Ultimately, skin electrode interface behaving as an electronic circuit has been
described in section 3.4.
Meanwhile the back-end block is divided into two different sections. First signal genera-
tion circuits depend on either extremely precise oscillators or Digital Signal Synthesizers
(DDS) to generate accurate signal waves in a wide bandwidth with highly accurate ampli-
tudes. The frequency exactness of these electronic circuits could scale up to 0.1 % [140].
Different kind of waveforms may be applied, but a sinusoidal wave is the most common one.
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Signal processing circuits lie at the other end of the spectrum, and are used to evaluate a
signal’s amplitude and phase sensed by the front-end block. Notably, powerful processors or
microprocessors are used to analyse and digitise the signals identified. Moreover, modern
devices are also aided by either Digital Signal Processors (DSP) or high-speed analogue to
digital converters (ADC) that are capable of oversampling the detected signals. This level of
precision in high-speed processors and chips makes them highly specialised and expensive.
Likewise, the front-end is divided into two different sections: current injection and signal
detection circuits. The current injection circuit, as indicated by its name, transmits the signal
coming from the wave generator into the electrodes; some characteristics of these circuits are
high bandwidth, accuracy and linearity.
On the other hand, signal detection circuits receive the signal after having passed through
the sample under test. As opposed to specialised digital circuitry used on the back-end,
the front-end mostly relies on highly precise analogue systems. These circuits can be
implemented with discrete components or custom chips. However, discrete components
may evince a limited response when there is a requirement of bandwidths in the order of
megahertz [141–143].
In an ideal system, the output impedance of the current injection circuit is expected to be
linear within its full bandwidth. However, at high frequencies, stray capacitances may reduce
the output impedance of the current drivers and could produce unwanted oscillations [142].
Some of the factors that cause a change in stray capacitance are the integration between
electrode impedance, cable capacitances, the capacitance between neighbouring electrode
leads, capacitances between the signal ground of the device and earth, and lead positioning
[141, 143]. figure 3.12 shows the stray capacitance (Cs) in parallel with the load (ZL).
Current injection
Is
Zo Cs ZL
Figure 3.12 Circuit of stray capacitances (Cs) at the output of the current source. These capacitances are in
parallel with the load (ZL), at high frequencies the stray capacitances become more dominant than the load.
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Custom microchip design replete with current injection and sensing circuits is a better
option because it reduces the influence of some of the stray capacitances. The implementation
of a short length of transmission lines, interleaving signal wires with the ground, twizzling of
signal paths, less logic and smaller devices reduce intrinsic and extrinsic capacitances of the
system [141, 144, 145].
3.7.1 Methods of measuring bioelectrical impedance
Bioelectrical impedance has been used in different ways to get measurements from the
human body. A wide range of approaches has been developed using single or multiple
frequencies or varying amounts of electrodes. This section describes the most common type
of bioelectrical impedance and explains their operation frequency, electrodes location, and
data representation. The table 3.3 summarises the different methods to measure biolectrical
impedance including application, advantages ans disadvantages.
As the table shows most of the methods focus on whole body measurements. These
methods provide an insightful approach to whole body composition analysis, including total
body water (TBW), free-fat mass (FFM) and a weighted sum of extracellular water (ECW)
and intracellular water (ICW) content resistivities [100]. Nonetheless, the measurements can
be significantly affected by the subject’s hydration level [146, 147].
On the other hand, localised bioelectrical impedance analysis aims to avoid the incidence
of the effects of different variables, such as hydration, fat fraction, geometry boundary
conditions, etc. Focusing on well-defined segments of the body enables the minimisation of
the effect of these variables. Moreover, when the segment is confined to a small volume, it
becomes possible to calculate plethysmography or blood flow. The use of four electrodes
assumes great significance for such applications because it creates the boundaries of such a
system.
The calculation of bioelectrical impedance also simplifies because it facilities the applica-
tion of empirical regression models as per their population [100]. Some cases involve the
dimensions of the limb being studied in order to obtain its geometric volume for a more
detailed calculation. Some cases where this technique has been successfully applied include
the analysis of limb ischaemia [54, 148] breast cancer [149], detection and monitoring of
Lymphedema [150] and local abdominal fat mass [151].
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Table 3.3 Comparison of the different methods to measure bioelectrical impedance
Method Application Advantages Disadvantages
Single frequency BIA
[100, 152]
• Whole body impedance analysis
• Analysis of full body composi-
tion
• Quantification of free-fat mass
• Measurement of total body water
(TBW)
• Easy to use, only four electrodes
(contact measurements)
• Single frequency measurement
(50 KHz)
• Low coefficient of variation
from 0.3 % to 3.6 % [152]
• Measurements affected by sub-
ject’s hydration and glycogen
levels
• Sensors placement
• Skin preparation
• Variations in manufacturers
equations
Multi-frequency BIA
[100, 153–155]
• Multi-frequency whole body
impedance analysis
• Similar body analysis as SF-BIA
• Assessment of amyotrophic
lateral sclerosis (ALS)
• Use more complex mathematical
analysis (Cole-cole and Hanai
formulas)
• Multi-frequency measurements
(up top 6 frequencies)
• More accurate predicting ECW
• Modelling techniques requires
further refinement in some dis-
eases
• Poor reproducibility below
5 KHz and above 200 KHz
• No clear consensus in which
algorithm must be used in calcu-
lations
• SF-BIA presented better results
assessing TBW in critically ill
subjects
Bioelectrical
impedance spec-
troscopy (BIS)
• Multi-frequency whole body
impedance analysis
• Cancer tissue analysis [156]
• Changes of fluid compartment
[157]
• Total body analysis TBW-ECW
• Use of Cole-cole and Hanai
formulas
• More data points than MF-BIA,
multiple frequencies
• Better results calculating of
TBW and ECW
• Requires previous modelling of
healthy population
• Calibration or different math-
ematical model required for
certain kind of illnesses [158]
• Regression method use calculate
results
Continued on next page ...
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Table 3.3 – continued from previous page
Method Application Advantages Disadvantages
Segmental bioelectri-
cal impedance analy-
sis [100]
• Multi-frequency differential
body segments impedance analy-
sis
• Fluid retention on patients with
renal failure
• Total body water analysis TBW
• Fluid shifts and fluid distribution
in some diseases (ascites, renal
failure, surgery)
• Noninvasive, simple and inex-
pensive method for body compo-
sition study
• Impedance analysis of different
body segments (torso, legs and
arms)
• Multiple electrodes measure-
ment, more than 4 electrodes
required
• Lack of standardisation on elec-
trodes position
• Not recommended for young
adults [159, 160]
Bioelectrical
impedance vector
analysis [100]
• Assessment of fluid body vol-
ume
• Four electrodes measurement in
the legs, arms and head
• Uses real (R) and imaginary (Xc)
values
• Classification according to body
type (Muscular, lean, obese or
cachectic
• Tested under different illnesses
• Data output depends on previ-
ously healthy population fit
• Bad diagnosis could be given if
previous population data is not
available
• Uses estimates, instead of quanti-
fied values
Localised bioelectrical
impedance analysis
[100]
• Plethysmographic analysis
• Limb ischaemia progression
[54, 148]
• Breast cancer study [149]
• Lymphodema monitoring [150]
• Measurment of localaised ab-
dominal fat [151] Muscle injury
[161]
• Simple to operate and use (4
electrodes)
• Hydration or fat does not affect
measurement greatly
• Electrode boundary limits tissue
volume to be analysed
• Localise measurement
• Not effective to measure ECW-
ICW
• Usually single frequency mea-
surement
• Lack of standardised electrode
placement
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3.8 The principle of bioelectrical impedance
plethysmography
As previously described in section 2.5.3.3, iPG denotes the measurement of volume changes
through the equivalent impedance of a human body part [24]. Indeed, when heart’s systole
increases the blood flow, the volume of a limb rises due to the inflow of arterial blood
(swelling) [98]. Consequently, there are changes of impedance that are correlated to the
changes of volume as well as flow in any part of the body. Some of the medical applications
of this technology include the measurement of heart stroke volume (SV), cardiac output
(CO), thoracic respiratory volume, oedema as well as the detection of deep vein thrombosis
(DVT) [7].
The genesis of impedance plethysmography can be traced back to the model that was
proposed by Jan Nyboer [102]. The author describes extremities as cylinders, where in an
inner cylinder signifies a blood vessel, and surrounding tissue accounts for the outermost
part. The whole electrical conductance path results from the sum of the parallel conductance
of blood and tissue within a segment. In fact, this theory known as parallel conductor was
subsequently confirmed by the experiments performed by Shimazu et al. [162]. There
have been some doubts about the extent of the blood’s impedance contribution to the total
impedance signal. Nonetheless, the in-vitro experiment demonstrated that blood (haematocrit
= 26± 4%) contributed to 10 % of the impedance signal. In the study, the final result
was obtained when comparing the measurements of a saline buffer solution and blood in
extensible arteries as well as rigid tubes [163].
	
𝐿	∆𝑣	
	
Figure 3.13 Two compartment cylinder model of length L and parallel volume increment of ∆v. Image adapted
from [98]
In principle, the normal volume (V ) of a human forearm contain within a certain length L,
the bones, muscle, fat and blood structure around a cross-sectional area (A) (see figure 3.13).
When a circulatory cycle takes place, an additional amount of blood enters the limb through
the brachial artery to raise total volume of the limb in ∆V . Thus, the new limb’s total volume
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at the peak of this systole will be equivalent to V +∆V . As a result, shunting impedance Zb
is produced by the following equation [164, 165]:
Zb = ρb
L
∆A
(3.27)
where ρb denotes the blood’s resistivity and ∆A refers to the increase of in the cross-
sectional area of the limb. However, for this formula to work, some assumptions need to
be taken into consideration: the arterial expansion is uniform along the tissue, the blood
resistivity (ρ) remains constant, and the flow of current is parallel to the artery [18]. Therefore,
the artery volume change can be obtained by using the following formula [164, 165].
∆V = L×∆A = ρb L
2
∆A
(3.28)
During the cardiac cycle, the area of the artery increases from A to A+∆A. However, the
impedance of Zb is also affected by the additional impedance (∆Z) that is produced by the
increment ∆A, and this Zb is connected in parallel to Z. Therefore, Nyboer [102] postulated
that the practical parallel resistive value of the displaced blood can originate from the parallel
relation between the initial base resistance and the new resistance value, signified by the
following expression:
∆Z = (Zb ∥ Z)−Z = Z
2
Z+Zb
(3.29)
where Z is equivalent to the limb’s original resistance at diastole and Zb represents the
increase of new total resistance. Zb ≫ Z, then Zb can now be rewritten as:
1
Zb
∼=−∆Z
Z2
(3.30)
Finally, the changes in limb volume in association with the variation of impedance are
denoted by the equation 3.31. It must be noted that the negative sign is an indication of
direction.
65
Bioelectrical impedance plethysmography
∆V =−ρb L
2
Z2
∆Z (3.31)
Different equations are derived by complementing Nyboer’s work. One of the modifica-
tions is the Kubicek et al. method [166–168]. His equation is widely used, especially when
taking the measurements of impedance cardiography from the thoracic box and deducting
stroke volume of the heart. Another popular work is the contribution of Sramek [169].
The author also modified Kubicek’s equation by eliminating the dependence L and ρb, and
introduced a constant that was obtained using statistical methods named "volume of electrical
participating tissue". Alternative calculation methods have been developed using admittance
instead of impedance.
In his research and patent work, Yamakoshi [22, 162, 170] uses impedance reciprocate
and admittance (Y = Z−1) to estimate blood flow using plethysmography which performed
better with analogue computers of the time. In his work, the author states that the first
gradient of the computation result to time indicates the blood rate in the limb being examined.
However, the algorithms used in this study will be confined to the equations proposed by
Nyboer.
3.8.1 Alternative applications of impedance plethysmography
The plethysmography waveform is also utilised to quantify the measurements of pulsatile
volume, blood flow beat to beat, blood pressure, and pulse wave velocity. In this case,
the waveform is equivalent to the AC component of the impedance signal. This signal’s
contribution to the total quantum of signal is between 0.1 % to 1 % of the total quantum of
the signal. Sometimes, it is necessary to implement low noise techniques in order to pick up
the hidden signal within the basal impedance.
The most typical application of this waveform is the quantification of blood flow beat to
beat. By applying Nyboer’s equation to the waveform signal, it is possible to quantify peak-
peak blood volume and peak net inflow. For instance, the patent presented by Marks [26]
denotes the application of quantifying blood flow in upper extremities by computing the
derivatives of the waveform signal producing the claimed results. As another example,
the work performed by Porter [23] included taking measurements from lower limbs where
an impedance cardiograph was used to obtain the waveform signals and computed using
Kubicek’s equation [166–168] to validate the signal’s potential use in evaluating limb oedema.
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Another application of this waveform is the continuous evaluation of blood pressure.
Blinov [171] demonstrated that pressure could be deducted if the blood flow is known. As
explained before, blood flow can be estimated beat-beat by changes into:
dV = ρ
L2
Z2
dZ (3.32)
Volume rate is denoted by the change of volume in time. Blood flow rate (Q˙) is repre-
sented by the following equation:
Q˙ =
dV
dt
=−ρ L
2
Z2
dZ
dt
(3.33)
where W refers to the hydraulic resistance and P signifies the pressure. The hydraulic
resistance is a function of the geometry of the artery provided by radius r as well as the
viscosity of the blood µ .
W =
8lµ
πr4
(3.34)
By replacing equation W into equation Q˙ the pressure for a defined segment can be
expressed as:
P =−8Lµπ
ρ
dZ
dt
= k
dZ
dt
(3.35)
where k denotes a constant value function of the distance between the electrodes and
the physiological constants of the blood at a particular measurement frequency. The sign
in equation merely indicates that the changes occurring in the resistance and pressure are
opposite. Thus, the sign can be disregarded while performing calculations.
Finally, the waveform obtained from impedance plethysmography can also be applied to
evaluate pulse-wave velocity (PWV) in limbs which is an important indicator of deterioration
of the cardiovascular system [172, 173]. More in detail, PWV is the time delay between the
pulse pressure wave generated by the heart measured at two different points in the body. This
can be achieved by placing probes in different sites and recording waveforms simultaneously.
It can also be measured independently comparing the time delay against an QRS complex
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of an ECG. As equation 3.36 shows, the PWV is the relation between the distance between
of the two measuring points and the time taken by the systolic peak to arrive to the second
point.
PWV = L/∆T (3.36)
Measuring PWV using bioelectrical impedance can be accomplished by estimating the
time difference between both waveforms at the same reference point, which is usually the
systolic peak. Figure 3.14 shows an example of how to calculate PWV placing sensors
along the path of the pressure waveform and the expected signal outcome. This method
requires two or more electrode arrays to measure the differential of electrical potential
along a body segment. Importantly, it can be applied to upper and lower limbs. This
measurement technology has been successfully demonstrated by researchers like Risacher
et al [172] who recorded the measurements using a multi-array electrode system. Some of
the recommendations made by the author about the successful application of this method
include a strong emphasis on the potential sensitivity to noise of this method [174], the use of
high-precision reproducibility by the electrode array, accurate measurement of the distance
separating measuring sites, and high sampling frequency to ensure heightened accuracy
in the calculation of time intervals. However, there are limitations when recording these
signals from a small body where the location and geometry of the electrodes assume prime
significance for this application. It is possible to record this signal from an area as small as
1.5 cm by 7 cm which also increases the possibility of portability [173].
3.9 Impedance plethysmography in the forearm
As noted before, impedance plethysmography is capable of measuring the changes of blood
in different parts of the body. This section will describe how these changes occur in a limb in
greater detail. During this study, localised bioelectrical impedance is found to be the most
suitable method to estimate blood flow within a segment of the human body. The cylindrical
shape of the forearm is a perfect place to measure impedance plethysmography. This location
also provides valuable information about circulatory peripheral illnesses as described in
chapter 2.
Depending on the medical application, an impedance plethysmography instrument (iPG)
device can provide two types of signals: one dedicated to the basal impedance and the other
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(a) Pulse wave velocity measured using bioelectrical impedance between points V1 and V2. Adapted from [173]
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(b) Waveform representation for V1 and V2, the delay between both signals is represented by ∆T
Figure 3.14 Pulse wave velocity between points V1 and V2 using bioelectrical impedance. The PWV calculation
derives from the distance between the electrodes and the time difference between both signals at selected peaks
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one intended for dynamic component. Both signals can be used to provide important medical
information about tissue health and also blood volume. Hence, one significant aim of this
study is to design a device that can potentially include an additional sensing channel to carry
out differential studies in the future.
There is not much variation in the structure of a bioelectrical impedance device, as seen
from figure 3.11 and the impedance plethysmography instrument. The electrodes are the first
points of difference observed from a bioelectrical impedance device. Circumferential band
electrodes are commonly used to take these measurements, as suggested by some studies
[18, 20, 22–24, 175]. However, other studies suggest that there is not much difference when
using single point electrodes such as ECG and band electrodes [176–178]. In fact, these
studies have demonstrated that spot electrodes improve the signal-to-noise ratio and enhance
the quality of the impedance being measured. Infection control is one plausible reason for
this. Using disposable ECG electrodes also curtails cross-contamination in a clinical setting.
While bioelectrical impedance measurements can be achieved with only two electrodes,
impedance plethysmography measurements commonly use four electrodes configurations.
Most of these studies rely on tetrapolar electrodes set-up, which is quite the norm for
volume/flow measurements [19, 21, 22, 120]. As shown by figure 3.15 a pair of electrodes
placed at the outermost part of the segment is used to inject a high-frequency current.
Meanwhile the second pair of electrodes senses the decline in voltage coming from the body
segment. These sensing electrodes are arranged between the current electrodes.
	
	
	
	
	
	
	
	
	
	
I 
V
I 
Current	electrodes	
Voltage	electrodes	
Figure 3.15 Electrodes distribution in tetrapolar configuration. Outermost electrodes (current) inject current
into the tissue. Inner electrodes sense the voltage drop caused by the tissue.
Another difference is the frequency used in iPG to measure impedance plethysmography;
this usually ranges from 10 kHz to 100 kHz [54, 130, 148, 179]. This level of frequency is
large enough to avoid any muscle stimulation that could be hazardous for the patient.
70
3.9 Impedance plethysmography in the forearm
The electrical currents incorporated by this method are in the range of few micro-amperes
(µA) to few milliamperes (mA), confining it within the limits of patient safety, as described
in section 3.1. Clearly, the higher the current, the higher the voltage output response, as
per Ohm’s law (v = R× i); this is because the body segment behaves like a resistor. To
ensure patient safety, it is recommended that current is injected instead of voltage because
circuits can limit the amount of injected electrical current and provide a better control on
the amplitude of the waveform. Overall, the amount of current required to obtain a clean
signal depends on the geometry of the volume being tested, the electrodes geometry, and the
physiological attributes of the tissue.
The data presented by an impedance device can be exhibited as a real or imaginary part
of the impedance. However, it has been demonstrated that operating at these frequencies
does not cause a major difference between the real part and the modulus of the measurement.
In fact, the imaginary component of the signal is less than 12° [180]. Therefore, the modulus
of an impedance plethysmography measure provides sufficient information about the volume
change in a limb section [175]. However, this phase might assume significance if higher
frequencies are used to isolate a particular tissue or physiological event.
As illustrated by the figure 3.16, it is possible to obtain an impedance plethysmography
signal by injecting the required current into the tissue at a specific frequency. One of the most
common signals is a sinusoidal waveform at 50 kHz. Once the electrical signals pass into the
electrodes, they get transformed into an ionic conduction. The interaction of current with the
tissue leads to a decline in voltage that can be detected by the sensing electrodes. From the
electrical viewpoint, an amplitude modulated voltage waveform is generated from the tissue.
However, this modulation remains synchronous to the heart cycle only represents 0.1 % of the
waveform [175]. The impedance modulus is obtained using Ohm’s law (equation 3.37). The
resultant impedance is known as either basal impedance (BI) or resting baseline impedance
(RBI). Moreover, the underlying dynamic signal is known as arterial pulse amplitude (APA).
|Z|= v
i
(3.37)
3.9.1 Blood contribution to impedance
As mentioned before, impedance plethysmography depends on the volume change caused
by blood vessels filling up all areas along the cardiac cycle; blood is highly conductive and
influences the amplitude of the waveform. However, other particular properties might modify
its intrinsic signal. In one of the earliest research works on the conductivity of blood, Sigman
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Figure 3.16 An impedance plethysmography waveform can be obtained by applying a constant current and
sensing the resultant voltage. The division between the potential and the current provides the impedance module
- which is the basal impedance. The arterial pulse amplitude can be seen within the basal impedance.
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et al. [181] demonstrated that blood’s resistivity depends on its flow. It was found that
when blood velocity decreased from 10 cms−1 to 40 cms−1 its resistivity fell by roughly 7 %.
Furthermore, it was found that haematocrit and temperature also affect the blood resistivity
[182]. However, the temperature remains nearly constant in an in-vivo setting. Blood can
be simplified as a suspension of particles (erythrocytes or RDC) using a high resistivity
floating within a conductive medium (plasma). The remaining blood cells do not represent a
significant component of the change of impedance owing to its small size in comparison with
the erythrocytes. In fact, the Sigman effect is absent in either plasma or electrolytes [183].
Blood has also been proven to be electrically anisotropic due to the orientation of the
RBC’s [184]. Moreover, geometry and orientation also end up affecting the reading of
resistivity, which means that direction of measurement also affects the readings.
3.9.2 Impedance plethysmography waveforms
The impedance plethysmography provides important information about the venous and
arterial circulatory properties within a particular bodily segment. The impedance waveform
comprises of a constant impedance value (basal impedance) and a dynamic component within
it (arterial pulse amplitude). However, it is possible to obtain details about peripheral venous
circulation when occluding a limb proximally. This kind of method is known as venous
occlusion plethysmography (VOP).
Figure 3.17 shows the three different components of an impedance plethysmography
waveform. The signal consists of the following components: basal impedance or resting
baseline impedance (RBI), venous volumes changes and arterial pulses.
3.9.2.1 Basal impedance
Also known as the resistive baseline impedance, this is the most significant data obtained
from an impedance plethysmography device (see figure 3.17). The main contributors to
this impedance include muscles, blood and bones. The resistivity of muscles is about
200Ωcm to 300Ωcm, whereas the resistivity of bone and fat is greater than 2000Ωcm and
the blood resistivity is about 150Ωcm [185]. Therefore, this combination of impedances
can be expressed as a parallel model of resistances wherein muscle and blood are the main
contributors of the RBI. The range of this impedance value is from 10Ω to 100Ω.
It has been demonstrated that it is possible to gather information about the development
of ischaemic tissue by studying the changes of baseline during a time. Some studies have
shown that the impedance value increases during ischaemic events in the bandwidth of 1 kHz
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Figure 3.17 An impedance plethysmography device can produce three signals: 1) the basal impedance or
resting baseline resistance; 2) by using a blocking venous return at (40 mmHg to 50 mmHg) to extract the
venous occlusion plethysmography wave; and 3) within the basal impedance is located the arterial pulse
amplitude which changes with the heart beat. Adapted from [175]
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to 100 kHz within different kinds of tissue [54, 130, 148, 179] which is within the frequency
measurement of iPG.
3.9.2.2 Venous occlusion plethysmography
The second signal obtained from the baseline signal provides information about the venous
volume changes. Variations in venous volume tone occur naturally during respiration, which
causes a modulation of the signal during the respiratory cycle between 0.2 Hz to 0.3 Hz.
However, by occluding the venous return, it is possible to produce larger volume variations
represented as a greater displacement of the basal impedance of nearly1Ω or 5 % from the
mean value.
The most common method to evaluate venous volume is known as venous occlusion
plethysmography, which is quite common in the assessment of peripheral vascular diseases
such as deep venous thrombosis. Impedance plethysmography VOP (see figure 3.17) provides
similar results as other well-established methods such as strain gauge[99] and air/water
displacement techniques [186]. This method requires occluding the limb’s proximal section
using a cuff with a pressure above the venous pressure staying usually about 40 mmHg.
The retention of the blood increases the volume of the limb with each heart cycle. The
accumulation of blood in the measured segment increases its conductivity and reduces the
total resistivity. A deviation from up to 10 % from the basal impedance can be achieved
depending on the occlusive pressure, arterial inflow, venous tone, central venous pressure
(CVP), and the capacity of the venous vascular bed.
3.9.2.3 Arterial pulse amplitude
The third signal component of an impedance plethysmography is the arterial pulsations, which
are waveforms synchronous with the heart cycle (1 Hz to 2 Hz). This signal is just a fraction
of the total impedance; it is just 0.1 % of the total impedance signal - approximately 0.02Ω
in the limbs of healthy young adults. Obtaining this signal can be challenging since its values
are in close proximity to noise levels. Therefore, the signal should be isolated by using sharp
filters and averaging some pulses. Changes in the waveform shape are attributed to different
reasons such as tissue volume, arterial inflow, arterial vessel compliance, proximal occlusion,
peripheral resistance as well as electrodes topology, geometry and location. Changes in the
signal amplitude are an indicator of arterial problems. For instance, arteriosclerosis reduces
the arteries elasticity with age. Hence the arterial pulse amplitude reduces in magnitude.
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3.10 Conclusion
Electrical impedance is the response that any conductive medium presents to an alternating
current or voltage. It is frequency dependent and can be described as resistive (R) or reactive
(X), which is determined by the resultant signal being in phase with the source or not.
When applied to the human body, it is known as bioelectrical impedance, which is a non-
invasive method that allows for the analysis of change in the human body using harmless and
imperceptible AC. The current applied on any part of the body should be within the limits of
patient safety.
Electrical impedance applied to humans can examine the health of tissue as well as
changes in blood volume. The measurements produced by this method are attributed to the
ions transport in tissue when a set of electrodes converts electrical current into ionic conduc-
tion. Bioelectrical impedance measurements can perform both whole body measurements
and local body segments. It can be applied using either single or multiple frequencies, or to
perform analysis over a wide range of the spectrum.
Bioelectrical impedance plethysmography measures blood-related changes in the human
body. It is commonly used in a tetrapolar configuration where a pair of electrodes injects
current and a second set measures the voltage drop. Instruments utilising this technology
produce two types of data: basal impedance is the whole impedance contribution of bones,
muscle, fatty tissue, skin and blood. Under normal conditions, this signal tends to be
unchangeable. However, within it lies another small signal that contains information about
the arterial pulsations, known as arterial pulse amplitude (APA).
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Method and protocols
This is the method and protocol chapter. It consists of two section, one describes the design
of the bioelectrical impedance plethysmography device and the second the protocol used to
collect data during the experimental procedure.
The first section shows the work performed to design and implement the iPG device.
In short, the instrument measures the magnitude of the impedance in the forearm using
a tetrapolar configuration at 50 Khz. Complementary information of the schematics and
scripts can be found in the appendix section. The second section describes the protocol of
the experimental procedure along with the calculations performed in order to quantify the
measurements obtained during the test. This study entailed the participation of eight healthy
volunteers, where 4 different instruments were attached to their left limb, including the one
iPG device presented here. The protocol consisted of 30 mins of measurements, while three
different mechanical occlusions were applied to partaker.
4.1 Design of a bioelectrical impedance plethysmography
device
As mentioned in the background section, there are multiple applications where impedance
plethysmography can be applied. Thus far though, this has only been achieved by devices that
can only provide either basal impedance (DC), waveform (AC) or single channel application.
This part of the work describes the design of the device that can be used to encompass any of
the previous applications in a single apparatus.
Designing an impedance device necessitates functional knowledge about the electrical
characteristics of the load under test. Nonetheless, meeting patient safety is a good starting
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point for the recommendations. This implies that the amount of current to be driven by
the device should be imperceptible within the limits of the safety standards. To that end,
one of the first recommendations is to be able to operate by batteries as a class B device in
order to ensure that electrical currents are floating in the patient and guarantee that current
will flow through the segment to be studied. The level of current sensation is predicated on
factors including gender and is also predicated on the electrode geometry. However, Brown
et al. [105] have established a threshold current that is frequency dependent where 5 mA
signifies the limit for sensory nerve stimulation and shock sensation. The device designed
can deliver as many as four levels of current using a dip-switch (1 mA, 2 mA, 3 mA and
4 mA). For the purpose of this document, the current was fixed at 4 mA which provided
excellent sensitivity for the system.
With regard to the electrical current waveform delivered by the device, a programmable
wave generator was included in the design which delivers a sinusoidal waveform at frequen-
cies between 20 Hz to 200 kHz, but for the purpose of this study the frequency was locked at
50 kHz was used during the experimental procedure.
4.1.1 Electrodes topology and location
As described in the section 3.4.1, bioelectrical impedance plethysmography measurements
can be attained with four electrodes. The device implemented for this study used this kind of
interface. A tetrapolar configuration requires four contact points; a pair of electrodes injects
current, whereas another couple sense the voltage. Using tetrapolar arrangement minimises
the decline in voltage during the measurements because the impedance of potential sensing
amplifier is bigger than the interface electrode-skin. This means that electrical current would
not flow between the electrodes and voltage amplifier.
Positioning the electrodes close to the main vessel improves the response of this system
since there is more conductive material where the free ions can flow through. Figure 4.1
illustrates the position of the electrodes to take measurements from the device. According to
the arm anatomy, the radial artery is an ideal site to use one of the current electrodes. The
other one was placed close to the brachial artery around the cubital fossa region where this
vessel is in closer proximity to the surface. The sensing electrodes were placed towards the
right hand side on the elbow, which is the nearest point to the brachial artery connected to
the radial artery thus forming the ideal loop to detect the changes in impedance ∆Z.
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Figure 4.1 General concept of the designed bioelectrical impedance device. It also includes the position of the
electrodes in the forearm.
4.1.2 Bioelectrical impedance device modules
A modular approach was used when designing the bioelectrical impedance device. Every
print circuit board (PCB) module was implemented in Altium Designer with a size of 50 mm
x 50 mm. Using this technique helped isolating any errors without manufacturing an entirely
new system. It also allows the experimentation of different circuits to get the most suitable
solution in order to obtain the most acceptable waveforms. During its development, different
methods were tested to drive current, generate waveform or measure impedance. Towards
the end, this solution was seen to present the best results. The optional modules will not be
included in this thesis since they were excluded from the studies presented here.
Figure 4.1 illustrates the block diagram of the instrument. Operating the device requires:
four ECG electrode, a battery bank, a DAQ card and a PC with LabView [32] installed. In
general, some of the characteristics of this instrument are: differential sine wave generation
through a DDS controlled by an Arduino Uno MCU [187] operating at 50 kHz. Four
different levels of differential current can be supplied 1.33 mA, 2.16 mA, 3.60 mA and
4.36 mA. Current sensing level on electrode E4 and forearm’s potential measurement through
electrodes E2 and E3. The impedance quantification value comes from the measurement
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of the current and voltage peaks. The arithmetic operation takes place on the PC after the
signals have been digitised.
Following the design structure presented in section 3.7, the proposed system can be
subdivided into two sections: 1) front-end, which is the part of the device that interacts
directly with the limb under test; and 2) back-end, which performs the wave generation, signal
conditioning, computational calculation, and data representation. The figure 4.2 displays the
general schematic of this proposed device. The features and characteristics of each module
will be illustrated as follows. The full schematics and part of the code used to control the
DDS can be found in the Appendix section.
4.1.2.1 Power supply module
Implementing an effective design requires good power supplies that can provide steady
voltage output and sufficient current required by the circuitry. Due to the need for applying
floating currents, a power supply was designed to operate using batteries by minimising
ground loops and increasing patient safety. The selection of this method of supplying power
lessens the likelihood of electric shocks and attaining dangerous voltage levels. For these
reasons, a couple of batteries A512/2 S (Sonnenschein) were used to power all the circuits.
These cells provide 2 Ah of capacity per bank. Some of the unique features needed for power
supply includes the ability to provide a dual voltage (±12 V) and (5 V) for analogue and
digital components respectively. Appendix B shows the schematic of the module designed.
In summary, the table 4.1 illustrates the characteristics and IC’s used in the power supply
module. This includes level voltages, output current per channel and the specific function of
each voltage level.
Table 4.1 Components of the Power Supply and its functions
Voltage
supply
Current
supply
IC Function
+12 V 1.5 A LM317 Power supply for single and dual Op-
Amps, In-Amps and as power sup-
ply for +5 V
-12 V 1.5 A LM337 Negative power supply for single
and dual Op-Amps and In-Amps
5 V 100 mA AP117E50G Power supply for digital compo-
nents working at TTL level
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Figure 4.2 Block diagram of the bioelectrical impedance plethysmography device
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4.1.2.2 Direct digital synthesis (DDS) module
Following the block diagram from left to right illustrated in the figure 4.2, the first part shows
the wave generator. This section of the circuit produces the sinusoidal wave required to take
the impedance measurements. This waveform needs to be low in distortion and noise. This
signal was created using a programmable direct digital synthesis (DDS) integrated circuit
(IC) that can produce sine waves from 10 Hz to 25 MHz. The IC used here is the AD5930
[140]. In summation, a DDS creates a wave in accordance to a table of digital words in
memory fed to a DAC that then produces the analogue equivalent. This IC requires a set of
instruction to be able to operate.
A microcontroller ATMEL (Arduino) controls the DDS sending commands via serial
peripheral interface bus (SPI) transmission interface. By making use of an instruction set by
the manufacturer, it is possible to set the oscillation frequency of the sine wave and start/stop
the signal generation. The appendix C shows the code used to communicate with the PC and
send commands to the DDS. The waveform generated by the DDS is differential, implying
that there are two sine waves outputs in a counter-phase (0° and 180°). The DDS provides a
current output of 3 mA which is transformed to an electrical voltage using a 200Ω resistor at
the output of the IC, setting the output at approximately 600 mV. A set of capacitors also
filters high-frequency noises. The connection between the microcontroller and other boards
is made possible using ribbon cables.
4.1.2.3 Differential amplifier gain module
The following stage consists of a differential voltage amplifier which, as its name suggests,
amplifies the sinusoidal waveform coming from the DDS. The gain of this amplifier can be
modified using a set of resistors at each side of the amplifier. It can also be adjusted to 16
different combinations of gain using resistors of 1 kΩ, 2 kΩ, 3 kΩ and 4.99 kΩ. Moreover,
the gain can be adjusted from 0.49 to 4.99 fold the original input. As a result, the DDS’
output voltage changes in accordance to the gain determined in the differential amplifier.
Owing to the fact that the DDS provides a DC coupled sine waveform and high-frequency
noises, the input of the DGA incorporates a band-pass filter, formed by a DC blocking
capacitor along with a low pass filter set to 1 MHz. The output of this differential amplifier
also includes another set of passive band-pass filters to eliminate any residual noise. The
figure B.7 in the appendix B shows the schematic.
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4.1.2.4 Modified Howland Amplifier module
This is a very popular circuit method used in bioimpedance analysis (BIA) measurements
[188], tissue characterization [103, 142], electrical impedance tomography (EIT) and diag-
nosis of breast cancer [149, 189]. It can be constructed using a single operational amplifier
(Op-Amp) as well as a handful of resistors [190]. Subsequently, a transconductance amplifier
is used to convert the voltage coming out from the differential amplifier into an electrical
current. Selected current will be passing through the patient. The chosen configuration is a
modified Howland circuit (MHC) set to 1 mS of gain. The Figure 4.3 illustrates the MHC
configuration that offers wide bandwidth operation and low power consumption.
Figure 4.3 Modified Howland circuit schematic
The MHC design requires low tolerance resistors to minimise potential errors caused to
the system. As a result, the resistors of 1 kΩ and 100 kΩ with a tolerance of 0.1 % were used
in the final implementation. Figure 4.3 shows the implemented schematic of the differential
MHC, only the top Op-Amp is analysed to prove that the equivalence was met, the one on the
bottom follows the same equations but with an inverted output. The circuit’s resistors from
the equation are equivalent to the followings: R2A = R1,R2B = R2,R1 = R3 +R4,R3 = R5
and R4 = R6. Thus, the equation can be re-written as follows:
83
Method and protocols
R1+R2
R3+R4
=
R6
R5
(4.1)
where R1 =R4 =R5 =R6 = 100KΩ and R2 =R3 = 1KΩ. Finally, the resistor equivalence
is calculated as shown by equation 4.1.
The transconductance of this circuit was calculated from equations 4.1. After the same
resistors equivalence that were previously described, the positive transconductance (G+m) and
negative transconductance (G−m) were calculated as described by the following arithmetical
operations:
G+m =
iout
vin+
=
100KΩ+1KΩ
101KΩ×1KΩ =
101KΩ
101MΩ
= 1×10−3S (4.2)
G−m =−
iout
vin−
=
100KΩ+1KΩ
101KΩ×1KΩ =
101KΩ
101MΩ
=−1×10−3S (4.3)
As can be seen from 4.2 and 4.3, the transconductance in both feedbacks is equivalent to
1 mS. The negative sign in G−m is caused by a phase shift of 180°. Due to the fact that top and
bottom Op-Amps shown in figure 4.3 has the same design, the total transconductance of the
circuit in differential mode is equal to 1 mS. In other words, for every volt generated at the
input (pins input- and input+) the output produces 1 mA of electric current. By interfacing
the previous DGA module with this one, it becomes possible to produce sixteen different
levels of current. Nonetheless, for the purpose of setting the instrument, only one switch
should be activated at a time to provide fixed currents of 1.33 mA, 2.16 mA, 3.60 mA and
4.36 mA.
The design also includes a high-pass filter at the output of the circuit. These RC networks
act as DC decoupling and ground clamping because floating loads can witness DC offset
coming from the signal, which might cause an error in the current. However, these capacitors
also have an effect on the bandwidth of the circuit. The resistor, which could be the potential
output impedance of the MHC, was chosen to be as high as possible (1 MΩ).
fc =
1
2πRC
=
1
2π1MΩ1µF
= 0.159Hz (4.4)
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4.1.2.5 Current and voltage sensing module
As shown in figure 4.3, at the output of the transconductance, amplifier resistors Rs of 10Ω
were placed at each side of the differential output. These small resistors sense the electrical
current passing through the unknown load. Using Ohm’s law v = R× i, it is possible to
convert this current into a proportional voltage value. However, by combining a small flowing
current around mA with a tiny resistor value, the voltage obtained is in the order of mV .
Consequently, this resultant voltage is too close to the noise level, and hence cannot be
detected by any analogue to digital converter. Therefore, using a high input impedance
amplifier is important to avoid current leakage through the current sensing IC and improve
the signal to noise ratio.
An instrumentation amplifier with high input impedance and adjustable gain was used
convert the flowing current into an equivalent potential. Figure 4.4 shows how the differential
signal was taken from resistor Rs which converts current i0 into equivalent voltage Vs.
SW-Gain
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0i
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Figure 4.4 Current sensing circuit schematic
Likewise, this same circuit was used to detect the voltage produced by the limb segment.
When the biological sample is excited with an electrical current, it leads to the emergence of
a potential, as described in section 3.2. To that end, the electrodes E2 and E3 (see figure 4.1)
provided the connection towards the input pins of the In-Amp AD8421 [121]. The robust
input impedance of this IC and typical input bias current of 1 nA guarantees minimal voltage
drop from the interface electrode-skin. Therefore, the maximum error introduced by this
voltage drop is close to 0.0001 % per mA which flows through the body segment. The gain of
the In-Amp can be modified using its gain pins, increasing the dynamic range of the sensing
circuit. Consequently, a dip-switch 4 SPST was used to provide as many as 16 different
combinations of amplification that could be adapted as per the nature of the signal. The final
schematic can be appreciated in the appendix B figure B.13.
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A sensing module was manufactured by combining the current sense and two channels of
potential. Channel one was used to detect the voltage produced by the limb segment, whereas
the second channel will be used for future studies carried out on differential impedance
measurements. The only difference between the current and potential circuits is the selection
of gain resistors that were allocated in accordance to the range of the signals to be detected.
The output signal produced by this module is then passed through a peak and envelope
detection circuit as described in the next section.
4.1.2.6 Envelope detection and AC extraction circuit module
This module has two functions: the first one detects the peak value of the current and voltage
sensing circuit, whereas the other one extracts the plethysmography waveform contained
within the baseline impedance. Hence, three output signals are produced by this module. The
first signal is a DC voltage equivalent to the amplitude of the voltage detected by the current
sense path denominated IDC. The second output channel is a DC signal equal to the potential
detected on the limb segment denoted by VDC. The third one is an AC signal that represents
the dynamic plethysmography signal or arterial pulse amplitude called VAC
The envelope or peak detection is achieved using a ”super diode” or ”perfect diode”
circuit, which is the combination of an active diode configuration and a hold circuit. In
short, the Op-Amp complements the diode’s voltage drop when the signal crosses zero. The
negative feedback resulting from the output of the diode towards the negative pin of the
Op-Amp mitigates the diode’s voltage drop. Resultantly, the output signal at the cathode’s
diode is essentially a half-wave rectified waveform crossing by zero. The figure 4.5 shows a
model of this circuit.
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Figure 4.5 Envelope detection circuit schematic
The signal obtained by the super diode circuit is passed on to a hold circuit denoted
by CE and RE in the figure 4.5. This RC configuration keeps its charge for a period of
the signal produced by the wave generator, as described in section 4.1.2.2. The frequency
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for measuring impedance plethysmography was selected at 50 kHz which implies that the
distance peak-to-peak is 20 µsec. The time constant (τ) of the RC network can be calculated
by the following equation:
τ = RC = 1µF×120KΩ= 0.12Sec (4.5)
The holding time of the RC network at 5× τ is 0.6 sec, which implies that this RC
combination can detect the peak of a signal with a frequency as low as 1.66 Hz. Consequently,
this circuit produces a DC voltage signal equivalent to the peak value of the input signal.
This makes it possible to generate the signals of channels IDC and VDC (see figure 4.2) which
are the voltage representations of the current driven by this device and the voltage provided
by the unknown load. Therefore, basal impedance is estimated by dividing the potential
over the current values. This calculation was performed during the post-processing stage in
Matlab [33] after digitisation.
The APA waveform can be extracted by isolating and amplifying the dynamic component
within the basal impedance. Therefore, the unbuffered signal from channel VDC channel gets
passed through a a band-pass filters with low-frequency cut at 10.26 mHz with a roll-off of
20 dB/decade as well as a high-frequency cut at 10.26 Hz with a roll-off of 40 dB/decade.
Appendix B figure B.16 explains the design of the circuit and filters used..
Finally, the envelope detection module was manufactured in accordance to these design
considerations. The output channels from this PCB are the ports which are known as IDC or
peak current value; VDC or peak impedance potential and VAC or arterial pulses.
4.2 Experimental Procedure
This section of the chapter describes the protocol of the experimental procedure along with
the calculations performed in order to quantify the measurements obtained during the test.
This experimental procedure and protocol gained the approval of the City University London
Research Ethics Committee. Examination authorised under reference ”SREC 15-16 01 E 29
09 201” of the 11th of November 2015.
This study entailed the participation of eight healthy volunteers; six of these participants
were males the remaining ones were females aged between 23 to 37 years-old (mean 28.77).
Prior to their recruitment, the participants received the documentation which explained
the entire procedure to them. Upon their approval, the party returned the consent form
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signed in order to schedule the study. The experiments took place at the Research Centre
for Biomedical Engineering of City, University of London. Upon arrival, the participants
acclimatised for 10 min wherein the room temperature was 22±2 ◦C. During this period, the
experimental procedure was clearly explained to the attendant. After filling paperwork and
completing the acclimatisation process, the instruments described in table 4.2 were used to
acquire the physiological signals used for the present study.
Table 4.2 Instruments used during the study and measurements taken
Instrument Device Method Measurement
ECG Cardioline® Delta 60
plus [191]
Sense of electrical
charges in heart
4 electrodes electrocardiogram
PPG Zen PPG Optical Measurement of changes of
volume in vascular bed using a
light source at 680 nm
LDF Moor VMS-LDF2
[192]
Optical Measurement flow in capillary
bed (Cell level) using a laser
light at a wavelength of 785 nm
Doppler
Ultrasound
Huntleigh MD2 [71] Electromagnetic Measurement of flow speed with
a sensor head of 8 MHz
iPG Bespoken Electrical Measurement of changes of
volume in a segment using
tetra-polar electrode
configuration
4.2.1 Instruments set-up
This section describes all the steps taken to attached the instruments on the participants.
Figure 4.6 illustrates the entire experiment set-up is, including sensors positioning from the
different methods. First, all the participants sat in a comfortable chair. Their left arm rested
on a soft cushion atop a table placed next to a chair that was adjusted to collaborator’s height.
Subsequently, blood pressure was taken using an automated instrument by recording diastolic
and systolic values for each one. Then, each participant positioned ECG electrodes on
themselves to form an Einthoven triangle. According to the device’s instructions, electrodes
need to be placed on each shoulder and ankle. Leads were secured to the electrodes in order
to verify that ECG signal was clean. The apparatus includes an output port that exports the
waveform for further processing.
As the next step, the PPG probe from the zen device was placed on the index finger. This
instrument was designed by the biomedical research group of City University. This equipment
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Figure 4.6 Instruments position in the forearm during the experiment procedure
has two available channels, but the experiment required just one port. Each channel provides
two outputs containing AC and DC components of the photoplethysmographic waveform.
Next, the laser Doppler Flowmetry probe [192] was attached on the forearm’s mid-section.
This device detects moving red blood cells within a vessel below the vascular bed in the
skin. In addition, this device has an external analogue port where the acquired signal can be
exported for post-processing.
The Doppler ultrasound probe was then placed as close as possible to the radial artery.
When the probe is placed closed to the main vessel, the speed of blood flow produces a
unique audible signal. However, calculating blood flow from this signal requires a set of
distinct skills by placing the probe at a fixed angle and maintaining closeness to the artery
for a good measurement. Therefore, the probe head of the instrument needs to be placed at a
fixed angle. Hence, the instrument’s head was secured using a laboratory stand and clamp
that was pointing at the party’s radial artery on the wrist. The appliance also features an
external port for additional off-line processing.
Finally, the impedance plethysmography electrodes were placed on the forearm’s skin.
To do so, ECG electrodes were used since they provide a good contact point, which is
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essential to carry out the experiment successfully. The electrodes were placed as show in
figure 4.1. The diameter of the circumference around these electrodes was recorded along
with its distance separation, as well as the distance from heart to shoulder, upper arm length,
and shoulder to index finger. These physical measurements facilitate the calculation of the
volume of the forearm’s segment that is to be measured.
4.2.2 Physiological measurements
The physiological measurements of the participants were taken at the beginning of the
study collecting data such age, sex and arm to heart length. The table 4.3 summarises
the information provided by all the participants. The ages of participants ranged between
23 year−old to 37 year−old (mean 29.12±4.94).
Table 4.3 Participants’ age, sex and forearm measurements
Dimensions [cm]
Age Sex Arm length Shoulder Total length
to heart
Participant 1 26 Male 80 26 106
Participant 2 23 Female 66 24 90
Participant 3 27 Female 74 24 98
Participant 4 37 Male 68 24 92
Participant 5 29 Female 62 24 86
Participant 6 36 Male 70 24 94
Participant 7 29 Male 73 23 96
Participant 8 26 Male 69 23 92
In addition to these measurements, the distance between impedance potential electrodes
(E2 and E3) and the arm circumference was simultaneously recorded using a measuring tape.
This data makes it possible to estimate the forearm’s segment total volume by gauging the
total distance between the potential electrodes (l), and the circumference of each electrode’s
location (C1 and C2). Table 4.4 illustrates the dimensions of the participant’s forearm between
the sensing electrodes and the segment’s volume as calculated from Equation 4.6.
Ve =
l× (C21 +C1×C2+C22)
(12×π) [cm
3] (4.6)
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where Ve denotes the segment’s volume, l represents the length between the potential
electrodes, and C1 and C2 are the circumference measurement at elbow and wrist electrodes,
respectively.
Using a measuring tape to accommodate these dimensions may induce some errors in the
data. For instance, applying excessive pressure on the arm, when taking the measurements,
may provide a lower circumference value. However, this also allows estimating the initial
volume of the forearm segment which signifies the original volume of the conductive portion.
Table 4.4 Participants’ forearm dimensions and initial total volume
L [cm] C1 [cm] C2 [cm] Ve [cm3]
Participant 1 14.8 17.5 27.5 606.05
Participant 2 11.0 15.0 20.0 269.90
Participant 3 13.0 19.0 26.5 540.27
Participant 4 10.0 17.5 25.0 363.07
Participant 5 10.0 17.5 23.5 336.81
Participant 6 11.0 18.5 27.0 458.32
Participant 7 13.5 15.0 23.0 393.55
Participant 8 11.5 17.0 23.5 378.49
4.2.3 Experimental protocol
One of the key endeavours of this experiment is to look into iPG waveform alterations in case
of an obstruction in the blood flow towards the forearm. Restricting blood circulation in this
area is possible by applying a mechanical blockage on the upper left arm using a standard
inflatable blood pressure instrument. The device necessitates being pumped manually using
an inflation bulb. A gauge in the instrument indicatives the cuff’s pressure level.
The protocol entailed the recording of three different types of blood flow occlusion. The
first kind restricts blood flow return by blocking the venous circulation. This method is
extensively used to assess peripheral circulatory problems using a Venous Occlusion (VO)
Plethysmography technique as described by Wilkinson et al. [15]. This obstruction can be
produced by inflating the cuff usually just below the diastolic pressure between 10 mmHg
to 20 mmHg. Therefore, blocking the upper arm obstructs blood flow within the median
cubital and basilic veins without obstructing the brachial artery’s arterial inflow. Overall, the
target pressure of the study was 20 mmHg for each participant under their diastolic pressure
recorded at the start of the session.
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A partial arterial occlusion (PAO) was the second class of blood flow limitation. This
kind of blockage lowers the amount of arterial blood coming into the forearm but also
impedes venous blood return. Studies have demonstrated that constricting an artery lowers
the arterial flow towards the periphery [193]. This can be obtained by applying a mechanical
compression on the upper arm between diastolic and systolic pressures, thereby intensifying
the wall pressure of the brachial artery. The midpoint of the partaker’s blood pressure was
calculated using the following equation.
Pm =
Pd +Ps
2
[mmHg] (4.7)
where Pd is diastolic pressure and Ps is systolic pressure.
The last kind of occlusion needed is total occlusion (TO), which can be achieved by
obstructing blood flow above systolic pressure. Also known as "Suprasystolic" or "stop-flow",
it can provide valuable tonometric information [194]. In this experiment, blood flow was
blocked by inflating the cuff 20 mmHg above participant’s recorded systolic value. This
method of occlusion completely restricts the inflow and outflow of venous and arterial blood.
Hence, no change of volume is expected to take all along this part of the test.
4.2.3.1 Blood flow occlusion protocol
In order to estimate the blood pressure point to achieve venous and arterial occlusion on
each participant, the normal blood pressure of each of them needed recording. For this, the
blood pressure of each participant was taken using an automated blood pressure instrument
brand Omron IntelliSense (Omron Healthcare). The mean systolic and diastolic pressures of
all the partakers of this investigation were 116.25±13.66 mmHg and 72.75±7.23 mmHg
respectively. The venous occlusion level was targeted at 20 mmHg below systolic pressure
the total mean was 55±8.01 mmHg, the partial arterial pressure was calculated using the
equation 4.7, the average was about 94.63±10.21 mmHg and total occlusion was around
136.25±13.67 mmHg. Table 4.5 details the blood pressures recorded per participant and the
pressures used during the experimental procedure.
The whole protocol required a total of 30 min to record all the signals from the instruments
presented in table 4.2. At the commencement, 5 min of data were collected during baseline
blood pressure. Then, immediately the cuff was inflated rapidly to 20 mmHg below the
diastolic pressure, thus producing venous occlusion along with an increment in the total
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Table 4.5 Participants’ initial blood pressure and levels for venous, partial arterial and total occlusion
Blood pressure Occlusion 1 Occlusion 2 Occlusion 3
(VO) (PAO) (TO)
[mmHg] [mmHg] [mmHg] [mmHg]
Participant 1 124/78 50 101 144
Participant 2 105/65 50 85 125
Participant 3 120/78 60 99 140
Participant 4 120/72 60 96 140
Participant 5 100/60 40 80 120
Participant 6 143/82 60 113 163
Participant 7 107/73 65 90 127
Participant 8 111/74 55 93 131
volume of the forearm due to blood pooling effect. This level of blockage was held for 3 min
followed by swiftly deflating the cuff.
The next step required producing the partial arterial occlusion using similar time spans as
the ones that were used during venous occlusion. As described previously in the literature,
reperfusion following an occlusion does not affect blood pressure, heart rate or blood flow
[195]. Hence, 5 min provides sufficient time to restore the blood flow to normal limits. It is
for this reason that the cuff’s air valve was left open to bleed all the air inside. Subsequently,
the cuff was quickly inflated again until reaching the pressures shown in column Occlusion 2
of table 4.5. The cuff’s pressure was maintained at this level for 3 min followed by a quick
release of pressure.
Last, a similar method was applied for total blood occlusion. Yet again, 5 min of baseline
waveforms were taken followed by a fleeting cuff inflation to 20 mmHg above the diastolic
pressure. This compression was kept for 3 min. At this point, maintaining this tourniquet
effect can become painful after a couple of minutes. As a result, some of the helpers ended up
re-accommodating producing motion artefacts in the data. Finally, the last 5 min of baseline
waveforms were recorded in order to study the recovering effect.
Figure 4.7 illustrates the pressure levels applied during the entire experiment. For a better
understanding of the different stages of this experiment, each event was identified as a region.
Thus, the regions 1, 3, 5 and 7 represent the non-occlusive events or baseline readings. In
contrast, regions 2, 4 and 6 are equivalent to VO, PAO and TO events.
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Work done – Experimental procedure
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Figure 4.7 Pressure applied to the participant’s upper arm during the experiment. The clear areas represent the
resting period of 5 min, and the shaded areas denote the pressure applied at the desired level during 3 min. All
the regions have been denoted for reference during the analysis.
4.3 Data processing
All instruments used in this experiment provided the external analogue ports for further data
processing. These output ports were connected to a DAQ NI-6211 (National Instruments).
All signals were sampled at 1 kHz with a reference voltage between 0 V to 10 V for the iPG
channel VDC and ±5 V for the other signals. Therefore, the resolution of DAQ was 152.6 µV,
which was calculated using equation 4.8.
Res =
Vp−p
2n
[V] (4.8)
where Vp−p denotes the reference voltage peak to peak with n being number of bits used
to sample the signal.
A virtual instrument using LabView [32] was created to display, process and store raw
data. In the main tab, the custom virtual instrument was able to display the live waveforms
of the iPG, ECG, PPG and Doppler ultrasound instruments. Band-pass filters were applied
to the iPG and PPG signals, removing unwanted DC components as well as high frequency
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noises. The waveforms from other instruments did not necessitate filtering since the devices
served clean signals.
The virtual instrument also included configuration capabilities. Two tabs in the program
featured a field for physical measurements, general application settings and other adjustment
for the PPG instrument. The participant tab recorded the following measurements: left arm
dimensions, blood pressure and file path name. Once this experimental procedure completed,
all raw data were stored on a LabVIEW Measurement file format (LVM).
The data imported from the LVM file was decimated to speed up the post-processing time
in Matlab [33]. All the waveforms were down sampled to a frequency of 100 Hz. Notably,
this data decimation does not impact the waveform data. In fact, according to Nyquist [196]
rate, data was over sampled. Physiological signals are between 1 Hz to 3 Hz depending
on the heart rate. Thus, 6 Hz would have provided sufficient sampling frequency for the
waveforms. Nevertheless, the new sampling frequency accommodates a high resolution of
the discrete-time signal which allows the implementation of high order digital filters with
sharp cut-off frequencies.
After importing decimated data into Matlab, a custom parsing program converted and
saved each waveform into a Matlab file format (.mat). A Graphic User Interface (GUI)
Matlab program was created to compare four waveforms time while simultaneously applying
filters, finding peaks and windowing different sections of data. A front-end of the application
can be seen in figure 4.8. Placing the data into Matlab file format accelerates the loading in
memory (of the data) and the waveform presentation within the GUI. Another advantage of
such a file conversion is that data processing can be performed online without using extensive
computing resources.
4.3.1 Data conversion
The data imported into the GUI represents the volts of the entire physiological measurements.
Therefore, this information must be converted into significant values that denote the physical
variable. This section describes the mathematical equations and tools used to convert the raw
signals effectively in greater detail.
4.3.1.1 Calculation of the basal impedance value
Impedance plethysmography signals must be converted from volts and current values into
its standard scale, which is Ohms (Ω). The iPG device has a channel for current sense
known as IDC, whose voltage is equivalent to the peak value of the current that is being
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Figure 4.8 Matlab application GUI used to qualify data and post-processing the signals acquired
delivered by the instrument. The effective electrical current in amperes (A) can be calculated
by the gain relation of the various stages of the signal path. In accordance to the circuit
schematic (see figure 4.3), the electrical current is being sensed by a 10Ω resistor (Rs) in the
module Modified Howland Amplifier module (see section 4.1.2.4). Subsequently, this signal
is amplified by an instrumentation amplifier in the current and voltage sensing module (see
section 4.1.2.5) which gain (G1) was fixed to 276. Following the signal path, the waveform
is fractioned by the super-diode circuit, which acts as a half-wave rectifier in the envelope
detection module (see section 4.1.2.6). The hold circuit keeps the DC voltage constant at
the signal output, which is equivalent to the peak value of the current in volts. Thus, the
electrical current in amperes can be calculated using the equation 4.9.
I =
VIDC×2
Rx×G1 =
VIDC×2
276× 10Ω =
VIDC
1380Ω
[A] (4.9)
The second channel of this iPG device labelled VDC produces a DC voltage tantamount
to the impedance of the forearm. Similarly, as the current senses voltage path, the channel
passes through a series of circuits that amplifies the original potential being sourced from the
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forearm’s segment. Therefore, the actual voltage detected by the device can be debunked by
the numerous gains involved during the signal path.
First, the unknown load is sensed by the potential electrodes (E2 and E3 in figure 4.1)
directly connected to the voltage sense module (see section 4.1.2.5). The instrumentation
amplifier (AD8421) of this module was configured to a gain 35.65. In the envelope detection
module (see section 4.1.2.6), the signal was rectified using the super-diode circuit and halving
the signal amplitude. As a result, the voltage can be deducted by using equation 4.10.
Vz =
VZDC×2
35.65
[V] (4.10)
where VZDC denotes the DC voltage coming from the port VDC.
Finally, the impedance value can be computed by converting the voltage into impedance
using Ohm’s law [197]. This can be accomplished by replacing equation 4.9 and 4.10 into
4.11. The GUI programmed in Matlab automatically carries out this impedance conversion
when the signal gets loaded in the GUI. This mathematical operation is undertaken by a
point-to-point division between the two signals after subtracting their gains from their raw
values.
Z =
v
i
=
Vz
I
[Ω] (4.11)
4.3.1.2 Calculation of the Arterial Pulse Amplitude value
The third channel is the APA signal designated as VAC. This waveform is an amplified version
of the dynamic signal within VDC. During the course of analysing the signal’s path, it can
be seen that the two circuits work on the waveform in tandem. First, it is the circuit from
where this signal originates which is the same voltage as seen in port VDC, implying that
the gain described in the previous section also has an impact on the signal VAC. The second
circuit which affects the signal is the band-pass filter within the envelope detection module
(see section 4.1.2.6). As can be appreciated in the appendix B figure B.16, this filter entails a
fixed gain of 142.42 and eliminates any kind of DC and high-frequency noise components.
Subsequently, the voltage of the plethysmography wave can be found by combining both
gains using the equation 4.12.
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VAPA =
VZAC×2
142.42×35.65 =
VZAC
2538.66
[V] (4.12)
where VZAC denotes the raw AC voltage coming from the port VAC.
Likewise, the dynamic signal’s impedance value (VAC) can be calculated using Ohm’s law
[197] by replacing the APA voltage from equation 4.12 as well as current from equation 4.9.
In Matlab, this impedance value is calculated as soon as the signal gets selected by applying
this mathematical formula.
ZiPG =
v
i
=
VAPA
I
[Ω] (4.13)
4.3.1.3 Converting ultrasound to flow
The instrument used in this study was a Huntleigh model MD2 with sensor type VP8. The
frequency of the transmitter is 8 MHz which makes it ideal for blood flow estimation. The
principle of this device pertains to the frequency of a source to its velocity relative to a sensor
[69]. Put simply, if an electromagnetic wave gets transmitted at a fixed frequency and is
reflected by a moving body, the frequency of the received signal will be shifted [71].
The device can detect moving blood cells inside a vessel. When a cell passes through the
electromagnetic beam, a frequency shift occurs that is proportional to the blood flow velocity.
Nevertheless, this Doppler shift is also affected by the angle of the head of the probe along
with the direction of the flow [69].
Since the average velocities found in the human body lies within the hearable frequency
range, the device reproduces this as an audible sound with the help of a speaker. The
apparatus has an output channel that produces the equivalent analogue signal for further
processing. According to the service manual of this instrument, a 3.5 V signal equals to a
8 kHz shift signal at the output [71]. Keeping this voltage as a reference, the shift frequency
can be calculated using the equation 4.14.
fD =
VDU ×8KHz
3.5V
[Hz] (4.14)
where VDU represents the analogue output voltage of this instrument.
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As per the Doppler equation described in 4.15, the velocity of a blood cell derived from
its frequency shift can be found. However, there is a correction angle (θ) between the
ultrasound beam and the direction of blood flow. Fixing the angle to a set value ensures that
all the measurements have the same correction index. As a result, the head of this instrument
was positioned at a 45° angle to the radial artery on the wrist.
v =
fD×C
2 fO×Cos(θ) [ms
−1] (4.15)
where fD represents the Doppler frequency, C denotes the speed of sound assumed to
be 1540 ms−1, f0 refers to the oscillation frequency of the Doppler instrument. In this case,
8 MHz and θ the angle between the ultrasound sensor and the target vessel, which is at 45°.
The position of this angle was locked using a laboratory stand and a clamp. The angle
was fixed to 45° using a goniometer. Nevertheless, this is one of the shortcomings of this
method. The angle can be estimated based on the position of the sensor’s case, but not to the
surface of sensor crystal. There is an incident error that cannot be quantified easily. However,
for this study, the angle was established to be at 45°.
The velocity can be converted into the blood flow if the vessel’s cross section area vessel is
known, as shown by equation 4.16. Not being precisely aware of this area is another drawback
of this method during the course of calculating blood flow accurately. Evaluating the real
cross section area of a vessel requires imaging techniques such as Doppler Ultrasonography.
Q˙ = v×A [m3 s−1] (4.16)
where Q˙ represents flow, v is the velocity of the blood cell and A denotes the cross-
sectional area of the radial artery.
However, blood flow can be estimated by using the average cross-sectional area of radial
arteries withn the general population. A study found that males have a slightly larger radial
arteries diameter as compared to females (2.3±03.9 mm and 2.11±0.29 mm respectively)
[198]. These dimensions were used to calculate the blood flow in the current experiment.
This information can be converted into a more conventional scale of a litre per minute by
multiplying it by 60 s and converting m3 into litres.
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Q˙ = v×A×60×1000 [m3 s−1] (4.17)
Another drawback of this method is that it needs to be positioned as close as possible to
the vessel. Highly skilled technicians can identify the difference in sounds between arteries
and veins. For this experiment, the position of the sensor was on the wrist are where the
radial artery is closer to the skin. The position of the instrument’s head was selected in
accordance to the loudest sound when measuring this area. The GUI programmed in Matlab
allows the conversion of UD waveform into blood flow straight from the front panel using
the equations described here.
4.3.1.4 Converting LDF
The Laser Doppler Flowmetry device utilised in this study was the Moor VMS-LDF in-
strument [192]. LDF is a non-invasive optical method used to estimate the blood perfusion
within the microcirculatory bed under the skin. This device uses the same Doppler principle
which is described in section 2.5.1. However, instead of sound, the source is a beam of light.
Similarly, when a red blood cell scatters a light of beam, it ends up producing a frequency
shift [6].
LDF produces a blood perfusion signal comparable to the RBC perfusion, also known as
flux. The units of this measurement include Blood Perfusion Unit (BPU),an arbitrary unit
scale. BPU denotes the product of the mean number of moving blood cells into the small
volume under probe as well as the average velocity of moving blood cells.
This instrument provides an output port that allows for the export of this waveform. This
connector provides a signal between 0 V to 5 V which varies in accordance to the flux signal.
The configuration menu allows the medication of output scale. It provides three steps at the
peak limit of 1000 BPU, 500 BPU and 100 BPU output for 5 V. The measurements taken
in this study were below 100 BPU. Hence, equation 4.18 converts the output voltage into
BPU’s.
BPU =
VBPU ×100
5V
(4.18)
Using this equation, the data in the Matlab GUI can be displayed using the correct
notation. This formula is applied to the data as soon as it gets imported into the software.
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4.3.1.5 Volume and flow calculation beat by beat from iPG signal
Impedance plethysmography also allows for the calculation of the change in volume as well
as the blood flow from every heartbeat [21, 30, 175, 199]. Achieving this calculation is
possible if there is high-quality plethysmography waveform. For this reason, the impedance
device includes an analogue port called VAC. As described previously in chapter 4.1, this port
extracts the plethysmography waveform from the basal impedance channel VDC. As a matter
of fact, due to the filtering as well as amplification stages of the circuit, the signal has been
amplified more than 2.500 times, thereby providing additional details of the signal’s features
and increasing its resolution after the digitisation.
The APA waveform as shown in figure 4.9 signifies a classic example of a plethysmog-
raphy wave starting from point L1 and finishing in L2. Notably, this signal is inverted in
impedance because an increase of blood indicates a surge in conductivity. As a result, there
is a reduction in impedance of the segment being measured.
L1 A B C L2
R1 R2
Figure 4.9 APA waveform representation.
The APA signal shows five specific reference points required to calculate volume and
blood flow. During the systolic process, two planes are evident in the plethysmography wave.
The first one is the upslope of the signal (L1) during the isovolumetric contraction of the
heart. This point marks the beginning of the plethysmography signal. Next, owing to blood
ejection from the heart, the aortic outflow raises the pressure within the circulatory system.
Therefore, an increase in blood flow is noticeable, which is pronounced as the maximum
amplitude in the plethysmography signal denoted as A in figure 4.9.
During the heart cycle’s diastolic development, the next observable reference point in
the plethysmography wave is the dicrotic notch. This waveform appears after a decline in
pressure within the circulatory system. In the APA wave shown in figure 4.9, two points can
be seen within this region. The dicrotic notch is located precisely at the landmark B followed
by a tiny peak C which marks the post-dicrotic notch segment or diastolic pulse.
101
Method and protocols
Finally, the cycle gets completed with the last dip in the APA waveform identified as L2.
It also marks the beginning of the next volumetric cycle. In the wake of these landmarks
in the waveform, it is possible to calculate blood flow from the following set of equations
adapted from [29]. First, the average basal impedance (RB) during the course of a pulse cycle
can be calculated by averaging the resistance values at points L1 and L2. The mathematical
operation used in Matlab GUI to calculate this basal impedance between cycles was equation
4.19.
RB =
RL1+RL2
2
[Ω] (4.19)
Subsequently, the extrapolation of the reference points from the APA pulse given by the
Nyboer back-projection [29] must be conducted. This value is equivalent to dR/dt in other
blood flow equation; instead, two reference points are used. The equation 4.20 exhibits the
mathematical operation used to calculate this value.
EXHT = (RB−RL1)+ (tB− tL1)(RA−RB)tB− tA [Ω] (4.20)
Another key physiological measurement used to calculate blood flow is the heart rate that
can be obtained directly from the APA waveform. The HR is equivalent to the difference
of time in a cycle multiplied by 60 s. Using equation 4.21 the heart rate in beats per minute
(bpm) can be estimated as follows.
HR =
60
(tL2− tL1) [bpm] (4.21)
The segmental blood flow beat to beat can be calculated using the Nyboer’s equation
4.22. Equation 4.23 illustrates the equivalent mathematical operation in function of the heart
rate that is obtained from equation 4.21 as well as the extrapolated APA pulse amplitude
denoted by equation 4.20.Due to the fact that the HR has been included in this equation, the
units of this formula are ml/min.
∆V
∆t
= ρ
l2
R2B
× ∆R
∆t
(4.22)
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BF = HR×EXHT ×ρ l
2
R2B
[ml/min] (4.23)
where BF represents the blood flow expressed in ml/min, ρ is the specific resistivity
of blood 150Ωcm−1 [102, 199], and l denotes the distance between sensing electrodes
(E2−E3).
Blood flow can be observed in different forms. For instance, it can be represented as
either flow per total volume of tissue between the potential electrodes or as a fraction of
that volume, since clinical use is usually represented as 100 ml of tissue. The equation 4.24
calculates the blood flow per total tissue volume.
BFV E =
BF
Ve
×1000 ml [ml/min l] (4.24)
where BFVE denotes the blood flow per litre of volume ml/min l, BF represents the
blood flow found in 4.23, Ve is the forearm’s segment volume in cm3 from equation 4.6 and
1000 ml is the scaling factor that converts the volume into litre.
The other option is to denote the rate of blood flow in the standardized form per 100 ml
of volume of tissue, also known as Perfusion Index (PI). As a result, the blood flow must be
segmented to 100 ml of tissue. The total volume can be derived from equation 4.6. Thus, the
PI can be calculated using the equation 4.25.
BF100ml =
BF
Ve
×100 ml [ml/min100ml] (4.25)
To reiterate, all these flow equations were implemented in Matlab to calculate the blood
flow rate during venous occlusion and beat-to-beat.
4.4 Conclusion
This section described the hardware design of an impedance plethysmography device which
senses the current delivered as well as the potential generated by an unknown load in the
forearm, A shows the final circuit assembly used for the experiments presented in this
thesis. The design of this device was replete with patient safety features by delivering an
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imperceptible electrical current. The electrical characteristics of the bioelectrical impedance
device included a wave generator (using a DDS) capable of producing a sine waveform of
50 kHz delivering four different levels of current between 1.33 mA, 2.16 mA, 3.60 mA and
4.36 mA (using a Modified Howland Circuit). The measurement of impedance was made
possible by measuring the delivered current and the potential measured. The sensing circuits
were implemented using high input impedance instrumentation amplifiers to guarantee high
noise rejection.
One of the unique features of this instrument is the capability to produce not just the
total impedance of a targeted segment of the limb, but also the arterial pulses amplitude.
The two signals have been used separately to either measure volume changes using venous
occlusion plethysmography [20–22] or estimate blood flow beat by beat [23–26]. However,
the author was of the view that additional information should be obtained when combining
both measurements. Therefore, it was imperative to design a device capable of providing both
signals in real time, similar to the ones presented in the literature which primarily focused on
one of the waveforms. Thus, The designed impedance plethysmography device incorporated
3 output channels. The first channel named IDC, provided the peak value of the electrical
current being driven into the patient. Thus, it is possible to sense the impedance readings
more accurately since the delivered current is constantly measured for real time processing.
One of the channels labelled as VDC provides readings of the peak voltage obtained from the
patient. The other channel called VAC displays the AC component of the impedimetric signal
lying within the impedance measurements.
An experiment was set up to measure the changes of impedance that can be converted
into blood flow when an occlusion occurs. The entire experiment aims to collect data when
three different kinds of occlusion occur: venous occlusion, partial arterial occlusion and total
occlusion. The protocol was designed to take 5 min of resting data followed by 3 min of
readings at the time of each flow restriction. The data derived from the instruments is in volts
V which does not represent a physiological measurement. Therefore, all these equations that
were required to convert the data were explained in significant detail. The data sourced from
the impedance device was also examined in greater detail in order to better understand and
use two methods of measuring blood flow.
In the end, the entire data along with the mathematical operations were input into Matlab
where a custom GUI was programmed. From this interface, it is possible to qualify and
quantify the data. In addition, filters were applied and a statistical analysis was undertaken.
This work adequately complements the design of iPG device, which combines the equations,
filters and algorithms presented in this chapter to produce equivalent physiological readings.
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Chapter 5
Investigation of changes of the basal
impedance signal
This chapter shows the results of the changes in basal impedance during the whole experi-
mental procedure. The results presented in this chapter elaborate on the different elements
that could potentially impact the baseline impedance during the course of a measurement.
The different regions from the study were taken under consideration to analyse the distinct
changes during resting and occlusive periods. First, it was analysed the variation of baseline
impedance during the resting periods (regions 1, 3, 5 and 7). The data showed that the median
impedance changed around −0.6384 % from the original baseline region 1.
The second part of the chapter includes an in-depth analysis of the change of impedance
during each of the occlusive periods (regions 2, 4 and 6). The results are shown in three
modalities: one describing the change of the measured impedance baseline, the second
presenting the change of impedance compared to the initial baseline and the third as the
change of impedance in time (dZ/dt) per every ten heartbeats. In general, the data showed
a decrease in baseline impedance during the occlusive periods due to the pooling effect of
blood. The difference in slope between venous and partial arterial occlusion provided the
initial clue in how to differentiate between these two occlusive events.
5.1 Basal impedance measurements during baseline
The basal impedance of the participants forearm was recorded from the port denominated ZDC
of the designed device. In general, the iPG device detected the forearm’s segment impedance
quite remarkably. Furthermore, the obtained values fell within the reported resistive value
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in the tens Ohms as per the estimation given in the literature [122, 123, 200]. However,
there are different artefacts that can alter the basal impedance during a measurement, such as
motion or respiration movement [201–204]. This section will analyse the extent of change in
the basal impedance between the measurements.
All participants were asked to stay still for the entire duration of the test. However,
in practical terms, this is not entirely possible as staying still in the same position for a
prolonged period of time can be quite tiresome. Inflating the cuff to a pressure above diastolic
level may also cause discomfort to the participants, like tingling sensation or even pain. Thus,
moving the limb to restore blood flow is a normal response of the body. The first 2 min of
the baseline impedance readings may be affected by the rearrangement of the participant’s
position, particularly after the upper arm’s occlusion. Moreover, the restriction in blood flow
also induced a physiological response which needed some time to revert to the baseline value.
Hence, the baseline data after 2 min is used for this analysis, thereby allowing some time for
recovery.
The data used for this analysis was compiled by extracting the lower envelope of the raw
basal impedance. The command envelope in Matlab [33] allows the isolation of the desired
signal baseline signal omitting the APA pulses. Figure 5.1 displays the waveform extracted
with the respective mean value for each region per participant. The region 1 is applicable to
the time when the initial reference was recorded; in total, 5 min were recorded but the last
3 min of data was extracted right before the occlusion between 120 s to 300 s. This basal
impedance is the reference to the other readings as it was unaffected by occlusion of any
kind. The other sections of data correspond to region 3, which denotes the recovery after
venous occlusion. The information extracted belongs to the time slot between 600 s to 780 s.
In a similar manner, the region 5 after partial arterial occlusion retrieves the last 3 min of data
between 1080 s to 1260 s. Finally, there is data after total occlusion in the region 7 between
1560 s to 1740 s.
The first observation from this figure is the presence of oscillations in the baseline signal.
This signal was present in all participants with subtle frequency variations between each
region. The frequency was calculated by extracting the period of the signal as the difference
between its peaks. On average, the frequency of the oscillation was 0.0685±0.0027 Hz. At
this point, it is not possible to establish whether this is a common noise from the instrument
or a physiological response. In the literature, there is lack of sufficient information about
impedance plethysmographic oscillations at this frequency band. However, a study that used
laser Doppler flowmetry found that the physiological measurements into this frequency spec-
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Z(
Ω
)
Figure 5.1 Basal impedance of all the participants during the entire study. The data has been divided into
regions. The regions (1, 3, 5 and 7) in white colour represent baseline measurements.
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trum may pertain to the sympathetic activity (0.02 Hz to 0.06 Hz) [205]. Further investigation
needs to be undertaken in order to discover the roof of this signal.
It is evident that the motion artefact did make some alterations into the measurements.
Participants 3 and 4 clearly displayed deviation from their mean values in region 2 and region
4, respectively. As a matter of fact, the figure had to be clipped off to adequately fit the
waveform information. On the other hand, it became difficult to detect changes on partaker 1,
but region 3 displayed significant variations when compared with other regions. Hence, this
qualitative analysis confirms the quantitative results shown in figure 5.2.
Additionally, it is also clear that there are variations on the baseline impedance between
different regions. Furthermore, there is an absence of a clear trend on either the increase
or decrease of basal impedance, with the exception of participants 7 and 8 where there a
decrease on impedance is observed. Big gaps (< 0.8Ω) between regions can be noticed on
participant 5 and participant 7, respectively.
From the quantitative standpoint, the figure 5.2 illustrates the statistical values of the
median basal impedance during the regions 1, 3, 5 and 7. The mean resistive baseline
impedance of all the participants was 78.62±14.61Ω. It must be noted that the impedance
was entirely independent of their gender.
Again, the analysis confirms that motion artefact triggered the outliers of the readings. As
noticed from the box plot figure, participants 1, 3 and particularly 4 presented the deviated
points during the study. Additionally, participants 3, 4 and 8 exhibited the biggest distri-
bution between interquartile values higher than 1Ω (mean 1.41±0.39Ω). The remaining
participants showed a distribution within first and third interquartile of about 0.57±0.27Ω.
Z 
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94.87
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76.25
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Figure 5.2 Mean basal impedance box plot of all the participants during the last 3 min of the baseline regions 1,
3, 5 and 7.
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5.1.1 Deviation of the basal impedance from baseline
The basal impedance signal contains noises that may deviate from the signal (from the
baseline). This section will quantify the error as compared to the basal impedance at the
beginning of the experiment. Numerous factors could affect a biolelectrical impedance
reading. One of this is the change of impedance on the electrode-skin interface. As described
in section 3.4, when there is a change in the geometry or the area of contact of the electrode, it
gets converted into variations in the total impedance. Also, air pockets that could potentially
form between the two elements could contribute to substantial changes in impedance. Another
contributing factor is the motion artefact. In this case, the movement of the skin and muscles
creates different current paths. As a result, the basal impedance deviates from the baseline.
In an in-vivo setting, it is difficult to keep a participant completely motionless for the
entire duration of the experiment. During each baseline, the upper arm’s occlusion caused the
participants to move and re-accommodate. Eventually, there was a change of impedance that
will be analysed; it could be caused by that movement or perhaps a physiological response.
The figure 5.3 shows the deviation in percentage from the baseline in region 1. Thus,
the median impedance was the starting point in this region. The data was calculated by
extracting the envelope of the impedance waveform. In the figure, each point denotes the
median value of the resistance and the whiskers the range of data. It was the oscillatory
component described in the previous section that triggered the major variations the resistance.
The baseline impedance tended to decrease in majority of the participants, except number 2.
Regions
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Figure 5.3 Deviation of the basal impedance for all the participants compared to region 1. Each plot shows
how much the impedance increase or decrease against the reference value for regions 3, 5 and 7.
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The effect of the motion artefact can be observed on the large whiskers of some of the
participants. For example, participants 3 and 4 demonstrated the bigger ones in region 3 and
5, respectively. Indeed, the data from participant 4 was clipped as the whiskers showed a
huge variation of up to 200 %. It is also important to note that only a few signals were able
to return to baseline. For instance, the waveforms that experienced a variation below 0.25 %
included regions 3 and 4 of participant 1, participant 2 in region 5, participant 4 in region 7
and participant 6 in regions 3 and 7. The rest experienced changes of roughly −2.353 % to
0.441 % from the baseline region 1.
The table 5.1 illustrates the range and mean of changes of impedance for all the partic-
ipants. The average impedance of the entire study was −0.6384 % with a range of about
1.5264 %. Certainly, participants 1, 2 and 7 illustrated the least impedance change with less
than 0.25 %, whereas the second one increased and others decreased. A change occurring
between 0.25 % to 1 % was experienced by participants 4, 5 and 8. Finally, participants 3
and 7 recorded the biggest change of impedance of over 1 %.
Table 5.1 Mean and range of the impedance change for each participant.
range (∆%) mean (∆%)
Participant 1 1.157 % −0.247 %
Participant 2 0.441 % 0.170 %
Participant 3 2.353 % −1.226 %
Participant 4 1.939 % −0.584 %
Participant 5 1.489 % −0.719 %
Participant 6 0.707 % −0.148 %
Participant 7 2.147 % −1.412 %
Participant 8 1.979 % −0.940 %
5.1.2 Confidence interval of the basal impedance baseline
Identifying when the basal impedance is outside normal levels requires a statistical analysis.
By using the entire percentage deviation (∆%) from the initial baselines as the data range, it
was calculated as the normal probability density function (PDF). Using the Matlab command
normfit the normal distribution was computed from the ∆%. The calculation returned
a µ = −0.6384 and a σ = 0.8518. Then the probability density function (PDF) of the
standard normal distribution was calculated using the command normpdf with the parameters
previously found. By plotting the probability distribution function, it can be seen how the
probability was distributed. Then by using the σ that was obtained from the data, a new
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PDF was calculated which centred at µ = 0. Therefore, the PDF produces a similar data
distribution where the confidence band (95 %) was calculated at ±1.96×σ .
Figure 5.4 shows the PDF obtained from the data and the new one calculated. The yellow
plot shows the confidence area from the baseline. Therefore, the confidence band is located
between ∆% =±1.66%. In other words, all changes of impedance within this confidence
band can be considered to be statistically important and is located within normal limits.
By comparing the results shown from the PDF, most participants were found to be within
that range. Nevertheless, some partaker’s regions do not lie within this confidence band.
These include regions 5 and 7 in participants 3 and 7, region 3 of participant 4 and region 7
of participant 8.
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Figure 5.4 Confidence interval of the baseline impedance. The yellow area shows the PDF when µ = 0.
The doted points shows the PDF with the normal points calculated (µ = −0.6384 and a σ = 0.8518). The
confidence band is located between ∆% = ±1.66%. In other words, all changes of impedance within this
confidence band can be considered to be statistically important and is located within normal limits.
5.2 Change of basal impedance during occlusions
From the experimental procedure, the data from the occlusive regions were extracted in
accordance to the type of blood restriction applied, as depicted in figure 4.7. The data
were separated in this section into the readings from venous occlusion (VO), partial arterial
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occlusion (PAO) and total blockage. The following is the data analysis performed to the
signal. Again, the arterial pulses were eliminated from the signal. Only, the lower envelope
of this impedance signal was used to perform this investigation.
The dataset for this study was subdivided in the following manner: two minutes of
baseline data followed by the occlusive period and two minutes of return to baseline after
releasing the cuff’s pressure. This is the analysis of the results obtained.
5.2.1 Basal impedance shift during venous occlusion
As expected, the basal impedance declined while performing venous occlusion in each
participant. As confirmed by figure 5.5, all the partakers witnessed a decline in their basal
impedance in region 2 of the experiment. The boxplot illustrates that three regions that were
part of this study. The data of the region 1 (R1) were the last 2 min of the initial baseline
(180 s to 300 s). Thereafter, it is the venous occlusion in region 2 (R2) during 3 min at the
pressure levels described by the column occlusion 1 in table 4.5. This makes it clear that the
median resistance value decreased. While analysing this candle-stick, it can be surmised that
bigger the distribution of the upper and lower quartile, the greater the resistance decline as
registered by most other participants, with the exception of participant 6 whose impedance
measurement settled quickly. After releasing the cuff’s air, the median impedance in region
3 was expected to return to a value close to the initial baseline. However, partakers 3 and 4
were unable to recover completely. While their resistance values improved for a few seconds,
they continued to reduce below the lower whisker of region 2. Meanwhile participants 1
rose over the initial baseline median. Participant 3 was the only one who showed a return to
baseline.
Figure 5.6 illustrates that the deviation of impedance in terms of the changes in percentage
of impedance (∆Z%) from the median baseline in region 1. The shaded area represents the
venous occlusion between 300 s to 400 s. These dots are the points of foot of the signal
equivalent to (RB). This signal was smoothed using the command smooth in Matlab which
assigns a lower weight to outliers within the regression [33]. This method assigns zero weight
to data outside of the six mean absolute deviations. By doing so, it eliminates most of the
rapid variations of impedance triggered by motion artefact.
The figure clearly reveals a linear trend during venous occlusion for majority of the
subjects. Nonetheless, the resistance of participant reduced immediately upon occlusion,
but the participant moved his arm a minute later to reverse the trend. Subsequently, the
impedance continued to decline again. Furthermore, participant 6 also showed a similar
response when the individual moved his arm, but the resistance settled instead of reversing the
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Figure 5.5 Box plot showing the statistical change of impedance in Ω during venous occlusion. The cyan
boxplot represents the baseline before (Region 1) and after (Region 3) the occlusion. The yellow marker is the
impedance during venous occlusion (Region 2).
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Figure 5.6 Percentile change of impedance during venous occlusion. The reference baseline is the average
baseline impedance during the last 2 min before the venous occlusion.
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trend in this case. Interestingly, participant 2 showed a saturation point after a few seconds,
which was specific for this subject.
The table 5.2 summarises the changes of impedance caused during the venous occlusion.
The average median of the resistance decline from the baseline value stood at roughly
−0.546±0.076 %, where participants 4, 5 and 7 recorded the biggest losses of impedance
(>0.5 %). The column Change on the same table shows the impedance difference from the
point of initial occlusion to the minimum point of the smooth curve, which was calculated
using equation 5.1. During the venous occlusion the whole slope was seen to record a
variation of 0.658±0.230 %.
∆Z%T = ∆Z%300sec−∆Z%min (5.1)
Table 5.2 Statistical analysis of the percentile change of impedance during venous occlusion. The data denotes
the median percentile change of impedance per participant, the maximum and minimum value of the occlusion,
and the difference between these two peak values.
Median Max Min Change
[∆Z%] [∆Z%] [∆Z%] [∆Z%]
Participant 1 −0.26± 0.09 -0.20 -0.47 0.26
Participant 2 −0.58± 0.21 -0.03 -0.69 0.66
Participant 3 −0.51± 0.22 -0.35 -1.00 0.66
Participant 4 −0.79± 0.22 -0.32 -1.06 0.74
Participant 5 −0.82± 0.30 -0.11 -1.09 0.98
Participant 6 −0.33± 0.09 0.03 -0.41 0.43
Participant 7 −0.72± 0.22 -0.22 -0.98 0.77
Participant 8 −0.40± 0.11 -0.09 -0.50 0.41
It is tempting to observe the immediate change of impedance as soon as the venous
occlusion occurs. The capability of impedance plethysmography device of detecting venous
occlusion in all participants is remarkable and almost instantaneous. As soon as the blockage
occurs, the impedance reduces for some time. If motion does not bring about changes in
the trend, some of them could reach the saturation point, as seen in the case of participant
2. However, it is also apparent that other signals reached a point of saturation, signalling a
decline of impedance in an exponential trend than linear.
This effect can be summarised in figure 5.7. The plot describes the change of impedance
in time (dZ/dt) against some data points (beats) during the venous occlusion. Accordingly,
10 data points of RB synchronised with the heart cycle were clustered computing dZ/dt.
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This differential value is equivalent to the velocity of the change in basal impedance per
second (Ωs−1). In general, the average impedance all along the occlusion was observed at
−0.0026±0.0018 beats.
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Figure 5.7 Speed of change of impedance in time (dZ/dt) per every 10 heartbeats during venous occlusion.
The colour lines represent the data per each participant. The dark bold line is the mean of all the measurements.
Based on the figure, it can be surmised that during the first 10 beats, there is a higher drop
of impedance as compared to the last data points. Indeed, the rate of change of resistance
during the first 10 beats was on average −0.0063±0.0037Ω/s. After 90 beats, the result of
this derivation was more than halved to an average of −0.0027±0.0018Ω/s. At 160 beats,
the ratio was reduced to merely −0.0002±0.0024Ω/s. The final data points (180 beats)
exhibited a reversion of the trend (0.0019±0.0005Ω/s). However, this is because only a
few participants were able to achieve that amount of heart beats. Moreover, at this point,
some data were already returning to the baseline because the cuff could have been released a
few seconds earlier.
5.2.2 Basal impedance change during partial arterial occlusion
The same analysis performed on the VO was applied to the partial arterial occlusion. A
partial restriction of arterial blood flow is achieved by mechanically occluding the upper arm
between diastolic and systolic pressures. The load levels used to create these occlusions are
detailed on the column occlusion 2 in the table 4.5. Similar time lapses were incorporated
to analyse the data, the last 2 min of the region 3 (660 s to 780 s), the entire partial arterial
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blockage in region 4, 3 min between 780 s to 960 s, followed by 2 min of return to the baseline
after releasing the pressure of the cuff in region 5 (960 s to 1080 s).
Occluding the blood flow at this pressure level induced a sense of discomfort among par-
ticipants; some of them felt numbness in their arms during the experiment. Therefore, some
partakers moved their arms like participant 1. In the case of others, the duration of occlusion
had to be shortened as was done in the case of participant 4 where the occlusion occurred
subsequently (840 s to 960 s) because ECG sensors had to be relocated and participant 8 who
asked to terminate the blockage a minute earlier (780 s to 900 s).
During this kind of occlusion, there is no venous return. In addition, the inflow is slightly
restricted as well. Indeed, the occlusion constricts the brachial artery where only a small
amount of blood passes through the obstruction. Moreover, the blood flow becomes turbulent
after the cuff’s constriction. Due to the venous occlusion, the arm is expected to increase its
volume as blood pools within the forearm to reduce the basal impedance.
Figure 5.8 confirms the reduction of the basal impedance all along the partial arterial
occlusion. When compared to VO, the box-plot shows a higher upper and lower quartile
distribution for majority of the participants in region 4, owing to a continued decline in
basal impedance during that occlusive action. However, partaker 4 depicted a significant
number of outliers primarily caused by motion artefact. Only a few participants were able
to get back close to baseline resistance, such as participants 2 and 7. Interestingly, some
members showed a swift recovery in region 5. For instance, the large data distribution across
participants 1, 2, 4, 6, 7 and 8 suggests a quick trend to return to the baseline. However, it
generally seems that a longer recovery time is required in order to return to an impedance
value close to the baseline after partial arterial occlusion.
Through a qualitative analysis of the change of impedance by percentage from baseline
region 3, figure 5.9 shows a linear trend during the cuff’s pressure exerted in region 4. It can
be seen that the impedance decline is more pronounced than the one recorded from venous
occlusion (see figure 5.6). In participant 1, the motion artefact becomes more evident, the
step drop of basal impedance immediately before releasing the cuff’s pressure is a reflection
of his forearm’s muscular movement. In this case, it is evident that the arm movement
augmented the change of impedance throughout the occlusion. While other participants also
experienced motion artefact, the change of impedance was within a few heart beats. For
example, participant 2 only showed a data point off the smooth line. However, in participants
3 and 4, the amount of data points off the soft signal was significantly higher. In summation,
majority of the participants described a straight drop of impedance, particularly linear in
participants 2 and 5.
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Figure 5.8 Box plot of the statistical change of impedance in Ω during partial arterial occlusion. The cyan
marker represents the baseline before (Region 3) and after (Region 5) the occlusion. The magenta marker is the
impedance during partial arterial occlusion (Region 4).
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Figure 5.9 Percentile change of impedance during partial arterial occlusion using as reference average baseline
impedance during the last 2 min before the occlusion.
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After releasing the cuff’s pressure, it is apparent that most of the signals change their
slope. The only member that did not reflect this change was participant 3. This impedance
correction is indicative of a restoration of blood circulation and a decline in the forearm’s
volume. Moreover, a lack of apparent settling impedance value can be observed, barring
participants 7 and 8. In general, this change in trend also confirms that the body might require
a longer time to recover after the partial arterial occlusion.
Table 5.3 reports the variations in percentage from the baseline impedance in region
3 in greater depth. The median impedance decline from the baseline was approximately
−0.783±0.324 %. However, participant 4 exhibited a lower median value since the initial
impedance value stood above the baseline average at 0.34 %. Evidently, there is a greater
reduction of impedance or an increase in the forearm’s volume as opposed to VO. The median
change of impedance from the maximum to the minimum value was nearly 1.133±0.482 %
which is about double when compared with venous occlusion. A physiological response
might have caused this increase in volume. The blood pooling could not have caused this
volume increase given that the arterial blood flow was restricted, which lowered the amount
of blood to enter the forearm segment.
Table 5.3 Statistical analysis of the percentile change of impedance during partial arterial occlusion. The data
represents the median percentile change of impedance per participant, the maximum and minimum value during
the occlusion and the difference between these two peak values.
Median Max Min Change
[∆Z%] [∆Z%] [∆Z%] [∆Z%]
Participant 1 −0.85± 0.50 -0.28 -2.56 2.29
Participant 2 −0.80± 0.35 -0.05 -1.23 1.18
Participant 3 −0.38± 0.32 0.10 -1.04 1.14
Participant 4 −0.03± 0.41 0.34 -0.78 1.13
Participant 5 −1.01± 0.54 -0.04 -1.80 1.76
Participant 6 −0.77± 0.33 -0.21 -1.30 1.09
Participant 7 −0.90± 0.26 -0.25 -1.19 0.93
Participant 8 −0.53± 0.22 -0.15 -1.01 0.85
The calculation of the velocity of the change of impedance (dZ/dt) displayed a similar
exponential response as was seen in VO. Figure 5.10 shows the calculation of these points
across all participants. The plot indicates that the first 10 beats of changes on a ratio average
of −0.0074±0.0037Ω/s was the largest acceleration. Subsequently, between 20 and 110
beats, the velocity stabilised to −0.0053±0.0007Ω/s. After this apparent settling, a new
increase was witnessed in the differentiation. However, it seems to have been aided by the
motion artefact seen on participant 1 for a few beats.
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Figure 5.10 Speed of change of impedance in time per every 10 heartbeats during partial arterial occlusion.
The colour lines represent the data per each participant. The dark bold line is the mean of all the measurements.
5.2.3 Basal impedance variation during total occlusion
In this study the blood supply towards the forearm was completely blocked by inflating
the cuff above systolic pressure, around 20 mmHg above this point. The column occlusion
3 in the table 4.5 illustrates the pressure level applied for the research. The data regions
involved in this part of the investigation were regions 5, 6 and 7. As was the case with
previous occlusions analysis, the last 2 minutes of the data sourced from region 5 were used
as impedance baseline (between 1140 s to 1260 s). The cuff was then inflated to accomplish
complete blood flow obstruction; the occlusion was maintained for 3 min between 1260 s
to 1440 s. Finally, the cuff’s air was released immediately, and the readings were taken for
further 2 min.
This test caused plenty of discomfort to most participants. Numbness and an unwill-
ingness to move their limb was commonly seen in all the participants. Hence, they ended
up moving their arms on a voluntary basis. Due to the absence of blood flow or pooling
during this aspect of the experiment, small impedance variations were expected. Additionally,
the mean restive value would be equivalent to the impedance of the tissue’s components
within the segment in addition to the impedance of the residual blood within the forearm.
However, when a change of resistivity takes place, this is mostly caused by the participant’s
re-accommodation as opposed to a physiological variable.
Figure 5.11 shows how the impedance changes during the total occlusion. Initially, it can
be seen that there was an absence of consensus on the signal trend all along the occlusion,
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as seen in the previous tests. Some of the participants reflected a small reduction in their
median impedance, such as study members 1, 4, 5, 6 and 8. Meanwhile the rest experienced
a slight increase. In addition, the trend of signal during the occlusion is ambiguous; different
signals have different data distribution points. For instance, participants 1 and 7 displayed a
large data distribution, indicating a constant change of their median impedance. In contrast,
the rest exhibited a data distribution centred in the median, illustrating a little impedance
variation during the occlusion. Only participant 5 exhibited a significant number of outliers,
denoting swift changes at one point of the measurement. In general, there is no linear trend,
as reported by the other kinds of occlusions.
After releasing the cuff’s pressure, no definite trend was observed in the direction of
the impedance. As figure 5.12 shows, some participants displayed an increase of resistivity.
However, participants 4 and 5 exhibited exaggerated changes in impedance. While the nature
of this rare variation remains unclear, it could be attributed to the limb movement after the
occlusion. Moreover, there was no swift change of impedance as was experienced in other
types of occlusions. This is congruent with the fact that no blood rushed in or out of the
forearm.
By analysing the variation of impedance during the occlusion as compared to the baseline
(region 5), the magnitude and direction of the resistivity change can be seen. Evidently,
participant 1 displayed the biggest and continuous impedance decrease, which is unusual for
this type of occlusion. Another unexpected resistivity response was shown by participant 7
where his impedance increased, albeit slightly.
The table 5.4 illustrates the impedance changes during the occlusion in detail. The
median impedance during total occlusion was−0.135±0.441 % which is fairly close to zero.
However, the sign of column median indicates that five out of eight exhibited a negative trend
in the impedance direction to indicate resistivity loss. In fact, most of the measurements
were below 0.5 %; only participants 1 and 5 exhibited higher changes of impedance. By
calculating the ∆% from the maximum and minimum changes (column Change), it can be
surmised that only participant 1 showed a change greater than 1 %, between 0.5 % to 1 %,
participants 3 and 6 displayed this data range, whereas the rest were below 0.5 %. In general,
the changes described by total occlusion were found to be significantly lower than the other
occlusions, indicating a minimum increase of volume. For instance, partakers 2 and 5 median
impedance signified a clear illustration of this. Some impedance changes were presented in
some measurements which can be associated with a muscular activity.
Figure 5.13 illustrates the analysis of velocity rate (dZ/dt) which is altered by the basal
impedance. Evidently, the basal impedance of participant 1 decreased swiftly when compared
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Figure 5.11 Box plot of statistical change of impedance inΩ during total occlusion. The cyan marker represents
the baseline before (Region 5) and after (Region 7) the occlusion. The red marker denotes the impedance during
total occlusion (Region 6).
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Figure 5.12 Percentile change of impedance, using as reference average baseline impedance all along the last
2 min before the total occlusion.
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Table 5.4 Statistical analysis of the percentile change of impedance during total occlusion. The data signifies
the median percentile change of impedance per participant, the maximum and minimum value during the
occlusion, and the difference between these two peak values.
Median Max Min Change
[∆Z%] [∆Z%] [∆Z%] [∆Z%]
Participant 1 −1.09± 0.33 -0.14 -1.38 1.24
Participant 2 0.14± 0.04 0.07 0.07 0.00
Participant 3 0.18± 0.28 0.30 -0.50 0.81
Participant 4 0.21± 0.16 0.05 -0.14 0.19
Participant 5 −0.06± 0.05 0.05 -0.23 0.28
Participant 6 −0.51± 0.14 -0.15 -0.89 0.75
Participant 7 −0.36± 0.15 0.05 0.05 0.00
Participant 8 −0.21± 0.06 -0.05 -0.27 0.22
to the rest. Moreover, participant 3 witnessed a rapid impedance drop between 80 beats to
140 beats. In general, the average velocity for the total occlusion procedure stood at around
−0.00061±0.00170Ω/s which is considerably small when compared with occlusions.
However, at the beginning of this occlusion, a modest increase was seen in the velocity;
the average for the first 10 beats stood at around −0.0027±0.0052Ω/s. Subsequently, it
stabilised close to the median value of the entire measurements until 140 beats. Nonetheless,
between 140 beats to 180 beats, an increase was seen in the velocity due to the contribution
of negative trends before releasing the occlusion.
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Figure 5.13 Speed of change of impedance over time per every 10 heartbeats during the total occlusion. The
colour lines denote the data per each participant. The dark bold line represents the mean of all the measurements.
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There are different bodily tissues that contribute to the impedimetric signal, such as fat,
muscle, blood and bone. Most of these organs or tissues entail intrinsic impedances. The
device took measurements within the expected ranges of a human forearm. However, motion
artefact or the interface electrode-skin, may have contributed to the change in resistance value
of the measurement. The baseline basal impedance varied from the median measurement
in average −0.6384 % with a maximum deviation of −2.353 %. After a statistical analysis
of these variances was undertaken, it was found that any values within ±1.66% lie within
statistical normal values.
From detection of circulatory problems point of view, it is evident that the basal impedance
changed linearly when an occlusion took place in the forearm. By occluding the venous
return and not bringing about changes in the arterial flow, blood can enter into the limb but
cannot depart from it. As a result, the volume of the forearm increased constantly when the
occlusion occurred. Hence, this capacity gain can be quantified by the impedimetric method
as a variation of the basal impedance median value. With an increase in blood cell population,
the conductivity of the forearm section also increased in terms of value. Therefore, the
resistivity declined proportionally.
During the occlusive events, the iPG device detected changes of impedance magnitude
caused due to the pooling effect attributed to the constriction of the upper arm. Clearly,
the basal impedance reduced during both partial and venous occlusion. Interestingly, the
impedance changed at a different ratio when venous and partial arterial occlusion was applied.
The impedance during the VO varied in a 0.658±0.230 %. On the other hand, all along PAO,
the impedance was seen to change in 1.13±04.82 %. This greater slope might be indicative
of a higher increase of blood volume. However, this could be incorrect as restricting the
brachial artery lowers the flow towards the arm’s distal section [206]. According to the data,
an arterial occlusion might be denoted in a swift decline of impedance, whereas in a venous
occlusion, the impedance might reduce at a slower pace. In contrast, the impedance did not
change as dramatically during total occlusion when compared to the other episodes. The
impedance went in different directions without establishing any common trend. This effect
might have been caused by forearm accommodation as opposed to a physiological response.
On average, the ratio change was well below the other occlusions around 0.250±0.446 %.
Analysing the acceleration of blood during the occlusions, it was found that after the
upper arm occlusion that occurred during the first 10 heartbeats, the impedance changed at a
faster pace when compared to the rest involved in this study. During these heartbeats, the
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change of impedance stood at around −0.0063±0.0037Ω/s for venous occlusion; quite
closely, partial arterial occlusion was about −0.0074±0.0037Ω/s, whereas total occlusion
was−0.0027±0.0052Ω/s. This acceleration indicates a physiological response of the veins
to allow additional blood supply in the forearm. Some studies [94, 207] suggest that an
increase in blood flow may be attributed to a syncopal response as a regulatory response of
the human body. Nonetheless, there is a need to conduct further research to corroborate these
assumptions.
All along the total occlusion (Region 6) no clear decline or increase of basal impedance
was observed that was common to all the participants. In general, the change of impedance
stood at about −0.135±0.441 %. A reason for this value close to zero was that neither
arterial nor venous blood was able to flow through the limb, which meant that no change in
volume was seen. In the end, this value was seen as the real basal impedance where all the
tissues were measured with their blood content. The information provided here is an indicator
of the development of ischaemia. A study has demonstrated that when total occlusion occurs,
cells starvation ensues, paving the way for the development of ischaemia [179] which could
be detected as a drop in the basal impedance.
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Research of the shape changes of the
arterial pulses during proximal occlusions
The arterial pulses amplitude (APA) signifies a dynamic component of the impedance
plethysmography signal. Importantly, it is located within the basal impedance that accounts
for around 0.1 % of the total impedimetric value [175]. It can be fairly challenging to acquire
these signals since noise levels can be higher than the actual signal, which makes it difficult to
isolate this waveform. However, such data collection imparts valuable information concerning
the haemodynamics per heartbeat. The shape of the waveform has been demonstrated to be
a major indicator of haemodynamic problems within the peripheral circulation [29]. This
chapter will analyse the waveforms with an aim to differentiate morphological changes
between signals in normal state and the ones that occur during venous, partial arterial and
total occlusion, respectively.
As it has been demonstrated in the previous chapter, the impedance plethysmographic
baseline shifts during each occlusion at different rates. However, it is also important to
examine the changes occurring in the APA pulses. This information offer clues as to whether
an occlusion may occur in the arterial or venous circulation. As illustrated in the design
section 4.1.2.6, the iPG device features an output port denominated ZAC that provides a
high-resolution view of these arterial pulses waveform. Additional post-processing was
needed to conditioning the signal. In this regard, tighter filters were applied in order to
remove low and high frequency components within the signal. In addition the lower envelope
component was removed and levelled to zero.
The APA waveform produced by this device is inverted, as represented by various other
plethysmography methods like photoplethysmography. During the systolic cycle, there is an
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expansion of blood vessels, which allows for more blood volume. As a result, the impedance
declines proportionally to the quantum of blood due to the fact that the forearm’s segment
is more electrically conductive. Meanwhile during the diastolic cycle, blood vessels end
up emptying, causing a decline in the quantity of blood contained within the arm segment.
Consequently, the impedance goes up.
The analysis of plethysmographic wave was carried out by averaging the detected wave-
forms using specialised algorithms in order to identify an APA signal. In short, two different
shapes of APA signal materialise during venous and arterial occlusion, which may allow
discerning between these two events. First, venous occlusion has shown an increase in the
three points measured (systolic peak, dicrotic notch and diastolic peak). Conversely, partial
arterial occlusion has displayed a decrease of the diastolic pulse amplitude in relation to the
dicrotic notch. As a result, a novel index ratio that combines the data from baseline and
APA is proposed to help to differentiate between these two kind of occlusions when certain
conditions are met. The following section discusses the changes within a wave shape from a
non-occlusion state to an occluded one.
6.1 Reference points and algorithm for the arterial pulse
amplitude analysis
The isolated APA waveforms from the iPG device reproduce the change in volume per heart
beat within the sensing electrodes placed in the forearm. Filling the vessels with blood leads
to small changes in resistivity that tend to vary with the circulatory cycle, describing different
peaks during the course of a heart cycle.
Commonly, an APA wave consists of several identifiable peaks and valleys. Figure 6.1
illustrates a typical impedance plethysmography pulse from the arm synchronous with a
heartbeat. The table 6.1 summarises the noticeable markers of these pulse waveforms when
compared to an ECG and used in this analysis to identify morphological changes.
An APA wave needs to be identified as a valid one in order to be included in the
computational analysis. As a result, the programmed algorithm begins with the identification
of the commencement and end of a pulse by locating the upslope point L1 and L2 in the
waveform. Upon the identification of these spots, the systolic peak A can be placed within
this time frame. The point B is expected to be a valley with an amplitude lower than the
previous peak. Subsequently, the algorithm looks at the following change of slope - the
diastolic peak C. If any of these conditions could not be met, the algorithm searches through
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L1 A B C L2
R1 R2
Figure 6.1 Peaks and valleys of an iPG waveform (∆R) compared to ECG waveform.
Table 6.1 Markers on the APA waveform
Marker Description
R1 Peak of the ECG QRS complex before an APA pulse.
L1 Start of the systolic upslope of the APA signal. Point where rapid
change of impedance occurs.
A Systolic point. Maximum peak of the APA signal.
B Dicrotic notch on the APA wave.
C Maximum pulse after the dicrotic notch, named diastolic pulse
R2 Peak of the ECG QRS complex after the APA pulse.
L2 Starting point of the next APA wave.
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the APA wave from the subsequent lower data point, seeking a matching wave pattern again.
In case a pattern is found (L1 > A < B > slopechange(C) > L2), this is considered as a
viabale wave. In the absence of a match, the pulse is marked as missing. In order to minimise
waves with abnormal amplitudes caused due to noise, the algorithm then calculates the mean
peak at A of the last 20 valid APA waves. If this value is found to be greater than 25 %
(A > A∗1.25) the wave is discarded.
The table 6.2 compiles the amount of APA waves recognised by the algorithm. The
column detected waves describes the pulses that adhere to the profile of an iPG plethys-
mography wave. Meanwhile the third column highlights the total pulses that did not match
the anticipated guide; subsequently, the algorithm attempted to fix them by identifying the
pattern within the next slope. Consequently, the fixed column shows the total amount of
identified pulses, whereas the last column shows the ones discarded.
Generally speaking, the quality of APA pulses validated by the iPG device and verified by
the algorithm were on average 57.86±16.37 %. Participants 3, 4 and 8 showed the highest
number of pulses with errors (above 50 %). However, by incorporating the fixing method,
the number of valid peaks improved to a total of 84.94±7.64 %.
Table 6.2 Total amount of iPG waves detected by the algorithm. Starting form the detection of valleys follow by
the detection of systolic peak, dicrotic notch point and diastolic peak. It also includes the waves reconstructed
by the software
Total Detected Waves Fixed Discarded
valleys waves with errors waves waves
Participant 1 1604 840 (52.37 %) 764 (47.63 %) 491 (30.61 %) 273 (17.02 %)
Participant 2 1689 1159 (68.62 %) 530 (31.38 %) 409 (24.22 %) 121 ( 7.16 %)
Participant 3 1651 699 (42.34 %) 952 (57.66 %) 695 (42.10 %) 257 (15.57 %)
Participant 4 1625 645 (39.69 %) 980 (60.31 %) 562 (34.58 %) 418 (25.72 %)
Participant 5 1664 1199 (72.06 %) 465 (27.94 %) 345 (20.73 %) 120 ( 7.21 %)
Participant 6 1745 936 (53.64 %) 809 (46.36 %) 471 (26.99 %) 338 (19.37 %)
Participant 7 1907 1654 (86.73 %) 253 (13.27 %) 146 ( 7.66 %) 107 ( 5.61 %)
Participant 8 1651 784 (47.49 %) 867 (52.51 %) 491 (29.74 %) 376 (22.77 %)
The algorithm compiled the location of all the valid spots A, B and C. The data showed
points of inflection when an occlusion occurs in the arm. The following analysis centres on
the changes of impedance amplitude all along the different regions of this experiment, as
well as the change of area of the waveform before and after the dicrotic notch point (B).
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6.2 Changes of the plethysmography waveform during
different occlusions
The detection of the APA waveforms makes it possible to independently analyse the change
of the shape form. To that end, an average waveform was computed for all these regions
during the experiment. The following section details the relevant changes made for each of
these points of interest.
6.2.1 Plethysmography waveform change during venous occlusion
The analysis performed in this section corresponds to the APA waveforms captured during
the baseline in region 1 (0 s to 300 s), venous occlusion region 2 (300 s to 480 s) and return
to control signal region 3 (480 s to 780 s). The previous section described the method of
collecting valid pulses. Consequently, all other valid pulses were grouped and aligned as per
region to calculate the average waveform.
Figure 6.2a shows an impedance plethysmography waveform calculated from one of the
participants during baseline and venous occlusion, with indicators of their amplitudes located
at the points of interest. These markers show the calculation of distance between systolic peak
(Point A) to dicrotic notch (Point B) and diastolic peak (Point C), along with the amplitude
for each of these markers. The distance between (A → B) and (A → C) was later transposed
into the occlusion wave in order to identify their values during the VO test. Clearly, from a
qualitative viewpoint, a difference can be noticed in the morphology of the waveform that
occurred during the occlusion. Indeed, figure 6.3 shows the change in amplitude at these
points for every participant as well as the return to baseline after releasing the cuff pressure.
A comprehensive analysis of this change (at each point) is detailed in the following manner.
6.2.1.1 Changes in systolic peak (Point A)
Figure 6.3a shows the statistical variation of the systolic peak magnitude (point A) during the
three conditions of the test baseline-occlusion-baseline. After the cuff was inflated below the
diastolic pressure, most APA signals showed an increase of the impedance magnitude of this
peak. As detailed in table 6.3, 87 % of the participants exhibited an increment in electrical
resistance during the venous occlusion of about 31.80 %; the lone exception was participant
8 where his/her impedance dropped in −12.01 %. When the cuff’s pressure got released,
all participants showed a decline in peak value with an average of −32.21 %, returning to
similar baseline values prior to the venous occlusion.
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Figure 6.2 Plethysmography waveform of the participant seven between baseline and venous occlusion
Pa
rtic
ipa
nt 
1
Pa
rtic
ipa
nt 
2
Pa
rtic
ipa
nt 
3
Pa
rtic
ipa
nt 
4
Pa
rtic
ipa
nt 
5
Pa
rtic
ipa
nt 
6
Pa
rtic
ipa
nt 
7
Pa
rtic
ipa
nt 
8
-0.1
0
0.1
0.2
Region 1
Region 2
Region 3
(a) Change of amplitude of the waveform at point A.
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(b) Change of amplitude of the waveform at point B.
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(c) Change of amplitude of the waveform at point C.
Figure 6.3 Changes of the impedance peak values during baseline, venous occlusion and return to baseline for
points A,B and C.
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Table 6.3 Change of amplitude of the waveform at peak A during the transition from baseline (region 1), venous
occlusion (region 2) and the return to baseline (region 3). The column change shows the percentile variations
between the different regions.
Point A Baseline [Ω] Occlusion [Ω] Baseline [Ω] Change
(Region 1) (Region 2 - VO) (Region 3) R1-R2 R2-R3
Participant 1 0.0270± 0.0233 0.0353± 0.0191 0.0295± 0.0305 30.49 % -21.41 %
Participant 2 0.0485± 0.0102 0.0609± 0.0140 0.0462± 0.0449 25.50 % -30.24 %
Participant 3 0.0345± 0.0351 0.0397± 0.0144 0.0292± 0.0294 14.96 % -30.55 %
Participant 4 0.0214± 0.0303 0.0289± 0.0139 0.0197± 0.0222 35.17 % -43.11 %
Participant 5 0.0352± 0.0112 0.0485± 0.0098 0.0382± 0.0376 37.99 % -29.20 %
Participant 6 0.0232± 0.0105 0.0300± 0.0124 0.0249± 0.0251 29.16 % -21.77 %
Participant 7 0.0357± 0.0080 0.0534± 0.0081 0.0365± 0.0365 49.33 % -47.17 %
Participant 8 0.0238± 0.0094 0.0209± 0.0091 0.0128± 0.0127 -12.01 % -34.27 %
6.2.1.2 Changes in dicrotic notch peak (Point B)
It can be seen that dicrotic notch (point B) is situated between the systolic (point A) and
diastolic peaks (point C), as illustrated in figure 6.1. Similarly, in congruity with the changes
experienced by the systolic peak during this part of the experiment, point B also ended
up increasing in its magnitude. Subsequently, when the cuff’s pressure got released, the
amplitude at this location returned to a level that was fairly close to the baseline. The
table 6.4 shows that most of the participants (87.5 %) exhibited an increase in magnitude
of their dicrotic notch point. Among those who experienced this increment, the impedance
changed roughly 47.73 % as compared to region 1, with the exception of partaker two whose
impedance decreased −2.06 %. In contrast, after releasing the upper arms blockage, all
participants experienced a decline in their point B magnitude of about −51.68 %.
Table 6.4 Change of amplitude of the waveform at peak B during the transition from baseline (region 1), venous
occlusion (region 2) and the return to baseline (region 3). The column change shows the percentile variations
between the different regions.
Point B Baseline [Ω] Occlusion [Ω] Baseline [Ω] Change
(Region 1) (Region 2 - VO) (Region 3) R1-R2 R2-R3
Participant 1 0.0126± 0.0231 0.0223± 0.0195 0.0119± 0.0153 76.94 % -82.52 %
Participant 2 0.0397± 0.0144 0.0388± 0.0167 0.0257± 0.0252 -2.06 % -33.19 %
Participant 3 0.0184± 0.0315 0.0323± 0.0181 0.0200± 0.0224 75.98 % -67.36 %
Participant 4 0.0130± 0.0294 0.0183± 0.0149 0.0113± 0.0138 40.21 % -53.52 %
Participant 5 0.0319± 0.0158 0.0402± 0.0138 0.0254± 0.0237 25.92 % -46.26 %
Participant 6 0.0127± 0.0138 0.0177± 0.0161 0.0124± 0.0128 39.75 % -41.55 %
Participant 7 0.0250± 0.0108 0.0382± 0.0092 0.0287± 0.0276 52.71 % -37.97 %
Participant 8 0.0102± 0.0111 0.0125± 0.0117 0.0073± 0.0071 22.58 % -51.08 %
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6.2.1.3 Changes in diastolic peak (Point C)
The last analysed peak corresponds to point C or the diastolic pulse of the waveform. To
reiterate, figure 6.3c illustrates that most of these participants (71.4 %) exhibited an increase
in magnitude of about 31.92 % as compared to region 1. Only participants 2 and 8 witnessed
a decline in their impedance (−7.97 %). Table 6.5 illustrates the mean values of impedance at
this location within the waveform. In contrast, after releasing the pressure from the upper arm,
a decrease was observed in the diastolic peak impedance of all participants, at an average of
−32.33 %. As a result, the diastolic peak returned to values that were similar to the baseline,
barring the ones that experienced a diminished resistance during the occlusion.
Table 6.5 Change of amplitude of the waveform at peak C during the transition from baseline (region 1), venous
occlusion (region 2) and the return to baseline (region 3). The column change shows the percentile variations
between the different regions.
Point C Baseline [Ω] Occlusion [Ω] Baseline [Ω] Change
(Region 1) (Region 2 - VO) (Region 3) R1-R2 R2-R3
Participant 1 0.0238± 0.0281 0.0283± 0.0260 0.0224± 0.0286 18.81 % -24.75 %
Participant 2 0.0429± 0.0150 0.0401± 0.0191 0.0279± 0.0278 -6.48 % -28.45 %
Participant 3 0.0221± 0.0397 0.0355± 0.0219 0.0236± 0.0310 60.85 % -53.94 %
Participant 4 0.0171± 0.0380 0.0184± 0.0174 0.0149± 0.0178 7.42 % -20.30 %
Participant 5 0.0350± 0.0175 0.0459± 0.0151 0.0287± 0.0279 31.16 % -49.18 %
Participant 6 0.0138± 0.0212 0.0182± 0.0251 0.0133± 0.0151 31.53 % -35.22 %
Participant 7 0.0276± 0.0127 0.0391± 0.0111 0.0312± 0.0309 41.77 % -28.58 %
Participant 8 0.0138± 0.0140 0.0125± 0.0163 0.0100± 0.0096 -9.47 % -18.24 %
6.2.2 Plethysmography waveform change during partial arterial occlu-
sion
During the partial occlusion of the brachial artery, the majority of the participants exhibited a
change in shape of their waveforms. An analysis of this section resembles the baseline time
outlined in region 3 (480 s to 780 s), three minutes of the partial venous occlusion in region 4
(780 s to 960 s) and a return to baseline region 5 (960 s to 1260 s). Next, the cuff was inflated
to the pressure presented in column Occlusion 2 in Table 4.5, laying between diastolic and
systolic pressures. Figure 6.4 illustrates the average waveform of all signals that were aligned
at baseline and during the arm’s occlusion for one of these participants. Evidently, there is a
surge in the systolic peak (point A), and a reduction in the diastolic peak at point C. Figure
6.5 also highlights the impedance change in all participants during the three regions. The
following sections will describe the changes made in each of the spots in greater detail.
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(a) Average baseline plethysmography waveform
before partial arterial occlusion region 3 (480 s to
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(b) Average plethysmography waveform during
partial arterial occlusion region 4 (780 s to 960 s)
Figure 6.4 Plethysmography waveform of the participant seven between baseline and partial arterial occlusion
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(a) Change of amplitude of the waveform at point A.
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(b) Change of amplitude of the waveform at point B.
Pa
rtic
ipa
nt 
1
Pa
rtic
ipa
nt 
2
Pa
rtic
ipa
nt 
3
Pa
rtic
ipa
nt 
4
Pa
rtic
ipa
nt 
5
Pa
rtic
ipa
nt 
6
Pa
rtic
ipa
nt 
7
Pa
rtic
ipa
nt 
8
-0.1
0
0.1
0.2
Region 3
Region 4
Region 5
(c) Change of amplitude of the waveform at point C.
Figure 6.5 Changes of the impedance peak values during baseline, partial arterial occlusion and return to
baseline for points A,B and C.
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6.2.2.1 Changes in systolic peak (Point A)
Figure 6.5a illustrates the change in amplitude for each participant. In addition, table 6.6
summarises the average impedances along with the variations in each region. Through this
occlusive experiment, seven participants (87.5 %) showed an increase in electrical resistivity
at point A of about 13.52 %. However, some of them exhibited a small surge in their peaks
between 0.29 % to 2.24 %. In general, the increase at this point can be observed. After the
deflation of the cuff, most participants (62.5 %) exhibited a decline in peak on an average of
−21.86 %. In contrast, participants 1, 3 and 4 registered an increase in impedance reading,
the latter being an outlier with a hike in his magnitude of 110.69 %.
Table 6.6 Change of amplitude of the waveform at peak A during the transition from baseline (region 3), partial
arterial occlusion (region 4) and the return to baseline (region 5). The column change shows the percentile
variations between the different regions.
Point A Baseline [Ω] Occlusion [Ω] Baseline [Ω] Change
(Region 3) (Region 4 - PAO) (Region 5) R3-R4 R4-R5
Participant 1 0.0295± 0.0194 0.0274± 0.0190 0.0282± 0.0265 -7.03 % 2.59 %
Participant 2 0.0462± 0.0140 0.0526± 0.0197 0.0503± 0.0461 13.78 % -5.11 %
Participant 3 0.0292± 0.0379 0.0298± 0.0185 0.0354± 0.0356 2.24 % 19.02 %
Participant 4 0.0197± 0.0242 0.0198± 0.0152 0.0416± 0.0453 0.29 % 110.69 %
Participant 5 0.0382± 0.0133 0.0458± 0.0115 0.0357± 0.0351 19.81 % -26.55 %
Participant 6 0.0249± 0.0096 0.0282± 0.0081 0.0247± 0.0251 13.21 % -14.09 %
Participant 7 0.0365± 0.0097 0.0529± 0.0092 0.0388± 0.0394 44.90 % -38.73 %
Participant 8 0.0128± 0.0104 0.0128± 0.0160 0.0096± 0.0098 0.38 % -24.86 %
6.2.2.2 Changes in dicrotic notch peak (Point B)
In the dicrotic notch position (point B), the increase of magnitude is more apparent than it
is in the systolic peak. In fact, all participants experienced an increase in their respective
impedance values at this point. Figure 6.5b encapsulates these changes in all the regions
before and after the occlusion. Table 6.5b details the participants’ median impedances along
with the ratio of change in each region.
In general, the average increase at the dicrotic notch stood at about 29.91 % as soon as the
occlusion was applied. When the pressure to restrict the blood flow was taken away, six out
of eight members witnessed decline in electrical resistivity towards the baseline. On average,
it was seen to reduce by −51.72 %. Here again, participants 3 and 4 were exceptions to this
reduction; their impedance increased by 37.37 % and 3.25 %, respectively.
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Table 6.7 Change of amplitude of the waveform at peak B during the transition from baseline (region 3), partial
arterial occlusion (region 4) and the return to baseline (region 5). The column change shows the percentile
variations between the different regions.
Point B Baseline [Ω] Occlusion [Ω] Baseline [Ω] Change
(Region 3) (Region 4 - PAO) (Region 5) R3-R4 R4-R5
Participant 1 0.0119± 0.0232 0.0162± 0.0220 0.0083± 0.0087 36.07 % -66.02 %
Participant 2 0.0257± 0.0142 0.0354± 0.0212 0.0251± 0.0231 38.02 % -40.44 %
Participant 3 0.0200± 0.0536 0.0222± 0.0247 0.0229± 0.0244 11.33 % 3.25 %
Participant 4 0.0113± 0.0256 0.0116± 0.0177 0.0158± 0.0143 2.64 % 37.37 %
Participant 5 0.0254± 0.0155 0.0314± 0.0107 0.0248± 0.0237 23.55 % -26.29 %
Participant 6 0.0124± 0.0150 0.0197± 0.0096 0.0121± 0.0141 58.95 % -61.59 %
Participant 7 0.0287± 0.0128 0.0340± 0.0104 0.0211± 0.0205 18.34 % -44.99 %
Participant 8 0.0073± 0.0118 0.0110± 0.0196 0.0058± 0.0069 50.41 % -71.01 %
6.2.2.3 Changes in diastolic peak (Point C)
Changes in the diastolic peak also presented a similar (increasing) trend as evidenced in
points A and B. However, these changes were not as pronounced as the ones witnessed in the
dicrotic notch. Figure 6.5c and Table 6.8 summarise the total obtained values. In totality,
75 % of the participants illustrated an increase of impedance between region 3 and 4. It went
up with a median of 18.74 %. Participant 8 witnessed a change that was significantly higher
than the mean (44.11 %). Meanwhile study members 1 and 7 exhibited a decline electrical
resistivity in −19.91 % on average.
On the opposite side of the spectrum, upon the release of pressure, (87.5 %) of the
participants experienced a decline in their impedance, including those whose impedance
was seen to increase during the occlusion. On average, it reduced by −19.77 % in total.
Participant 4 exhibited a surge in the ratio of change prior to and after the blockage, thereby
significantly exceeding the median of all measurements. Moreover, this specific study
member outperformed the average ratio after the occlusion (90.32 %). As evidenced by other
measuring points, it confirms the fact that the data obtained from this participant were not
related to physiological origin, but motion or randomness.
This point of the data is a clear differentiator between venous and arterial occlusion. It
seems that the diastolic pulse dims during arterial occlusion. Still, it is not clear if the drop of
this peak is due to compliance or derived from the blood flow restriction. One could assume
that vessel compliance might play a role in the waveform change, but so far, the data shows
that it is only present in this place of the data, which makes it unique compared to the other
observed points.
135
Research of the shape changes of the arterial pulses during proximal occlusions
Table 6.8 Change of amplitude of the waveform at peak C during the transition from baseline (region 3), partial
arterial occlusion (region 4) and the return to baseline (region 5). The column change shows the percentile
variations between the different regions.
Point C Baseline [Ω] Occlusion [Ω] Baseline [Ω] Change
(Region 3) (Region 4 - PAO) (Region 5) R3-R4 R4-R5
Participant 1 0.0224± 0.0323 0.0176± 0.0307 0.0171± 0.0206 -21.35 % -2.21 %
Participant 2 0.0279± 0.0196 0.0295± 0.0272 0.0250± 0.0252 5.96 % -16.45 %
Participant 3 0.0236± 0.0826 0.0275± 0.0284 0.0256± 0.0283 16.56 % -7.98 %
Participant 4 0.0149± 0.0327 0.0166± 0.0229 0.0301± 0.0306 11.22 % 90.32 %
Participant 5 0.0287± 0.0171 0.0308± 0.0119 0.0293± 0.0287 7.32 % -5.03 %
Participant 6 0.0133± 0.0252 0.0174± 0.0111 0.0123± 0.0176 30.32 % -37.72 %
Participant 7 0.0312± 0.0189 0.0254± 0.0124 0.0241± 0.0232 -18.48 % -4.27 %
Participant 8 0.0100± 0.0139 0.0141± 0.0224 0.0076± 0.0087 41.11 % -64.75 %
6.2.3 Plethysmography waveform variation during total occlusion
It was observed that performing a total occlusion completely blocks both the inflow and
outflow of blood below the arm’s cuff. This implies that there is no change of volume within
the arm’s segment. As a result, it can be surmised that impedance plethysmography must not
present the changes in magnitude.
Figure 6.6 shows the APA waveform during the baseline in region 5 (960 s to 1260 s)
and the total occlusion in region 6 (1260 s to 1440 s) of the seventh participant. As clearly
illustrated by the figure 6.7, the amplitudes of most participants reduced during the occlusion.
However, participant 4 experienced different behaviours across all these points. The member’s
standard deviation also suggests a problem with his plethysmography signal during this test.
In general, point A decreased by −66.15 % on average at its peak value occlusion. Upon
the release of pressure, impedance recovered its value in 75.98 %. A similar event occurred
at point B; peak signals reduced by a median of −63.29 % during blockage and recovered
on average by 74.02 %. Similarly, point C decreased (on average) by −50.27 % and rose by
58.71 % following the occlusion.
The previous section showed that the baseline impedance during this type of occlusion
did not change in a clear trend. However, form the analysis of the APA waveform, it can
be concluded that the total absence of peaks in the signal is equivalent to no flow in the
forearm. At this point, it becomes essential to observe the changes in basal impedance for
more extended periods, as a high increase in impedance may suggest the development of
hypoxia or even ischaemia.
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(a) Average plethysmography waveform during
venous occlusion region 5 (960 s to 1260 s)
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(b) Average plethysmography waveform during
venous occlusion region 6 (1260 s to 1440 s)
Figure 6.6 Plethysmography waveform of the participant seven between baseline and total occlusion
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(a) Change of amplitude of the waveform at point A.
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(b) Change of amplitude of the waveform at point B.
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(c) Change of amplitude of the waveform at point C.
Figure 6.7 Changes of the impedance peak values during baseline, total occlusion and return to baseline for
points A,B and C.
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6.3 Novel evaluation of blood obstructions using iPG
baseline over APA waveforms
The information provided by the designed iPG device comprises of basal impedance and
arterial pulses amplitude. These two variables have been studied separately as an effective
source of information for circulatory problems. However, still more studies are required to
find methods that allow to discern between arterial and venous circulatory problems. To
the authors knowledge, the results presented in the this sections are the first to combine the
readings from baseline impedance and the morphological change of the APA waveform into
a qualitative indicator.
The chapter 5 demonstrated that during a circulatory occlusion, the baseline impedance
decreases slightly. Although the basal impedance drop rate is one of the first indicators of
occlusion, still the variation between both kind of blockages is quite close. The literature
has studied extensively the changes of baseline impedance during the venous occlusion
plethysmography manoeuvre and the continuous monitoring tissue health [102, 21, 22, 120].
Additionally, simulations using COMSOL models have corroborated the change of impedance
of a vessel in normal condition, stenosis, blockage and swelling. The study presented by
Shash et al. [208] suggested that using a frequency of 50 kHz is high enough to penetrate
tissue at high depth. Additionally, it demonstrated that the total impedance changes at
different rates according to the kind of flow restriction simulated. This results agree with
the one demonstrated in this study where the basal impedance varied according to the
levels of occlusion applied. From this information can be concluded that using the baseline
impedance is the first source of information for detecting anomalies in the circulatory path
but double-checking with additional data may help to corroborate diagnosis.
The use of the APA signal to investigate changes in the circulatory path has been used
from the qualitative point of view. Studies have used the amplitude pulses as a method of
quantifying blood flow in different parts of the body. The literature have demonstrated to
be quite effective to measure changes of volume, oedema and the detection of deep vein
thrombosis (DVT) [134]. However, this kind of measurements use amplitude of the pulses
to compute these physiological variables. Regarding to the analysis of the morphology of
the waveform, an attempt to analyse the waveform has been performed by Montgomery
et al. [29]. However, the analysis of the waveform was used to assess the progression of
Lymphedema during arterial and venous cycles of the iPGb waveform. Their work flagged
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out changes in the waveform morphology and changes in the dicrotic notch when compared
to the opposite healthy arm.
Another example of decomposing the iPG can be seen in the work of Klum et al. [209].
In this report, the author uses the iPG waveform as method to extract the respiratory rate. In
there, the study decomposes the waveform in different points and amplitude of the systolic
and diastolic peak. These two studies validate the use of waveform decomposition to study
physiological changes in the body.
The findings presented here demonstrated that morphological changes occur to the arterial
pulses during blood flow restriction. Two different shapes of APA signal materialise during
venous and arterial occlusion, which may allow discerning between these two events. First,
venous occlusion has shown an increase in the three points measured (systolic peak, dicrotic
notch and diastolic peak). Conversely, partial arterial occlusion has displayed a decrease of
the diastolic pulse index in relation to the dicrotic notch.
However, it could be quite challenging to make decisions by considering only one
parameter of the impedimetric signal. For this reason, a method that combines both sources
of data could provide an immediate indicator of a possible occlusion. Therefore, a ratio index
between the APA waveform and the basal impedance is proposed to differentiate between
venous and arterial circulatory problems. To do so, it is imperative to identify the three points
of the plethysmographic waveform: systolic peak, dicrotic notch, and diastolic pulse. For
this reason, the section 6.1 described the algorithm required to break down the impedimetric
signal into the baseline value and these three points.
The following steps briefly describe the process to calculate the index ratio. Due to the
noise in the signal, further processing takes place which conditions the waveform. First, all
the baseline points of the raw impedance signal need extraction; this can be achieved by
identifying the point L1 (figure 6.1). This value is equivalent to the impedance baseline (ZBAS).
All these points in the signal also represent the lower envelope of the impedimetric signal.
The second step requires extracting the APA waveform. For this, the baseline impedance
is deducted from the raw signal leaving just the APA waveform. In this study, the APA
waveform was extracted electronically using the port VAC of the designed device. This APA
signal also contains high-frequency noise. Therefore, the waveform is filtered, removing
these unwanted components. The next step consists of zeroing the waveform. So, the points
L1 and L2 are synchronised with the heart rate and levelled to zero. All the waveform points
are moved accordingly to the new reference point.
The final stage consists of identifying the three markers of the APA signal (Points A, B
and C). Waveforms that comply with the expected plethysmography shape (L1 > A < B >
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slope change (C)> L2) are detected and data points collected. In a constant heart rate, the
location of these points can be predicted by averaging the previous time between points.
Hence, the algorithm takes the previous twenty heartbeats to predict roughly the position of
the current peak or valley. Moreover, to make sure that the algorithm is detecting the right
spot, the program also analyses the change of slope. Therefore, if a change of slope occurs in
the expected time-frame, this can be disclosed as a valid APA waveform.
With this information, a relation between baseline impedance and the amplitude value
of every point can be used to magnify the change of position of the systolic peak (point A -
∆Z(A)), dicrotic notch (point B - ∆Z(B)) and diastolic pulse (point C - ∆Z(C)). Hence, the
proposed ratio consists of the relationship between the impedance amplitude at each of these
points over the baseline point (ZBAS). The introduced index (iZ(x)) can be calculated using
the following equation.
iZ(A) =
∆Z(A)
ZBAS
iZ(B) =
∆Z(B)
ZBAS
iZ(C) =
∆Z(C)
ZBAS
(6.1)
The index ratio is dimensionless with three indicators referencing each point of the
impedance plethysmography waveform. The method was applied to the study participants
data, and the results were outlined in figure 6.8. The data was separated into three waveforms
representing the index at point A (blue line ), point B (orange line ) and point C (yellow
line ). The strong continuous line in the graph represents the mean value of the point in
every region.
The index ratio value highlights some of the events registered in this study. Analysing the
data for the systolic point (point A), straight away can be noticed an increment of the index
during venous and arterial occlusion in most of the participants. Compare to the previous
baseline value; the value swelled in most participants. An elevated index value at this
point might suggest a circulatory problem. This information could be useful in post-surgery
recovery, where blood cloths need tracking after a procedure or for home patients that require
constant PVD monitoring.
The dicrotic notch (point B) and the diastolic pulse (point C) seem to change as a matching
pair for the majority of the baseline signals (regions 1, 3 and 5). In general, the dicrotic
notch appears to be slightly lower than the diastolic pulse under normal conditions. However,
during venous occlusion, the index value seems to swap for these two points. This seems to
be caused by the nearly absence of the diastolic pulse during this part of the test.
Nevertheless, something remarkable happens all along with partial arterial occlusion. The
index value swapped position for some of the participants. Before the arterial occlusion, the
location of the markers follows suit as a standard baseline (iZ(A) > iZ(C) > iZ(B)). However,
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Figure 6.8 Representation of the calculated the index ratio between the APA waveform over the basal impedance
during the whole experiment. The blue line represents the index ration at the systolic peak (Point A - iZ(A)),
the yellow line the dicrotic notch (Point B iZ(B)) and the red line the diastolic pulse (Point C iZ(C)).
The continuous line en each region is the mean value of the index ratio
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during partial arterial occlusion, there is a change in the position (iZ(A) > iZ(B) > iZ(C)). This
event is a clear differentiator between the two types of flow restriction. Participant 2, 6 and 7
are the perfect example of the behaviour of the index when these conditions are met. The
rest of the participants showed a different behaviour, but these readings were affected but
motion artefact and other issues described in this document.
6.3.1 Analysis of the novel index ratio between the three different levels
of occlusion
The index ratio (iZ) required an extensive signal analysis to extract the relevant data. However,
according to the data recorded the waveform varied at the dicrotic notch and diastolic pulse
is the most critical differentiator to distinguish between venous and arterial occlusion. This
detail is an initial clue of the potential of impedance haemodynamic analysis on the detection
of circulatory problems. Figure 6.9 and table 6.9 show the mean index ratio value for each
participant during the initial baseline data, venous, partial arterial and total occlusion. In the
figure, markers have been added to facilitate interpretation. In there, the blue bar represents
the index ratio at the systolic peak (point A ), the dicrotic notch index with the orange bar
(point B ), and the diastolic pulse with the yellow bar (point C ).
In general, from this point of view, it is possible to identify the general enlargement of
the waveform during venous occlusion, which it is also confirmed in table 6.9. Most of the
participants presented an increase of index in nearly all the points. Nonetheless, participant
8 showed a different trend possibly associated with discomfort in the course of the test.
Furthermore, participant 4 also display adverse trend for point B and C, possibly related
external factors as his/her signals were noisy after this part of the study.
In terms of partial arterial occlusion, most of the participants experience and increase of
the systolic index and a shortening or inversion in the index ratio between point B and C. The
data in table 6.9 shows that participants 2, 6 and 7 showed the ideal response for the system.
Once again partakers 1, 4 and 8 depicted adverse results related to the events previously
mentioned and motion artefact. Performing partial arterial occlusion can be painful and
required most of the participants to re-accommodate during the data collection causing extra
data noise. In total occlusion the data is more conclusive as almost everyone experience a
decrease in the index ratio in values below baseline signal. The only exception was again
participant 4 for same motives described.
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Figure 6.9 Bar graph of the index ratio iZ for every point during baseline (BL - region 1), venous occlusion
(VO - region 2), partial arterial occlusion (PAO - region 4) and total occlusion (TO - region 6). In the figure the
blue bar represents the index ratio at the systolic peak (point A ), the dicrotic notch index with the orange bar
(point B ), and the diastolic pulse with the yellow bar (point C ).
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Table 6.9 Index ratio iZ for every point of interest during baseline (BL - region 1), venous occlusion (VO - region 2), partial arterial occlusion (PAO - region 4)
and total occlusion (TO - region 6). This is the data used to create the figure 6.9, the colours used in the headers match the ones in the figure. The index value was
calculated using the equation 6.1 for each point. In venous occlusion, the bold numbers represent the indexes which increased in value compared to baseline. The
values in partial arterial occlusion that are bold and italic are the ones where the dicrotic notch is higher than the diastolic pulse.
Study
member
Baseline
(iZ ∗10−4)
Venous occlusion
(iZ ∗10−4)
Partial arterial occlusion
(iZ ∗10−4)
Total occlusion
(iZ ∗10−4)
Point A Point B Point C Point A Point B Point C Point A Point B Point C Point A Point B Point C
Participant 1 3.65 2.06 3.51 4.43 3.01 3.70 3.59 2.70 3.30 1.86 1.38 1.96
Participant 2 5.07 3.95 4.32 6.16 3.95 4.03 5.15 3.57 3.24 0.77 0.48 0.79
Participant 3 3.70 2.10 2.99 4.00 3.33 3.55 3.30 2.52 2.88 1.77 1.34 1.80
Participant 4 3.97 2.78 3.55 4.33 2.74 2.94 3.43 2.17 3.03 7.22 3.38 7.16
Participant 5 4.93 4.20 4.71 6.92 5.53 6.50 6.26 4.26 4.30 1.03 0.63 1.00
Participant 6 4.04 2.35 2.86 5.31 3.28 3.60 4.74 3.37 2.95 1.28 0.94 1.41
Participant 7 3.79 2.71 3.10 5.72 3.99 4.07 5.68 3.54 2.70 0.83 0.47 0.70
Participant 8 2.96 1.35 1.79 2.64 1.59 1.61 2.03 1.61 2.07 0.65 0.63 0.98
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The iPG signals provided additional information about blood distribution during the occlusive
events. The oscillations of the APA signal are attributed to the expansion of arteries and
veins during the heart cycle, thereby creating small changes in the impedance. While this
tiny waveform is contained within the basal impedance, it is merely a fraction of it.
The designed impedance device in its entirety, including hardware and software al-
gorithms, was able to identify the plethysmography waveforms by localising distinctive
landmarks such as the systolic peak, dicrotic notch and diastolic pulse. Obtaining this level
of detail was vital because it provided more details about the changes occurring in different
segments of the impedance plethysmography waveform. From this premise, it could recog-
nise the changes in shape during each types of occlusions performed during the test. It is
evident that at the time of each occlusive event, the amplitude of systolic and diastolic peaks
manifested a particular response in accordance to the type of blood flow restriction. Notably,
the waveform shape might be unique to this kind of set-up, and it is possible that altering the
electrodes distance or using different frequencies may impact the impedance waveform.
Meanwhile changes were observed in the size of the systolic peak (point A), dicrotic
notch valley (point B) and diastolic peak (point C) when an occlusion took place. The
increase in size might be attributed to a physiological response during the occlusion where
the volume capacity of veins increased to accommodate the pooled blood. An example
of this is evident in figure 6.3 which described the differences between region 1, 2 and 3.
According to the figure, there was an increase in the size of all reference points in majority
of the participants during the occlusion, which was followed by a return to the baseline.
However, the observations made in the partial occlusion for regions 3, 4 and 5 suggested that
while the systolic peak did increase in size, the dicrotic notch and diastolic peak declined in
amplitude when compared to the venous occlusion and baseline waveform. The difference in
waveform is an accurate indicator of an obstruction in either a arterial or venous circulation.
The chapter 5 demonstrated that during the occlusions, a different slope was noted during
in each kind of occlusion. By combining the information of basal impedance with the
APA waveform, it is possible to generate a 3-point ratio index that could be indicative of
a potential obstruction within the forearm. This observation suggested that if there is a
significant increase in the relation index of the systolic peak, it could be the first prominent
indicator of circulatory blockage. On the other hand, an increase in the dicrotic notch and the
diastolic pulse indicates that the occlusion might occur in the venous return if the dicrotic
notch ratio index is higher than the other following one. While undertaking a comparison,
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the data showed that if there is a surge in systolic peak size, the diastolic pulse index tends to
reduce or is at similar amplitude of the dicrotic notch ; it might then be an indicator of an
imminent arterial occlusion.
146
Chapter 7
Quantification and correlation of iPG,
Doppler Ultrasound, LDF and PPG
This chapter describes the quantification of the raw data obtained from the different instru-
ments inclusive the bespoken iPG device. The data acquired from the aforementioned device
and the other methods were quantified and correlated to establish the statistical associa-
tion between the impedance’s APA signal (iPG technique), arterial flow (US method) and
micro-circulatory flow (optical methods).
As mentioned in chapter 4, the iPG device recorded the basal and APA impedances. Some
of the other signals recorded were: the heart’s electrical signals using the ECG. The Doppler
Ultrasound used to estimate the arterial blood flow in the wrist’s radial artery. The PPG
placed on the index finger provided plethysmographic information from the vascular bed
close to the fingers’ area. Finally, the Laser Doppler Flowmetry attached to the mid-section
of the forearm gauged the changes of RBC in the vascular bed around the arm.
The signals provided by the instruments were scaled in volts, hence these needed trans-
lation into physiological measurement units. So, the first section of this chapter shows the
data converted from voltages to values like flow (m3/s). The second section describes the
correlation between the iPG data and the other measurements. This investigation endeav-
ours to understand the contributing factors to the impedance plethysmography signal. As
explained in previous chapters, blood flow can be estimated from the APA; but still, it is
not clear the contribution of venous and arterial blood. The extent of blood flow belonging
to any blood type remains ambiguous. Besides, it was evident that the main blood vessels
contribute to the measurement of blood flow, although microcirculation might also be able to
provide additional information under the iPG waveform.
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7.1 Quantification of the measurements of the devices
This section describes the measurements of all the devices attached to the partakers. The
signals were converted to clinical values, and the changes registered during each occlusion
were quantified and analysed. The measurements showed that every instrument showed a
particular change in slope or waveform amplitude during each occlusion applied.
7.1.1 Measurements from the ECG device
The ECG signals provided information concerning the electrical activity of the heart during
the study. Therefore, extreme changes occurring in the heart rate or shape could not be
registered through the test unless there was a bad connection. The data that was gathered
also served as a clock reference during the data processing. Figure 7.1 illustrates the typical
ECG for one of the participants.
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Figure 7.1 ECG measurement from one of the participants. The points can be clearly identified as P, Q, R, S
and T. This signal did not change during the entire experiment.
All the detected waveforms were typical and provided sufficient information about the
characteristic peaks in an ECG waveform. The points P, Q, R, S and T were visible in all
the signals. Nonetheless, participant 1 showed an elevated T-wave, which is presumably
attributed to his athletic vocation. He said that he had a ventricular hypertrophy, which
implies that one of his ventricles got enlarged.
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7.1.2 Blood flow calculation from arterial pulses signal
Thus far, blood flow has been analysed from occlusive methods that incorporated the tech-
niques described in section 2.5.3. However, these procedures necessitate mechanical occlu-
sion to produce an increase in volume within the forearm that is being measured. Nevertheless,
this can oftentimes be uncomfortable, particularly when the pressure is applied above the
systolic value or when the person is unable to tolerate restricted blood flow.
For such cases, analysing the waveform offers key information about various aspects
of blood flow. The rush of blood into the vessel leads to a tiny surge in volume within the
limit of potential electrodes, which then can be translated into a quantifiable blood flow. It
is imperative to have a device that is sensitive enough to detect these changes providing an
accurate estimation of the blood flow (speed). As mentioned in section 3.9.2, the waveform
contained within the basal impedance got amplified by the device, thereby attaining a great
level of detail.
In fact, different studies have demonstrated that it is indeed possible to calculate blood
flow by analysing the APA waveform [21–26]. Here, the change of impedance used to
perform this calculation takes place between the foot of the wave and the systolic peak. This
∆Z is used to calculate blood flow by applying Nyboer’s equation 3.31.
Figure 7.2 illustrated the flow of blood derived from the amplitude of systolic peak
throughout the entire experimental session. Green dots indicate blood flow measurements
taken during baseline readings (regions 1, 3, 5 and 6). Meanwhile venous occlusion is shown
in blue, partial arterial occlusion in red, and total obstruction in grey. The dark line drawn
above the signals corresponds to the smoothing of each measurement event using robust
loess method of the smooth command in Matlab. Overseeing the amplitude transition in
every region will help explain how the flow changes with each occlusive event. The value of
the calculated blood flow depicted in the figure excludes the negative sign that denotes the
direction of flow relative to the potential electrodes.
As portrayed in this figure, between each transition - in the middle of baseline and
occlusion - some participants clearly described the marked shifts in the calculated flow. In
most participants, when the venous occlusion occurred, the changes between baseline and
venous occlusion created a blood surge that was followed by a tendency for the flow to
stabilise. Notably, the increment of blood flow in participant 2 occurred prior to the venous
occlusion because the obstruction probably commenced before 300 s and the pressure exerted
on the arm was rather slow. Meanwhile there are other instances where the flow change
took place at such a quick pace that an entirely blank space can be seen to connect both
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Figure 7.2 Blood flow calculated from the impedance plethysmography for all the participants during the
whole experiment. Each dot signifies the peak value of the waveform that has been converted into flow
(ml/min100ml). The green dotted area denotes the baselines measurements (regions 1,3,5 and 7). The region 2
(venous occlusion) is represented by the blue dots; arterial occlusions (region 4) are in red and total occlusions
(region 6) are in grey.
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events, as was seen in participants 5 and 7. This scenario, in contrast to participant 2, was
more probable since the cuff was inflated at a faster pace, which led to a sudden change in
flow, as opposed to a gradual one. However, it could also be correlated with a physiological
bodily response such as vasodilation response, where one reacts faster than others. Finally,
participant 8 was an exception to this rule and experienced a decline in the calculated flow,
which was followed by a period of stabilisation. A flow surge was not identifiable in this
participant.
Between venous occlusion and the return to baseline in region 3, the cuff was swiftly
deflated so as to restore blood flow to the normal level. However, the calculated data
suggests that no extreme changes were observed in the blood flow between these two
sections immediately after the release of blockage. As noted before, most participants,
except partakers 5 and 7, did not experience significant changes between these two sections,
indicating a slight change in blood flow. This can be attributed to a hyperaemic effect where
as soon as the pressure is released off the cuff, the blood in the vessels of the forearm rushes
out to the upper part of the arm. Subsequently, the blood flow tended to stabilise towards an
average value.
Similarly, as seen between regions 1 and 2, the change between baseline (region 3) and
partial arterial occlusion (region 4 - red colour) generated alterations in the calculated blood
flow. Some participants, such as partakers 6 and 7, experienced a rapid surge in blood flow
after the occlusion followed by a settlement in the blood velocity, where the latter becomes
more prominent. Meanwhile others such as participants 1, 2, 3 and 5 showed a Gaussian
bell-shaped flow during the occlusion. Evidently, their flow did not set in a mean value.
The only ones that enacted a different behaviour were participants 4 and 8, who did not
experience a significant change. However, the continuous change of amplitude in participant
8 became prominent at this point, which is in contrast to the remaining participants.
The change occurring between partial arterial occlusion (red dotted section) and baseline
entailed a similar effect as the one described for releasing the pressure of venous blockage.
Most participants had a decreased blood flow, immediately upon the release of cuff’s pressure,
possibly due to a hyperaemic effect. At this point, participant 4 began exhibiting random
blood flow readings.
Total occlusion (grey dots) evinced an expected response in nearly all the members.
When the blood flow was completely stopped, its calculated value was expected to be zero.
In this case, the device could successfully detect these changes. Participant 4 was the lone
exception who again displayed random results. There were strong indications that there
could be something wrong with his measurements. Upon the release of tourniquet, the blood
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flow returned in an exponential form and was then set to an average value. In this case, the
hyperaemic effect became more visible. Importantly, participant 8 witnessed a decline in
blood flow towards the midpoint of the test. This event concurs with the partaker’s expression
of not feeling too well by the end of the test. It can be speculated as pure coincidence, or it
could be that the device was indeed able to detect these physiological changes within him.
It is likely that there is a blood surge when an occlusion occurs from the impedance
computation. Thereafter, the blood flow tends to stabilise at an average value. After the
release of blockage, it seems that in certain cases, the flow tends to decrease; in other
instances, no apparent change is found. The following sections will extrapolate on the
findings of the change in median blood flow during each occlusive event.
7.1.2.1 Blood flood quantification and analysis during occlusion
The following is the analysis of the quantified blood flow rate during the three occlusive
stages. The table 7.1 sums up the results obtained by the measurement flow in the scale
ml/min100ml. To reiterate, the results do not signify an absolute value, dropping the
negative sign as this is indicative of the direction of the flow relative to the electrodes.
Table 7.1 Median blood flow calculation in ml/min100ml from the iPG APA waveform
Region 1 Region 2 Region 3 Region 4 Region 5 Region 6 Region 7
(ml/min100ml)
Participant 1 2.046 2.688 2.710 2.251 2.977 0.564 3.466
Participant 2 2.516 3.766 3.119 3.484 3.537 0.284 2.922
Participant 3 1.794 1.416 1.325 1.299 1.647 0.567 1.277
Participant 4 1.811 3.296 1.748 1.665 4.832 4.350 3.786
Participant 5 2.033 3.024 3.110 3.454 2.841 0.342 3.500
Participant 6 3.054 4.019 3.566 3.417 3.866 0.448 4.103
Participant 7 2.555 3.993 2.483 4.441 3.389 0.343 3.689
Participant 8 2.461 2.068 1.207 0.882 0.693 0.098 0.399
The mean blood flow in region 1 was about 2.283±0.437 ml/min100ml. When the
venous occlusion occurred by inflating the cuff below the diastolic value, the average blood
flow calculated in region 2 stood at 3.034±0.938 ml/min100ml, reflecting an increase of
blood flow of approximately 33 %. This rise could be attributed to a physiological response.
It appears as if a vasodilation process allowed for the retention of extra blood in the venous
circulation. However, study members 3 and 8 were outliers depicting a decrease in blood
flow during this transition. After releasing the cuff’s tension in region 3, the data portrayed
a decrease in blood flow. Six out of eight of the participants witnessed a reduced flow rate
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during this section of the experiment. The average blood flow for region 3 stood at nearly
2.409±0.885 ml/min100ml, equivalent to a 5.5 % difference with the initial baseline at
region 1.
The change of blood flow between the baseline (region 3) and partial arterial occlusion
(region 4) was not as apparent as the venous one. It can be seen that three out of eight
participants did show an increase in their blood flow, whereas the others witnessed an slight
decline. During the partial arterial occlusion, the average blood flow of all the participants in-
creased from baseline in about 8.4 % to approximately 2.612±1.266 ml/min100ml. When
the upper arm pressure was released in region 5, most of the participants were expected
to experience a decline in their flow rate. However, this was not the case. At this stage,
the average blood flow stood at 2.973±1.293 ml/min100ml, equivalent to an increment of
23 % from the baseline region 3. Three study members recorded a drop in their rate (5, 7 and
8) with an average of −0.618±0.431 ml/min100ml. The remaining members meanwhile
showed a surge in their data of nearly 0.948±1.263 ml/min100ml. At this stage, it is not
possible to draw a clear conclusion as to whether an arterial occlusion would indeed result in
a increase or decrease of blood flow from the impedance measurement.
During the total occlusion, the APA amplitude was merely a fraction of the baseline
waveform. Therefore, the ∆Z obtained to calculate the blood flow is a small number, which
results in a low or null calculation. In this aspect of the analysis, most of the study members
showed a decline in blood circulation rate close to zero. Table 7.1 makes it clear that
nearly all participants posted a significant decline in their blood flow calculation when
the brachial arterial constriction was applied in region 6, lowering the flow rate to nearly
0.3953±0.1412 ml/min100ml. Normally, one would expect the reading to show zero as no
blood flow passed through the forearm. However, this could be due to an error of equipment
measurement induced by noise which was picked up by the device. After the withdrawal of
tourniquet, the blood flow recovered exponentially, portraying a fast return to the baseline
accompanied by an overshot peak and followed by the settlement towards a midpoint, as
indicated by figure 7.2. This shape is typical of a hyperaemia where the return of blood flow
produces such an overshot response, owing to the rapid filling of the vessels. The mean
blood flow in region 7 stood at about 2.892±1.332 ml/min100ml, which is very close to the
original baseline region 5. At this stage, the sensitivity for the calculation of small changes in
blood flow requires improvement because it detected flow values in other participants when
there was an absence of plethysmography signal. However, it is quite remarkable that the
instrument detected changes in trend.
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7.1.3 Blood flow estimation from Doppler ultrasound instrument
As part of the procedure, a Doppler ultrasound was used to estimate blood flow using the
radial artery in the wrist as a reference. The raw data produced by this instrument was in
the form of volts, which was subsequently converted into more meaningful data using the
equations 4.15 and 4.17 which convert this information into units litres per minute (lmin−1).
As described in these equations, the angle was fixed at 45° using a laboratory support and a
clamp. The cross-sectional area for calculating the blood flow was the median value of [198].
The head of this ultrasound device was placed as close to the artery as described in the
user manual, using a conductive gel as an interface between the skin and the device. When
taking the last participant measurements, the Doppler ultrasound instrument had an electrical
problem. Hence, it was not possible to collect the data from participant 8. The data presented
in figure 7.3 and table 7.2 comprise of the results of the first seven participants.
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Figure 7.3 Blood flow calculated from the Doppler ultrasound measurements for all the participants during this
experiment. The greyed out areas are indicative of the raw sign of the DU waveform whereas the dark blue
lines represent the envelope calculated from the peak values. The data was converted into blood flow with units
(l/min).
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7.1.3.1 Blood flow estimation from Doppler Ultrasound instrument
Figure 7.3 shows the peak values of the Doppler ultrasound that were converted into the
arterial flow rate. The shaded areas signify the occlusive events during the study. The
measurements depict the blood flow of the radial artery and the changes occurring during
each occlusive event. During venous occlusion, no significant change in arterial flow rate
was expected since the brachial artery was not occluded higher than the diastolic pressure.
On the other hand, a partial arterial occlusion between the diastolic and systolic pressure
curbs the inflow of blood flow towards the radial artery. Finally, at the moment of occluding
the brachial artery above the systolic pressure, null blood flow is likely to be displayed.
A qualitative analysis of DU data shows that various participants showed an alteration
in their calculated median arterial flow during the venous occlusion in region 2. Whereas
others experienced a rapid variation within the first few seconds, others took some time
to show a resting point. Participant 1 evidenced an exponential flow rate drop during this
aspect of the test. Further, participants 2 and 4 displayed a swift decline within the first few
seconds followed by a settling at a mid-point. However, the remaining participants did not
show a significant change in flow rate during this transition. Nevertheless, the quantified
data showed in 7.2 demonstrated that during the transition between baseline regions 1 and
2, five out of seven participants witnessed a reduction in their median blood flow, being
Participant 1 the most obvious among them with a drop of 52.41 % of the blood speed. The
other ones who exhibited a slight decline were partakers 2,3,4 and 6 whose their blood flow
was about 25.80±18.50 %. On the other hand, participants 5 and 7 showed a slight surge
in their calculated blood flow in 10.16 % and 6.25 %, respectively. Upon the release of the
cuff’s pressure, most participants showed a recovery within the detected blood flow. Only
participants 2 and 5 exhibited a minimal decline.
During the partial arterial occlusion, the arterial blood flow changed unmistakably in all
the participants. In this case, it is evident that the narrowing of the brachial artery curbed
blood flow in the arm’s arterial circulation, altering the flow rate speed that was detected by
the DU. As shown by the figure, most participants exhibited a swift change of blood flow as
soon as the constriction was applied, with the exception of participant 5. Generally speaking,
the reduction of blood flow in the radial artery stood at around 48.79±11.91 %. As soon
as the flow was restored, majority of the participants witnessed a surge in their blood flood
caused by a rush of blood within the arterial circulation passing through a quick inflow for a
few seconds. However, participant 5 showed a different response which might have been
caused by the misalignment of the sensor head.
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Table 7.2 Mean blood flow calculated form the Doppler Ultrasound waveform during all the regions of the
experiment.
Region 1 Region 2 Region 3 Region 4 Region 5 Region 6 Region 7
(l/min)
Participant 1 0.954 0.430 1.285 0.618 1.049 0.003 0.719
Participant 2 1.211 1.014 0.967 0.546 0.843 0.002 0.712
Participant 3 0.928 0.860 1.307 0.716 1.940 0.002 1.675
Participant 4 0.826 0.581 0.764 0.297 0.754 0.002 1.245
Participant 5 0.643 0.708 0.655 0.483 0.348 0.003 0.606
Participant 6 0.495 0.248 0.499 0.230 0.542 0.002 0.641
Participant 7 0.962 1.022 1.320 0.535 0.876 0.002 1.040
Finally, the tourniquet effect can be noticed in the composition of the signal all along
the total occlusion with a sharp decline as soon as the occlusion took place. As expected,
no arterial flow was recorded; the minimum values might signify the artefacts in the signals.
After releasing the tourniquet, all participants experienced a surge in their flow rate to values
of normality.
7.1.4 Measurements from Laser Doppler Flowmetry
The LDF device provided raw data in Volts which was subsequently converted into BPU
units. This conversion was made possible by applying equation 4.18 to the collected data.
As explained in section 4.3.1.4, it resulted in an arbitrary unit, which denotes the movement
of blood cell beneath the skin’s micro-circulatory bed. This unit called BPU refers to the
product of the mean number of moving blood cells into the small volume under the probe
and the average velocity of moving red blood cells in the forearm. Converting the raw data
to BPU unit could be done using the equation 4.18.
Figure 7.4 shows the peaks of the LDF waveform signal in BPU. The grey points are
the measurements’ raw data. The purple line in this figure represents the smoothed signal
averaged per heartbeat. The boxed areas describe the data portions where these occlusions
occurred. This plot shows that evidently, the movement of blood cells is affected when an
occlusion occurs. Indeed, there is a diminution of the magnitude of signal during each flow
restriction. During the course of experiment, the LDF signal was very susceptible to noises;
this explains the rationale behind massive peaks witnessed during some of the measurements.
In particular, participants 1 and 3 showed a significant number of high peaks. From the
qualitative viewpoint, the strong impact on some parts of the data is evident, such as in
participants 1 and 4.
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Figure 7.4 Results of the Laser Doppler Flowmetry measurement for all the participants after being converted
to BPU. The values presented in purple are equivalent to envelope signal of the peak points.
Nevertheless, a trend is noticeable in all the participants. During the occlusions, a drop
in the red blood cell movement was noticed. It seems that the blockage of venous return in
regions 3 and 5 slowed down the movement of RBC in the capillaries. Additionally, during
total occlusion, the amplitude reaches its lower values. After the restoration of blood flow,
the RBC movement depicted a Gaussian bell shape peak throughout most participants. This
hyperaemic effect shows an acceleration of blood cells following the blockage event. While
this acceleration is evident in every occlusion, it varies in magnitude with each occlusion.
The BPU magnitude is clearly larger on in all participants following the total occlusion. In
comparison, two other occlusions created a smaller Gaussian shape as a response where
the one that ensued after the partial arterial appears to be slightly bigger. Nevertheless,
participant 8 seems to be an exception to this rule. The BPU measurements increased only
slightly during the transition from region 3 to 4. Also, in contrast to the other participant’s
waveforms in the transition from partial arterial occlusion to the baseline in region 5, his
mean BPU dropped. The results obtained from this participant could also explain some of
the adverse readings that were captured by the iPG signals.
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Lastly, during total occlusion, all the mean BPUs of the participants reduced significantly.
At a subsequent stage when the tourniquet was released, the rush of blood flow is evident
in the hyperaemic effect registered by the instrument, which was also detected by other
instruments. Table 7.3 reviews the values of the mean BPU data. These results are in absolute
harmony with the figure that was previously analysed.
Table 7.3 Media perfusion index (flux) calculated from the LDF data for all the regions during the experiment.
Region 1 Region 2 Region 3 Region 4 Region 5 Region 6 Region 7
(BPU)
Participant 1 23.65 11.59 17.20 9.20 19.81 5.16 14.60
Participant 2 16.88 9.10 14.44 8.19 13.17 6.07 14.83
Participant 3 29.46 17.43 32.86 19.76 41.80 7.83 33.87
Participant 4 9.81 6.14 9.53 6.99 14.11 5.94 12.19
Participant 5 15.56 10.35 13.85 9.28 14.02 4.73 18.03
Participant 6 18.66 8.80 16.03 9.56 15.06 6.60 14.56
Participant 7 11.96 7.25 10.37 9.51 10.24 5.08 11.91
Participant 8 15.54 12.40 13.85 17.93 12.29 8.40 10.97
7.1.5 Measurements from the PPG Red-light signal
The photoplethysmographic device provided key information about the change of volume
within the vascular bed underneath the skin. It is capable of detecting venous or arterial blood
change in accordance to the light wavelength [210]. The finger probe used throughout the
experiment comprised of red and infrared sensors. Nevertheless, the red-light information
was collected because it was more sensitive to the changes made in the venous blood.
The device employed in this experiment has an output port that provides the unprocessed
raw photoplethysmography waveform. Similarly, as is evident in the iPG signal, the PPG
comprises of DC and AC components. The DC portion of this signal is equivalent to the blood
volume noted under the light beam. Moreover, it contains data about the respiratory rate in
addition to other physiological information, which is not necessary for this experimental
setting. On the contrary, the magnitude of AC component changes synchronously with the
cardiac cycle and blood volume under the capillaries.
The raw signal displayed in figure 7.5 reveals the DC (left side) and the AC (right side)
components of all the participants. Additionally, within the plot, the shaded regions are
indicative of each occlusive event during the experiment. The DC component of the signal
was obtained by decoding the bottom values that envelope the raw PPG waveform. In other
words, these are points on the foot of the waveform. In addition, the AC component of
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(a) DC component of the PPG waveform for each
of the participants
(b) AC component of the PPG waveform for each
of the participants
Figure 7.5 PPG measurements using the red spectrum. The plots show the DC and AC components of the
waveform. The shaded areas represent the occlusion events during the venous occlusion (region 2), partial
arterial occlusion (region 4) and total occlusion (region 6))
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this signal was obtained by subtracting the low envelope of the raw data. Furthermore, the
resultant waveform was inverted to permit only the dynamic element of the signal. Lastly, the
peaks detected from the plethysmography waveform were redrawn in black, thus highlighting
the peak values during all the occlusive events.
7.1.5.1 Changes in the DC component of the signal
After analysing the DC signal, it can be seen from the figure that all participants showed
a definite decline in their DC components during venous occlusion (region 2) and partial
arterial occlusion (region 4). It illustrates that the DC value reduced dramatically in most
participants following the occlusive event. Nevertheless, some participants displayed an
exponential drop in their recordings, as shown in participants 3 and 8 during both occlusive
events.
The visible changes of the DC value is confirmed when analysing the mean values of
the DC data presented in Table 7.4. From there on, the calculated average baseline prior to
the occlusions were 1.44±0.55 V for Region 1 and 1.51±0.54 V for Region 3. In contrast,
the DC components dropped about 0.435±0.210 mV and 0.528±0.247 mV during the
occlusive transitions for region 2 and region 4, respectively. When comparing the DC values
between both events, it can be seen that difference between the two is not significant - only
4.47 %. Nevertheless, during total occlusion, the signals were erratic with no definite shape or
direction. Some participants did exhibit a slight decline, but others did not display significant
changes. In general, the DC data provided valuable information during the venous and partial
arterial occlusion, but no conclusive results could be observed when the blood flow stopped
altogether.
Table 7.4 Mean peak value of the PPG DC signal for all the participants in all the regions.
Region 1 Region 2 Region 3 Region 4 Region 5 Region 6 Region 7
(V)
Participant 1 0.75 0.44 0.91 0.43 0.94 0.91 1.03
Participant 2 2.09 1.38 2.22 1.33 2.25 2.24 2.24
Participant 3 2.24 2.20 2.24 2.16 2.23 2.24 2.20
Participant 4 0.76 0.46 0.80 0.36 0.72 0.79 0.89
Participant 5 1.60 1.07 1.73 0.93 1.66 1.64 1.64
Participant 6 1.36 0.84 1.38 0.76 1.41 1.08 1.35
Participant 7 1.26 0.79 1.25 0.75 1.56 1.32 1.34
Participant 8 1.48 0.88 1.48 1.07 1.64 1.71 1.70
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7.1.5.2 Changes in the AC component of the signal
The AC component also produced a notable swing of magnitude during each blockage event.
When compared to the DC, the AC signal not only changed its amplitude all along the
venous and partial arterial occlusion, but also during the total occlusion, where it reached its
minimum magnitude which is consistent with the fact that no change of volume is evident at
that precise instant. Reviewing the AC signals qualitatively, participants 2, 3 and 5 exhibited
low-quality waveforms since amplitudes were quite close to noise levels (amplitude < 10 mV).
Participant 2 registered noisy waveforms during region 1 of the study and small magnitudes
for the remainder of this experiment. Participant 3 meanwhile exhibited low signal amplitude
and over peaks during the entire test, although the changes through each occlusion continue
to be visible.
From the numeric point of view, Table 7.5 shows the average values of the amplitude in
mV. During all baseline measurements (regions 1, 3, 5 and 7), the mean peak value stood
at 436.41±110.81 mV. However, it is evident that the overshooting displayed considerably
higher values than the mean.
In general, during venous occlusion, the signal amplitude dropped in all the experiment
members in around 422.97±212.17 mV. However, participant 3 was an outlier showing
the smallest change (24.50 mV) in comparison to the remaining signals. It seems that the
poor-quality signal ended up affecting the entire measurement. After the cuff’s pressure
was released during the transition from venous occlusion to baseline, participants 2 and 3
witnessed a decline in their mean amplitude. Yet again, their poor signal quality caused them
to show conclusive measurements. The rest of the partakers recorded a recovery in their peak
signal to a peak of nearly 221.28±211.24 mV.
Table 7.5 Mean peak value of the PPG AC signal for all the participants in all the regions.
Region 1 Region 2 Region 3 Region 4 Region 5 Region 6 Region 7
(mV)
Participant 1 724.83 180.45 546.76 66.13 490.87 109.85 441.54
Participant 2 926.02 245.24 158.34 110.32 51.30 5.97 92.58
Participant 3 94.21 69.72 68.76 37.19 71.62 10.54 122.67
Participant 4 436.74 92.42 315.26 37.22 354.44 58.08 296.36
Participant 5 873.38 324.60 638.53 155.21 703.81 51.36 751.62
Participant 6 658.05 188.75 501.10 112.57 480.41 38.14 517.01
Participant 7 731.50 190.43 746.34 125.76 547.89 26.92 660.43
Participant 8 360.69 130.06 216.80 74.43 168.52 89.77 217.06
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During partial arterial occlusion in region 4, this device detected the physiological
response. In this case, all participants witnessed a drop in their mean PPG signals amplitude
of an average of 309.14±219.43 mV. When comparing the mean values during occlusions
in region 2 and 4, the signal amplitude in region 4 was slightly lower than the one in region 2
by close to 87.86±46.91 mV, which is the difference between both circulatory occlusions
49.75 %.
Finally, throughout the total occlusion, all participants exhibited a substantial reduction in
their AC amplitudes. This was expected due to the absence of blood flow within the vessels.
In entirety, the signals went below 109 mV with an average value of 48.83±36.62 mV. In
fact, this confirms that the measurements taken from participants 3 were below this level.
In conclusion, the PPG waveform witnessed changes of DC and AC components during
all the occlusions conducted throughout the study. The DC signal successfully detected
changes during both venous and partial arterial occlusions. The difference of their mean
DC values during these two events was minimal at only 4.47 %. Furthermore, during total
occlusion, no noticeable change in DC value of the signal was observed. On the other hand,
the AC component effectively distinguished between venous and partial occlusion. The
difference between these two regions stood at about 50 %. Moreover, the signal lost most of
its magnitude during total occlusion due to inadequate blood flow.
7.2 Correlations of the iPG amplitude wave and Doppler
ultrasound, PPG and LDF
In this section, the correlation between iPG and the other techniques will be analysed. An
analysis in the frequency domain will be shown, identifying the similarities between measure-
ments and noise levels. The Bland et al. [211] method was used to analyse the correlation of
the measurements comparing the normalised data magnitude between modalities.
The endeavour of this investigation is to understand the contributing factors of the
potential impedance plethysmography signal. As explained in previous chapters, the change
of volume in the forearm section allowed the estimation of blood flow. However, both arterial
and venous blood contributes to the information of blood flow that was calculated by the iPG
device. The extent of blood flow belonging to any blood type remains ambiguous. Besides,
it was evident that the main blood vessels contribute to the measurement of blood flow,
although microcirculation might also be able to provide additional information under the iPG
waveform.
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7.2.1 Analysis of the heartbeat detection in the frequency domain
The signals obtained from each device throughout the experiment are synchronous with the
heartbeat. Due to this synchronisation, the systolic peak is also present in the waveform of
these instruments in their dynamic component.
Nonetheless, some noises do have a negative impact on the proper detection of systolic
peaks carried out during the study. The designed algorithm can detect the shape of the
waveform by finding the signal’s foot and peaks. Nevertheless, some of its peaks might be
missing due to the noise levels.
A Fast Fourier Transform was used to detect the waveforms’ main harmonic in a random
window data set. The data was selected between 580 s to 780 s for the AC components only,
hence the data from ZAC channel. The algorithm was programmed to detect the frequency
peak ( fp) from 0.85 Hz to 1.75 Hz. Meanwhile the FFT was limited to detect the frequencies
between 0 Hz to 5 Hz owing to the filters applied to the waveforms, as explained in section
4.1.2.6.
From Figure 7.6 the frequency components from all the participants’ measurements can
be seen. The ECG plots illustrate the frequency response that is typical of such a signal. Some
signals presented a high level of high-frequency components such as the ones witnessed in
participants 1 and 8. Participant 3 illustrated a high 2 Hz harmonic peak whose power was
greater than the first harmonic. This response seems odd, but by examining the waveform in
detail, it showed a lower Q wave which might influence the abnormal frequency component
presented in the graph.
The iPG device had a mixed frequency response to detect the cardiac heartbeat. As can be
seen from the shown plots, some signals exhibit a low-frequency noise which, in some cases,
is bigger than the first expected harmonic. For instance, participants 1, 3, 4 and 6 found it
difficult to detect the frequency peak related to the cardiac cycle for this particular data set.
However, the remainder of partakers registered a frequency peak at a similar heartbeat like
the ECG.
PPG frequency components were quite evident in all participants. Some of them showed a
high-frequency noise, such as participant 8. However, this signal generally shows low signal
to noise ratio in comparison to iPG, which is understandable, as the PPG-AC is significantly
bigger than the iPG-AC amplitude.
Lastly, DU exhibited clear FFT components in most participants. Only Participant 1
demonstrated a high noise component in his measurements; the rest showed a response that
was similar to the ECG.
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Figure 7.6 Fast Fourier transform for all the measurements in the study. Any DC level was removed previous
the FFT. The main harmonic represents the heart frequency. The data range corresponds to the time between
580 s to 780 s for the AC components at the measurements.
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Table 7.6 demonstrates how close the cardiac frequency is to each instrument. However,
the iPG mean harmonic and frequency distribution from participant 8 clearly shows that his
data was not clean.
Table 7.6 Cardiac frequency obtained from the Fast Fourier Transform for each of the instruments used during
the experiment. This peak corresponds to the one with in the hearth cycle in the study (0.5 Hz < fp > 1.5 Hz)
ECG iPG PPG LDF DU
( fp [Hz])
Participant 1 0.967 0.952 0.949 0.897 0.949
Participant 2 0.964 0.964 0.989 0.964 0.964
Participant 3 1.041 0.916 1.041 1.038 1.019
Participant 4 1.425 1.437 1.422 1.321 1.425
Participant 5 0.940 0.940 0.937 0.940 0.940
Participant 6 1.239 1.242 1.242 1.233 1.239
Participant 7 1.163 1.163 1.163 1.163 1.163
Participant 8 1.346 1.401 1.337 1.367 N/A
7.2.2 Correlation between iPG and Doppler ultrasound
The Chapter 6 showed how the waveforms obtained during the course of this experiment
changed in amplitude at each occlusive event. By observing the equation 4.15 from the
Doppler ultrasound section, it can be surmised that the velocity (v) is directly proportional to
the Doppler frequency ( fD). The remaining terms can be assumed as constant. Subsequently,
the same rule holds true when this velocity is converted into blood flow. Equally, the blood
flow calculated from this iPG device with equation 4.23 signifies a function of RB that is
directly proportional to the impedance waveform’s amplitude at the point L1 (see figure 6.1)
as illustrated by equation 4.19. In other words, the magnitude of both these measurements
alters in accordance to the blood flow.
However, the Doppler ultrasound is solely focused on arterial flow over the blood vessel
under observation. Instead, iPG records the changes in flow of both arterial and venous
circulation in the volume segment under test. Notably, both devices measure blood flow,
albeit in a different manner. The Doppler ultrasound requires precision when placing the
instrument’s head on the patient’s skin. The best signal is obtained when the device is kept
exactly over the blood vessel. Hence, the clarity is predicated on the operator’s skills to
maintain a constant angle and always over the artery. During the course of the experiment,
this procedure was replicated using laboratory instruments, keeping angle and skin contact
constant. However, using this set-up does not counter rest the participant’s arm movement,
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which causes a misalignment of the sensor. Consequently, the amplitude of this ultrasound
signal is not as steady as one might expect.
As was observed in section 7.2.1 the AC components of the iPG device are not clean of
noise among all partakers. In fact, participant 2, 5, 6 and 7 showed the best signals to work
with. For this reason, the waveforms from these partakers were used when performing the
correlation between both instruments.
Figure 7.7 shows the correlation between iPG and DU. The data range corresponds to
the entire duration of the experiment and includes the changes of blood flow caused by the
occlusions. In the plot, this data was discriminated with a different marker point and colour
in accordance to every event during the test. It can be noted that odd regions are baselines,
and even regions are blockages. The data was normalised and referenced to the highest peak
of the total data set. Each systolic peak detected from the iPG waveform was used to the
find the corresponding Doppler ultrasound systolic peak around the same segment of time.
Subsequently, the iPG and DU data sets were smoothed by calculating the mean value of
every 20 peaks detected within a non-cumulative average.
The method for analysing the correlation of both measurements was proposed by Bland et
al. [211]. It allows for the comparison of a traditional technique with a new method. Hence, it
is ideal to compare the measurements between DU and the designed device. This technique is
mostly used to compare similar unit measurements. For this reason, the data were normalised.
Therefore, the comparison will be made on the change of magnitude undertaken between
both modalities.
On the left side of the plot, the result of the linear regression between both waveforms can
be seen. At a certain degree, the data trend is off the line of equity (dotted line), implying that
there is no perfect agreement between the two methods concerning their amplitudes. As a
matter of fact, this graph shows the linear correlation between both signals with a coefficient
correlation of r2 = 0.35 to confirm a link between both signals. However, there is an absence
of perfect alignment of the reference signal’s (DU) variability alongside the y-axes.
Analysing region by region illustrates how the data points were distributed along the
correlation graph. For instance, there seems to be a good data distribution in both axes
throughout regions 1 and 2. It is evident that both waveforms amplitudes spread quite
uniformly. Region 1 appears to be closer to the line of equity than region 2 when venous
occlusion took place. Apparently, the magnitude of DU signal did not change when compared
to the iPG’s ones. Undeniably, the impedance plethysmography device detected changes that
could not be noticed by DU, which is in agreement as the venous occlusion does not alter the
arterial flow.
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However, region 3 shows a bigger distribution of data points (than iPG) adjacent to y-axes.
It is possible that the participants’ movements caused this significant variation of the DU
amplitude. By reviewing the envelope of signal illustrated in figure 7.3 it can be seen that
Participant 7 showed the largest waveform amplitudes; this can also be confirmed in the
mean blood flow computed on the same region. In fact, the linear regression improves to
r2 = 0.45 when the data was run without this participant.
Region 4 demonstrates a similar behaviour as region 2; there is a good amount of data
distribution, but the iPG amplitude changes more than the DU. Notably, there is a greater
concentration of data points in the lower region of both axes. However, this is expected as
there is a reduction of arterial blood during this event. The higher data points towards the
iPG axes pertain to the blood flow rush towards the beginning of the occlusion on participant
7, which is illustrated in 7.2.
Region 5 shows a higher distribution of the data adjacent to the iPG axes. On the other
hand, some data points on the lower part of the DU axes impact the linear regression in
this region. During total occlusion occurring in region 6, the DU device witnesses a better
response. Here, a significant number of the Doppler’s ultrasound data points are set to zero,
whereas the data from iPG is mostly distributed among 0 and 0.2. Finally, region 7 exhibits a
good distribution that is adjacent to the line of equity, which is in congruity with some of the
other baseline behaviours.
The plot on the right side of figure 7.7 shows the precision between the estimated
limits of agreement of the experiment. On the y-axes, the mean difference between the
two measurements and the points of its standard deviation is plotted. The differences have
normally been distributed in a Gaussian space. Hence, 95 % confidence interval of the
difference should be located between ±1.96SD. This graph shows a high number of points
out of +1.96SD. However, it can be seen that values from regions 2 and 4 are outside of the
agreement region. This confirms that when an occlusion occurs, there is a different response
between iPG and DU.
7.2.3 Correlation between iPG and PPG
The correlation between iPG and PPG was also investigated when looking for amplitude
similarities between both signals during the occlusive events. In a similar manner, the method
used in the previous chapter was used here as well in order to analyse the change of magnitude
between both AC waveforms. The two signals represent the changes of volume within a
part of the body, PPG in the finger and iPG in the forearm. Although the PPG reflects blood
movement within the blood vessels beneath the skin in a not so well-defined volume [39],
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iPG provides crucial information about the change of volume by the blood vessels being
filled with blood but limited by the sensing electrodes.
However, the PPG method used in this study was very simplistic when compared to
more sophisticated methods that may be able to detect the changes in venous and arterial
flow using other wavelengths, sensor placement, or data interpretations. The correlational
study of this section looks to decipher the changes in amplitude among AC components of
both signals. As detailed in previous chapters, both signals illustrated changes within their
DC components for the time that they were occluded. However, the AC component of both
signals changed oppositely. While there was a magnitude increment in the iPG waveform all
along the occlusions (see figure 7.2), the PPG waveform (see figure 7.5) witnessed a decline
in amplitude during these events.
As shown in figure 7.2 participant 2 displayed abnormal AC amplitudes during the time
of this experiment. Also, detailed in the previous section, participants 2, 5, 6 and 7 showed a
better AC response. It is for this reason that the data of participant 2 was excluded from the
correlation between these two waveforms. The data sets were smoothed by calculating the
mean value of every 20 peaks in a non-moving average.
The Bland et al. [211] statistical analysis was also implemented in this study. Figure 7.8
shows the correlation between iPG and PPG magnitudes. The chart on the left shows the
absence of a perfect correlation during the study, which was expected because the signal’s
amplitude goes in opposite directions all along the venous and arterial occlusions. Notably,
the graph shows a poor linear correlation between both signals with an r2 = 0.07.
Most of the baseline data points (regions 1,3,5 and 7) are closer to the line of equity. In
fact, if the venous and arterial occlusive events were removed, there would be a significant
improvement in the correlation between both measurements (r2 = 0.40). By analysing the
results of this graph, it can be confirmed that the iPG magnitude changed significantly while
PPG’s amplitude reduced during the course of venous and arterial occlusions. It is also
verified that the PPG amplitude all along the arterial blockage is lower than venous occlusion,
as illustrated by the data points in the figure. On the other hand, there was a similar response
to both signals at the time of total occlusion, and the absence of blood flow translated into
small amplitude values. The PPG data points were closer to zero in comparison to the iPG
magnitudes that were closer to 0.1.
The BA (Bland and Altman) plot on the left side of figure 7.8 illustrates greater precision
at the time of these baseline readings. Most of the data points are within the 95 % confidence
interval (±1.96SD), while the measurements taken during occlusion were mostly outliers.
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7.2.4 Correlation between iPG and LDF
The signal from the LDF device provides information about the flow movement of red blood
cells within the microvascular network under the skin. However, a weak correlation between
measurements is not surprising because data errors in this instrument have been widely
documented, especially at low blood flow [212]. Another shortcoming of this technique is
that it is unclear whether the measurements belong to a venous or arterial blood, although
some peaks seem in sync with the cardiac cycle. However, this is expected as the movement
of RBCs occurs during the systolic peak.
The position of this LDF sensor head helps understand the blood flow under microvascular
bed beneath the forearm. In there, it is possible to monitor microvessels like terminal
arterioles, metarterioles, capillaries, and venules. As described in section4.2.1, the sensor
was placed on the forearm midpoint between the iPG’s sensing electrodes but it is not possible
to assert with certainty the kind of blood being monitored, only the movement of RBCs in
that section of the skin.
The signal coming from the LDF device is similar to a plethysmography wave, which is
formed by the AC component on a DC signal. For the purpose of a correlation analysis of this
study, the DC component of this signal had to be removed, which only left the comparison
between of normalised AC magnitudes of the LDF and iPG signals. Similarly, as evidenced
in the previous analysis, the data was smoothed by taking the average value of 20 data points.
Due to the high level of noise of the signal in some participants, the data depicted in this
analysis belongs to participants 2, 5, 6 and 7.
Figure 7.9 illustrates the linear regression and BA analysis between both signals. Notably,
the data points show a poor correlation among both signals (r2 = 0.08). Most data points are
far from the line of equity and mostly spread across the plot x-axis. The data points from this
LDF signal are not well scattered around the figure. This imbalance can mostly be noticed
in the region 7. One plausible explanation of this effect is that the LDF peak extension is
impacted by the hyperaemic effect upon the release of total occlusion, as can be seen in
figure 7.4. Nonetheless, if this portion of the data were removed from the plot, there would
still be a weak agreement between both signals (r2 = 0.08).
Based on the BA chart, on the left can be observed poor linear correlation between
both normalised signals. On the right side of the figure, a poor accuracy is observed when
comparing the amplitude of both signals. Practically, all the data points are outside the
confidence area (±1.96SD). Therefore, it is not possible to establish any relation within the
magnitude waveform of these two instruments.
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7.3 Summary of the changes and correlations
The information presented in this chapter showed the changes in the clinical numeric values
of the different instruments used in the experiment. As the table 7.7 shows, all the instruments
were able to distinguish changes during venous occlusion, partial arterial and total occlusion.
This table indicates the percentile change between baseline and the following circulatory
occlusion, from the quantified value in clinical units.
Interestingly, the blood flow calculated from the iPG signal showed dramatic changes
throughout venous and partial arterial occlusions. For instance, during venous occlusion,
the iPG signal showed an increment in the estimated blood flow, which may be related
to the pooling effect of blood. Once again, during partial arterial occlusion, the blood
flow calculated from the iPG signal also surged but on a smaller scale. Which, it suggests a
differentiator between both type of occlusions. In contrast, all the other instruments illustrated
a decrease in all their measure units.
It is noticeable the change of values obtained from the other instruments. The Doppler
Ultrasound monitoring arterial blood flow perceived some restriction during venous occlusion
but effectively detected changes while partial arterial occlusion. The correlation between
Doppler and iPG suggests that the latter follows the arterial pulses during normal conditions
but the behaviour changes through occlusive periods. The optical methods also distinguished
changes in the course of venous and partial arterial occlusion. However, the settling values
between both occlusions are quite tight together, making it hard to identify variation values
between both occlusions.
One common point between all the instruments is the severe reduction of quantifiable
data during total occlusion. The Doppler ultrasound unquestionably showed nearly zero flow,
followed by PPG and iPG values. However, the LDF performed a bit poorly as the readings
were close to the ones during occlusive periods.
Table 7.7 Summary of the comparison between the changes of blood flow calculated from the iPG data, the
arterial flow from the Doppler modality, flux from LDU and volts from the PPG.
Method
Venous Occlusion
Region 1-2
Partial arterial occlusion
Region 3-4
Total occlusion
Region 5-6
Corr
iPG APA 32.84% 8.43% -70.58%
DU -19.21% -49.61% -99.75% r2 = 0.35
LDF -41.31% -29.43% -64.55% r2 = 0.08
PPG AC -70.42% -77.48% -86.38% r2 = 0.07
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7.4 Conclusion
This chapter described all the instrument’s waveform changes during the entire experiment
and their correlation with the iPG APA signal. The devices used in the experiment evinced
a different signal response following the technology used by each one of them. The data
obtained from these devices (except PPG) was converted into meaningful clinical units to
decipher the changes occurring in circulatory occlusion.
In general, the impedance APA waveform in units of blood flow showed apparent
amplitude changes characteristic of each occlusion. During venous occlusion in region
2, the blood rate increased by nearly 33 % when compared to the previous baseline in region
1. In contrast, during partial arterial occlusion, the calculated flow rate increased 8.4 % (on
average) in region 4. While the blood flow was expected to reduce as the normal artery flow
got restricted, the impedimetric measurement presented a slight surge in blood flow. In both
cases, it appears as if the rise in blood flow might be attributed to a vasodilation response
where the forearm veins’ cross-sectional area got enlarged, which allowed for blood pooling.
The extra blood flowing into the expanded vein may be viewed as a surge in the blood flow
rate.
The other methods also detected changes in the arterial and venous circulation. The
Doppler Ultrasound instrument perceived arterial flow changes during both partial arterial
and total occlusion. The arterial blood rate reduced to nearly 48.79±11.91 % throughout
partial arterial occlusion, and practically zero in the course of complete obstruction. However,
any miss-aligning between the device’s head and the vessel would introduce errors to the
measure.
The optical methods yielded data about the venous circulation. The LDF provided details
of the blood cells moving into the capillary bed, whereas the PPG in the red spectrum
correlated to the venous circulation. The LDF amplitude average signal displayed changes
during each occlusion. However, the high level of noise avoided identifying common trends
changes in all the participants. Regarding PPG, the DC component of the signal showed no
apparent distinction between venous and partial arterial occlusion (4.47 % voltage difference).
However, the AC signal showed a clear difference between both type of blockage with an
amplitude change of nearly 50 %.
The data correlation between the iPG arterial pulses and other instruments helps us
understand the kinds of blood that significantly contribute to the iPG signal. The data
from blood flow (per volume of tissue) quantified from the iPG data shown in section 7.1.2
highlighted increments in their respective systolic peaks all along the venous or partial
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arterial. Indeed, the systolic pulses during partial arterial occlusion were slightly higher than
the ones that occurred during venous occlusion — this information contrasted with the data
observed in Doppler Ultrasound measurements. As described in section 7.1.3 the arterial
flow was mostly affected when the blockage occurred at a point that was above diastolic
pressure. The amplitude of the iPG’s systolic pulses was also expected to decrease during
disturbances of the arterial flow due to restricted blood flow into the limb, but it actually
increased. One explanation could be that the body triggered a vasodilatory response when an
occlusion occurred where the veins’ cross-section area veins increments to accommodate
more blood into the tissue.
The response seen from the iPG signal is unique since other instruments exhibited a
reduction in their systolic peaks in a similar proportion. For instance, as shown in 7.1.4 and
7.1.5 both signals witnessed a reduction in their amplitudes during venous and partial arterial
occlusion. This same response can be attributed to the measurement of changes in the venous
blood, but not in the arterial. In fact, the decline in LDF amplitude suggests a reduction in
the velocity of RBC coming into the microcirculation. Additionally, this decline of the PPG
amplitude is indicative of a shift in blood volume activated by the venous occlusion. During
this experiment, the magnitude of PPG reduced significantly during partial arterial occlusion.
In general, it appears as though the arterial blood is a significant contributor of the iPG’s
APA signal by not merely detecting the arterial blood coming into the limb, but by also giving
an insight into how the tissue responded to a blood occlusion. The acceptable correlation
with the Doppler Ultrasound (r2 = 0.35) as shown in section 7.2.2, illustrated that the iPG
waveform amplitude did change with the arterial blood. Nevertheless, while reducing the
arterial blood, the forearm’s iPG waveform reacted differently, causing a spike in the systolic
magnitude possibly because of a venous response. When correlating the iPG data with optical
methods like PPG (see chapter 7.2.4) and LDF (see chapter 7.2.3), a low correlation was
found (r2 < 0.08); this was apparently caused by the different direction that the amplitudes
went towards during venous and arterial blood blockage. While the iPG increased, the optical
methods decreased. This reaction seems to indicate that the changes occurring in venous
blood presented an increase in the iPG amplitude pulses, probably due to an increase in the
vessels’ diameter during an occlusion.
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Chapter 8
General conclusion and future work
The primary objective of this thesis was to present a home diagnostic system that would be
capable of measuring changes in blood volume - and by extension flow - using bioelectrical
impedance. Such a system was realised in 4.1 in the form of a modular device which carried
out the required measurements and exhibited the capability of being used safely in a home
setting. The device functioned as expected within the stated operational characteristics. Some
of its key technological achievements and innovative features are highlighted as follows:
• Some of the studies described in the literature had used impedance devices that were
not explicitly designed to measure blood-related alterations in limbs. For instance,
some investigations used impedance cardiographers [23, 136, 120, 213], whereas other
circuits merely aimed to measure either basal impedance [20, 22, 102, 170, 120] or
arterial pulses [20, 21, 24, 25, 120, 214]. In comparison, the instrument presented in
this thesis is primarily focused on measuring impedance within the range of the limbs’
tissue [185], simultaneously measuring the changes in the basal impedance and arterial
pulses.
• Although some studies used either their circuits or IC designs to measure bioelectrical
impedance, most of their techniques focused on quadrature demodulation and the aver-
age DC value of the signal [215–217]. The method outlined in this thesis incorporates
the envelope demodulation with a super diode circuit; this returns the peak value of the
detected signals.
• Using envelope technique to measure the current amplitude and voltage from the limbs
reduces the need for calibration. This instrument continuously measures the amplitude
of the injected current and the voltage sensed from the limb’s segment. Thus, the
impedance was calculated directly from these two waveforms.
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• The iPG data presented in this literature are either basal impedance or arterial pulses.
Some instruments extract the arterial pulses from basal impedance, which results in
low-quality waveforms [20, 120]. The instrument separates the arterial pulses from
the forearm impedance via hardware. Thereafter, both signals are separately displayed
which provides the opportunity to analyse changes in both signals at the same time.
The instrument’s innovation presented in this thesis not only lies in the hardware design,
but also in the analysis of impedance plethysmography waveform. The protocol of this
experimental procedure described in section 4.2 impacted the blood flow towards the limb.
The instrument was able to effectively detect changes in the basal impedance as well as
arterial pulses, which is evidenced in chapters 5 and 6 respectively. More importantly,
clear changes could be detected in most participants when performing venous and partial
arterial occlusions. According to the author, considering the changes observed during this
experimental procedure, the following innovations can be derived:
• Although studies performing occlusive techniques have been carried out, they have
largely focused on the quantification of flow rate or volume heightened volume during
VOP [20–22]. However, none of these studies provided details on the rate of change
during either venous or partial arterial occlusion. In contrast, the analysis presented in
5 showed that the rate of change during partial arterial occurred occured more swiftly
than venous occlusion. This slope change may be one of the first indicators as to when
an arterial blockage may occur when it is continuously monitored.
• A study reported changes in the arterial pulses wave morphology during issues surfac-
ing in the lymphatic system [29], but based on the author’s understanding, no evidence
of analysis was furnished during the mechanical occlusion. As evident in this thesis,
it is clear that the morphology of this waveform varies in accordance to the type of
occlusion applied to the upper arm. The data demonstrated that during both kinds of
occlusions the systolic peak increased considerably. Thus, this might be an indicator of
irregular blood flow towards the limb. Moreover, the data revealed that a difference in
amplitude at the dicrotic notch as well as after pulse. During partial arterial occlusion,
the amplitude of these points was seen to be considerably lower than venous occlusion.
In fact, the information demonstrated that during partial arterial occlusion, the post
dicrotic amplitude tended to be of a lower magnitude when compared to dicrotic notch.
Therefore, this is a clear differentiator between the two kinds of occlusion.
• To the best of the author’s knowledge, no other study had previously been able to focus
on the methods for early detection of venous and arterial circulatory problems using
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iPG. After a quantitative as well as qualitative analysis of the basal impedance and
the arterial pulses, measuring the ratio between both signals in order to identify faster
alterations in the circulation was considered. It was demonstrated that there was a shift
in either basal impedance or APA morphology during each blockage. therefore, by
combining these two sets of information, it is possible to detect early changes in the
blood circulation.
8.1 Future work
The present work showed an initial prototype to measure iPG within an upper limb along
with the potential to detect circulatory problems in a limb. Nonetheless, some improvements
in hardware and software would be able to refine the full prototype. The author recommends
a comparative study between the device presented in this document and a commercial
impedance device. The results from this investigation will allow to validate the performance
of the iPG apparatus shown in this study.
Furthermore, clinical experiments are suggested to confirm whether the systemic body
response triggers changes in the iPG waveform differentiating between arterial and venous
components of the impedance signal. One suggested examination would be cold room
studies. In this kind of test, a cold environment may set off a sympathetic stimulation,
causing vasoconstriction in the skin, arms and legs [218]. The analysis should centre in the
changes of impedance baseline, as well as the three APA points signalled in this document.
Finally, the author considers that performing experiments in a clinical setting would
be beneficial to confirm the accuracy of the methodology presented here. Patients with
any peripheral vascular disease, arterial occlusive disease or lymphedema would be perfect
candidates to analyse their impedimetric waveforms.
8.1.1 Improvements of the iPG device
The device performed well during all the tests. However, there are items of interest that could
be implemented in future studies. From the standpoint of design, there is room to miniaturise
the instrument. A modular approach was used for this initial prototype. Nonetheless,
designing an integrated PCB, which could include the MCU on board along with a DAQ
system, would simplify the design considerably. Some challenges may arise for the design of
the board. During the PCB manufacturing, it was found that combining digital with analogue
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channels increased the crosstalk between signals. Therefore, special care must be undertaken
when designing a board of these characteristics.
In addition to this improvement, the device could accommodate a small set of batteries.
The instrument included battery packs of 12 V but it would be possible to achieve a better
portability if lower power banks were installed. Furthermore, using a small current could
be considered as an option to use a smaller battery bank. However, this may also lead to
additional challenges. For instance, the impedance magnitude will get closer to the floor noise
when using a lower electrical current. Therefore, the noise will cover the signal of interest.
Another potential improvement to the design will be analysing the signal phase. As is the case
with most bioelectrical impedance devices, the instrument only measured the magnitude of
the impedance. However, additional information about volume or flow haemodynamics may
be embedded within the phase shift data. Therefore, a channel dedicated to this phase could
be an interesting add-on for future research. Nonetheless, there are quite a few challenges to
achieve this. First, the phase shift at the frequency which the instrument was implemented
at is only 12° [180]. Therefore, the level of noise at that level can pose a serious challenge.
Using a higher frequency could be an option, but then that would affect the actual part of the
signal.
8.1.2 Waveform analysis under different conditions
The use of additional instruments provided insightful information on the changes in blood
volume, arterial flow and microcirculation. However, it could be of high interest to compare
the iPG waveforms and NIRS method. The latter can provide critical data about tissue
oxygenation, and within the basal impedance, reading yields information about the amount of
blood within the tissue. Therefore, the effectiveness of iPG in measuring perfusion changes
can be established and compared to an optic method.
The analysis of waveforms has divulged differences when calculating the blood flow
during both venous and partial arterial occlusion. The results that have been presented
throughout the course of this experiment suggested an increase of blood flow, which can only
be explained by a vasodilation caused by a syncopal response. However, performing cold
tests are recommended to investigate whether the narrowing of vessels also causes changes in
the dicrotic notch point. Analysing the waveform in legs could also be of high interest. Some
illnesses like diabetic food require constant monitoring of blood delivery towards the feet.
The instrument could be adjusted to take the measurements within the impedance level so as
to obtain a clear waveform signal. The changes in basal impedance and amplitude waveform
could lead to an accurate indicator of poor perfusion in the compromised limbs.
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Appendix A
Final assembly circuit
The figure A.1 shows the final circuit assembly. All these modules were fixed to a board, and
the different circuit stages were interconnected using jumper cables. In the same board, a
DAQ NI USB-6212 (National Instruments) was mounted to connect the output channels IDC,
ZDC and ZAC. Additionally, in order to ensure a cohesive system, the Arduino MCU was also
affixed and connected to the DDS module.
As inputs and outputs, the instrument includes data and power ports. The data ports have
two USB cables connected to the DAQ box and the Arduino PCB. They work as a digital
data bus and system command controller, respectively. The system is powered by the battery
bank using the PSU module. For this to happen, a 4-pins cable was designed as interface.
The electrodes cables run from the MHC and sensing boards. These cables were designed
using alligator clips that got hooked on to the electrodes end.
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Final assembly circuit
Figure A.1 Assembly of the bioelectrical impedance device showing all the modules, electrodes, DAQ and
MCU.
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Appendix B
Schematics of the iPG instrument
Power supply
The schematic circuits for the power supply designed are mentioned in the appendix B, figure
B. Operating the iPG device requires positive (VIN+) and negative (VIN-) supplies that can
be provided by any external power. For safety purposes, batteries were the source of choice.
The table 4.1 shows the components employed in the implementation, which operates within
the desired appropriate range as required by the device. The regulators LM3XX [219] are
voltage variable regulators. However, their output was set to ±12 V for each source using the
appropriate selection of resistors. The capacitors which were added to all the regulators were
selected in accordance to the manufacturer’s recommendation to evade the prospects of any
ripple at the output voltage.
In Altium Designer a PCB of 50 mm x 50 mm was produced considering input and ports
in addition to indicators and sensors. For instance, the ports included three input voltage
pins VIN+, VIN- and ground (GND) coming from the batteries, along with an eight-pin
male connector that provides regulated board to the next board. These indicators and sensors
included a dip-switch working as power ON/OFF button, a set of three red-LED indicating
the power of +12 V, -12 V and 5 V, and a three-pin port connected to the ADC port of the
microcontroller which monitors the batteries’ capacity. It also includes additional regulated
voltage ports in order to feed other external modules.
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Figure B.1 Top-up view of the power supply. Each box represents the Voltage regulators circuits. The schematic also includes indicators LED, switches and
output ports.
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Figure B.2 The schematic shows the configuration of the voltage regulator LM317, the resistors selected set the output voltage at 12 V. The capacitors filter
ripples from the batteries.
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Figure B.3 The schematic shows the configuration of the voltage regulator LM337, the resistors selected set the output voltage at -12 V. The capacitors filter
noise peaks.
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Figure B.4 The schematic shows the configuration of the voltage regulator AL117E50G, the output is fixed to 5 V. The capacitors filter noises from the power
bank.
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DDS
The figure B.5 shows the schematic used in the design of the wave generator. Owing to
the noise that a digital circuit would feed into an analogue system, a separate power supply
powers up this module. For this purpose, two voltage regulators (AP117E50G [220]) provide
5 V energy sources for digital and analogue components using two separated ground paths
(GND - AGND). In addition, a 3 V reference is needed for the oscillator to operate - which
is supplied by the IC REF196 [221]. The DDS requires an external clock in order to work.
Therefore, a 50 MHz oscillator provides the desired clock signal.
  
✁✁
✂✂
✄✄
☎
☎
✆
✆
✝
✝
✞
✞
✟✠✡☛
☞
✌✍
✎✏
☞✑
✒☞✓
✠✔✠✕
✖
✗✠✘
☞ ✞✄ ☎✙✡
☞✚
✂✛✜
✛✢✜
✁✛ 
✣
✗✤☞
☞✡
✕✥
✦✠☛☞
✚
✆ ✚✧
★✔☞
✑✔✧✩
✩✧✪✕
✫☞✑
✬✗✍
✭✭☛
✮✬✞
☎✯
✰✂✛
✩✗✱
✤☎✕
✱☎✑✙
✫✖
✝ ✮✚
✲
✳✌
✂
✴★
✟
✁
✴★
✟
✄
✞☎
✵
★✁
✞✪
  ✣
✶✯✛
✷
✁✁✍✆ ✯
✸✠✖
✹
✸✠✖
✺
✷✌
☎
✸✠✖
✺
✻✼
✽
✾✿
❀❁
✼❂
❃❄
❀✼
❅❆
❄❇
❈❉
❊❋
●❍
■■
❍❏
❑▲▼
◆❋■
❉❉
❍❊
▼■▼
◆❍
❖❈
❏❈◆
▼▲
P❖
❖
◗■❋
❘
❃❙
▼▲❋
❏P
❖❖
❚❄
❇❍
❃❖
❯❱
❲❳
●❈
▲▲❨
❍◗
❍❍
❩●
❈◆❇
❃P
❖❖
❬▼
❉●
❍▲▲
▼❉
✼❊
❭❃
❘❊
❈❙
◆❇❍
❉❪
❉◆❍
❘❚
❖❈
❏❈◆
▼▲
P❖
❖
❊■❋
❫❈❩
❍❉
❍❙
❍■❏
❪◆
❋ ❴
▲❋ ❴
❵❉
▼❙
❩❏
■❋❑
❙❩
❉●
❈▲▲
❨❍
❉❍❊
▼■▼
◆❍❩
❚❄
❇❍
■❍
❉❇
❋❑
▲❩
❨❍
❲❩
❈◗◗
❍■❍
❙◆
❛■
❋❑
❙❩
❉❍ ❴
◆❈❋
❙▼
❙▼
▲❋❏
❑❍
❜❃
❛❅
❖❝
❬❩
❈❏❈
◆▼▲
❜❖
❛❅
❖❝
▼❙
❩
❛❅
❖❚
☎✸
☎☎
✪✕✫
☞✑❞
✕❡✍
☛☞✔
✁✩✛
❞✙
✑✠✕
✷✩
✝ ☞❢
✙✑✙
✖✕
❞✩
 
❣
❤
✐
❥
❦
❧
♠
♥
♦
♦
♣q
✷✌
☎
✲
✳✌
✂
✴★
✟
✁
✴★
✟
✄
✞☎
✵
★ 
✞✪
  ✣
✶✯✛
✷
✁✁✍✆ ✣
✞✷
✌☎
✸✠✖
✺
✞✸
☎☎
✟✪
 
✟✪
✯
✌✆
✣
✴✍
✡✭✍
✡
✢
✗☛☞
☞✭
✂
✸✗
✁
✌✆
r
✷✌
☎
✄
★✂ ✒✶
✦ ✰
✢
 ✛✛
✖
✆  ✛
✷✌
☎
✸✠✖
✺
 ✛✛
✖
✆ ✄
✷✌
☎
 ✍✆ ✢
✸✂
✩✂
✷✌
☎
✷✌
☎
 ✁✂✄
✪  s☞✙
❡☞✑
✸✠✖
✹
✸✠✖
✺
✷✌
☎
 ✁✂✄
✪✁ s☞✙
❡☞✑
 ✛✍✆    ✛✍✆ ✂
 ✛✍✆ ✁
Figure B.5 The power supply circuit provides 3 different voltages 5 V for analogue and digital circuitry, and
3 V for voltage reference. There are three different ground paths for each source.
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Figure B.6 Schematic of the AD5930, it includes the 50 MHz oscillator and output filters.
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Differential gain amplifier
The IC AD8137 [222] was the main component of the DGA. Low tolerance resistors were
placed at each channel to achieve a steady gain at the output. Since the DGA needed a
separate power supply to operate within the limits of the batteries, a dual power supply of
6 V and -6 V was designed using the IC LF60CDT [223] and LM337 [219], respectively.
Since the latter is a variable voltage regulator, a set of resistors was used to adjust the level
of regulation to the desired level. The schematic circuits can be found in the appendix B,
figures B.8 and B.9
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Figure B.7 Differential gain amplifier controlled by 4 position dip-switch adjusting the gain of the signal
output.
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Figure B.8 Power supply circuit based on the IC LF60CDT.
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Figure B.9 Power supply circuit based on the IC LM337, the resistors were adjusted to achieve -6 V.
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Modified Howland circuit
The Op-Amp selected for this design was the AD8066 [224], a dual Op-Amp that offers
high bandwidth of 145 MHz, high input impedance of 1000 GΩ @ 4.5 pF, low noise of
7 nV/
√
Hz at 10 kHz, open loop gain of 113 dB and CMMR of -100 dB [224]. All these
characteristics made this Op-Amp an ideal choice to implement a MHC. The design also
included a dual power supply of 5 V and -5 V provided by the IC’s AP117E50G and L79L05,
respectively. The final circuit schematics, which include the MHC and power supplies, are
shown in figures B.12, B.10 and B.11. From that design, the PCB was produced using the
same manufacturing method of the previous ones.
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Figure B.10 Power supply circuit based on the IC AP117E50G.
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Figure B.11 Power supply circuit based on the fixed voltage regulator (-5 V) IC L79L05.
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Figure B.12 Differential gain amplifier controlled by 4 position dip-switch adjusting the gain of the signal output.
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Schematics of the iPG instrument
Voltage sense circuit
The In-Amp AD8421 [121] was used as the main component to sense current and voltage.
Some of this device’s features include the low noise of 3.2 nV/
√
Hz at 1 kHz, a high band-
width 10 MHz at a unitary gain, a high CMRR of 80 dB at 20 kHz and dual supply operation
within the range of the power supply designed. This component also benefits from adjustable
gain using external resistors between pin 2 and 3. In fact, a four dip-switch with four different
resistor values was included in the design process to increase the gain of the voltage detected
as shown here 4.4. Hence, if the device uses a small value of current (1.3 mA), it becomes
possible to adjust the gain derived at this stage to obtain a more accurate reading.
Figure B.13 The voltage sense circuit sense voltage from an unknown source. This same circuit was used to
sense the current driven by the MHC, as well as the potential from the load under test (unknown Z).
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Envelope detection circuits
The envelope or peak detection is achieved using the combination of an active diode con-
figuration and a hold circuit. The first part of this circuit was created using an Op-Amp
TL08XX [225] as well as a diode 1N4148 [226]. The combination creates a ”super diode” or
”perfect diode” circuit. Thus, the Op-Amp complements the diode’s voltage drop when the
signal crosses zero. The negative feedback resulting from the output of the diode towards the
negative pin of the Op-Amp mitigates the diode’s voltage drop. Resultantly, the output signal
at the cathode’s diode is essentially a half-wave rectified waveform crossing by zero. The
figure B.15 shows a model of this circuit.
Figure B.14 The iPG device has designed to work with two voltage channels ans one current channels sensor.
Each envelope detector extracts the peak detection, which output is passed to the output ports of the device.
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Figure B.15 The current of the MHC is converted to voltage which later can be detected by this circuit. The voltage detected from the current drives consist of
a perfect diode configuration based on a TL084 and a diode 1N4148. Then the signal is sampled and hold by a capacitor.The output is buffered to get a low
impedance output.
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APA waveform isolation
Figure B.16 shows the circuit used to isolate the Arterial Pulse Amplitude waveform. Follow-
ing that schematic, a high pass filter (HPF) is used to remove the signal’s DC components,
which is possible by implementing a passive filter composed by capacitor and resistor C4 and
R5, respectively. Notably, R5 is virtually connected to ground (GND) through the negative
pin of the Op-Amp. The cutting frequency of the HPF was calculated using the equation B.1
- which demonstrates that this circuit section practically blocks any DC component of the
impedance signal.
fc =
1
2πRC
=
1
2π330KΩ4.7µ f
= 10.26mHz (B.1)
Subsequently, a second order active filter eliminates any high-frequency noise occurring
within the plethysmography signal. The cut off frequencies were calculated as outlined in
equations B.2 and B.3. The first Op-Amp configuration is an inverting amplifier circuit with
a frequency cut at 10.61 Hz and a gain in DC of 30.30. The second Op-Amp configuration
10.26 Hz has an amplification factor in DC of 4.70.
In general, the extraction of the APA signal is achieved with a band-pass filter with
low-frequency cut at 10.26 mHz with a roll-off of 20 dB/decade as well as a high-frequency
cut at 10.26 Hz with a roll-off of 40 dB/decade. Finally, the final output was passed on to a
buffer configuring the channel VAC. The APA waveform is then amplified using a fixed gain
of 142.41.
fc =
1
2πRC
=
1
2π10MΩ1.5n f
= 10.61Hz (B.2)
fc =
1
2πRC
=
1
2π47KΩ330n f
= 10.26Hz (B.3)
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Figure B.16 The voltage detector consist of a perfect diode configuration based on a TL084 and a diode 1N4148. Then the signal is sampled and hold by a
capacitor. The output of this signal is later passed to a band-pass filter and a buffer.
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Appendix C
Arduino program to control DDS AD5930
1 /*
2 AD5930 Controller program
3
4 This program receives instructions via serial USB connection
from LabView or Matlab.
5 It communicates vias SPI portocol to the AD5930.
6
7 The Host PC send commands such as frequency Lock, start/stop
waveform.
8
9 modified 19 October 2015
10 by Mario Bejarano
11 City University London
12 */
13
14 #include "SPI.h"
15 int ss=10;
16 int del=200;
17 int incomingByte = 0;
18 int CTRL_pin=8;
19 int IPin=4;
20 int VPin=3;
21 int PhasePin=2;
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22 int Bank1 = 0;
23 int Bank2 = 1;
24 int val1=0;
25 int val2=0;
26 int val3=0;
27 int Battery1 = 0;
28 int Battery2 = 0;
29 int LED = 7;
30 String Z;
31 String frequ;
32
33 #define AD5930_F_MCLK 50000000 // 25MHz clock
34 #define AD5930_2POW28 16777216 // 2 to the power of
24
35
36 void setup()
37 {
38 Serial.begin(115200);
39 pinMode(VPin, INPUT);
40 pinMode(IPin, INPUT);
41 pinMode(PhasePin, INPUT);
42 pinMode(Bank1, INPUT);
43 pinMode(Bank2, INPUT);
44 pinMode(ss, OUTPUT);
45 pinMode(CTRL_pin, OUTPUT);
46 pinMode(LED, OUTPUT);
47 SPI.begin();
48 SPI.setBitOrder(MSBFIRST);
49 SPI.setDataMode(SPI_MODE2);
50 digitalWrite(ss, HIGH);
51 digitalWrite(CTRL_pin, LOW);
52 }
53
54 void setValue(int value)
55 {
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56 digitalWrite(ss, LOW);
57 SPI.transfer(0);
58 SPI.transfer(value);
59 digitalWrite(ss, HIGH);
60 }
61
62 void loop()
63 {
64 delay(100);
65 // send data only when you receive data:
66 if (Serial.available() > 0) {
67 // read the incoming byte:
68 char command = Serial.read(); //Read command
byte
69 long incommingData = Serial.parseInt(); //Read data
attached to it
70
71
72 if (Serial.read() == ’\n’) //Wait for newline (ENTER)
73 {
74 //Serial.print(command);
75 //Serial.print(incommingData);
76 if (command == ’A’)
77 {
78 //Serial.print("Data received:");
79 //Serial.println(incommingData);
80 calc_freq_reg(incommingData);
81 }
82 else if (command == ’B’)
83 {
84 CTRL_signal();
85 }
86 else if (command == ’C’)
87 {
88 val1 = analogRead(VPin);
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89 Serial.println(val1);
90 }
91 else if (command == ’D’) //Low BATTERY Control
92 {
93 val1 = analogRead(VPin);
94 val2 = analogRead(PhasePin);
95 String stringOne = "M";
96 String stringTwo = stringOne + val1;
97 // Serial.println(stringTwo);
98 String stringThree = "P";
99 String stringFour = stringThree + val2;
100 // Serial.println(stringFour);
101 String stringFive = stringTwo + stringFour;
102 Serial.println(stringFive);
103 if (val2 < 307)
104 {
105 digitalWrite(LED,HIGH);
106 Serial.println("Low Bat");
107 }
108 else
109 {
110 digitalWrite(LED,LOW);
111 Serial.println("Good Bat");
112 }
113 }
114 else if (command == ’E’)
115 {
116 val1 = analogRead(VPin);
117 val2 = analogRead(IPin);
118 val3 = analogRead(PhasePin);
119 String stringOne = "V";
120 String stringTwo = stringOne + val1;
121 // Serial.println(stringTwo);
122 String stringThree = "I";
123 String stringFour = stringThree + val2;
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124 // Serial.println(stringFour);
125 String stringFive = "P";
126 String stringSix = stringFive + val3;
127 String stringSeven = stringTwo + stringFour;
128 String stringEight = stringSeven + stringSix;
129 Serial.println(stringEight);
130 }
131 else if (command == ’F’)
132 {
133 Battery1 = analogRead(Bank1);
134 Battery2 = analogRead(Bank2);
135
136 String stringOne = "B1:";
137 float eq1 = (Battery1*5.0)/1024.0;
138 Serial.println(eq1);
139 float val1 = 3*eq1;
140 String stringTwo = stringOne + val1;
141 // Serial.println(stringTwo);
142 String stringThree = "B2:";
143 float eq2 = (Battery2*5.0)/1024.0;
144 Serial.println(eq2);
145
146 float val2 = (eq2 - 3.70535)/0.18445;
147 String stringFour = stringThree + val2;
148 // Serial.println(stringFour);
149 String stringFive = stringTwo + stringFour;
150 Serial.println(stringFive);
151 if (abs(val1) < 12)
152 {
153 digitalWrite(LED,HIGH);
154 Serial.println("Low Bat Bank1");
155 }
156 else if (abs(val2) < 12)
157 {
158 digitalWrite(LED,HIGH);
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159 Serial.println("Low Bat Bank2");
160 }
161 else
162 {
163 digitalWrite(LED,LOW);
164 Serial.println("Good Bat");
165 }
166 }
167 else if (command == ’X’)
168 {
169 Serial.println("Ok");
170 }
171 else
172 {
173 Serial.println(" is an incorrect command ");
174 }
175 }
176 }
177 }
178
179 void AD5930_Control(uint16_t control)
180 {
181 control = control & 0x3FFF; // Mask off upper 2
bits so we are writing to control register
182 control = control | 0x2000; // Ensure the B28
control register bit is set
183 Serial.print("Control command :");
184 Serial.println(control);
185 digitalWrite(ss, LOW); // Set FSYNC low
186 delayMicroseconds(5);
187 AD5930_Write(control);
188 digitalWrite(ss, HIGH); // Set FSYNC high
189 }
190
191 void AD5930_Write(uint16_t value)
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192 {
193 SPI.transfer(highByte(value));
194 SPI.transfer(lowByte(value));
195 }
196
197 void AD5930_Phase(uint32_t phase)
198 {
199 digitalWrite(ss, LOW); // Set FSYNC low
200 delayMicroseconds(5);
201 AD5930_Write(0xC000 | (0x1FFF & (uint16_t)(phase)));
202 AD5930_Write(0xE000 | (0x1FFF & (uint16_t)(phase>>12)));
203 digitalWrite(ss, HIGH); // Set FSYNC high
204 }
205
206 void AD5930_Raw(uint16_t value)
207 {
208 digitalWrite(ss, LOW); // Set FSYNC low
209 delayMicroseconds(5);
210 SPI.transfer(highByte(value));
211 SPI.transfer(lowByte(value));
212 digitalWrite(ss, HIGH); // Set FSYNC high
213 }
214
215 void calc_freq_reg(long freq)
216 {
217 int MSB;
218 int LSB;
219
220 AD5930_Raw(0x0FFF); // Reset
221 uint32_t AD5930Val = (uint32_t)(((freq/(double)
AD5930_F_MCLK))*(double)AD5930_2POW28);
222 MSB = (0xD000 | ((AD5930Val & 0xFFFF000)>>12));
223 LSB = (0xC000 | (AD5930Val & 0x0FFF));
224 AD5930_Raw(LSB);
225 AD5930_Raw(MSB);
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226 CTRL_signal();
227 }
228
229 void CTRL_signal()
230 {
231 digitalWrite(CTRL_pin, HIGH);
232 digitalWrite(CTRL_pin, LOW);
233 }
226
